{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:43:46Z","timestamp":1792079026906,"version":"4.4.0"},"reference-count":1332,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["pharmrev.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reviews"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1124\/pr.58.3.2","type":"journal-article","created":{"date-parts":[[2006,9,12]],"date-time":"2006-09-12T23:09:57Z","timestamp":1158102597000},"page":"389-462","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1800,"title":["The Endocannabinoid System as an Emerging Target of Pharmacotherapy"],"prefix":"10.1016","volume":"58","author":[{"given":"P\u00e1l","family":"Pacher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e1ndor","family":"B\u00e1tkai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Kunos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/pr.58.3.2_REF1","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1185\/030079905X46313","article-title":"Optimising antiemetic therapy: what are the problems and how can they be overcome?","volume":"21","author":"Aapro","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1124\/pr.58.3.2_REF2","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1378\/chest.70.4.480","article-title":"Effect of oral administration of \u0394-tetrahydrocannabinol on airway mechanics in normal and asthmatic subjects","volume":"70","author":"Abboud","year":"1976","journal-title":"Chest"},{"key":"10.1124\/pr.58.3.2_REF3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0091-6773(75)91684-3","article-title":"Cannabis: effects on hunger and thirst","volume":"15","author":"Abel","year":"1975","journal-title":"Behav Biol"},{"key":"10.1124\/pr.58.3.2_REF4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0304-3940(01)02065-1","article-title":"Activation of the CB1 cannabinoid receptor protects cultured mouse spinal neurons against excitotoxicity","volume":"309","author":"Abood","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.1124\/pr.58.3.2_REF5","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1097\/01.TP.0000131164.43015.4B","article-title":"De novo malignancies after intestinal and multivisceral transplantation","volume":"77","author":"Abu-Elmagd","year":"2004","journal-title":"Transplantation"},{"key":"10.1124\/pr.58.3.2_REF6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0165-5728(99)00149-6","article-title":"Dexanabinol (HU-211) effect on experimental autoimmune encephalomyelitis: implications for the treatment of acute relapses of multiple sclerosis","volume":"102","author":"Achiron","year":"2000","journal-title":"J Neuroimmunol"},{"key":"10.1124\/pr.58.3.2_REF7","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1038\/sj.bjp.0704625","article-title":"Gastric antisecretory role and immunohistochemical localization of cannabinoid receptors in the rat stomach","volume":"135","author":"Adami","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1476-5381.1976.tb06957.x","article-title":"Tolerance to the cardiovascular effects of \u03949-tetrahydrocannabinol in the rat","volume":"56","author":"Adams","year":"1976","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF9","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1007\/BF01922330","article-title":"A cannabinoid with cardiovascular activity but no overt behavioral effects","volume":"33","author":"Adams","year":"1977","journal-title":"Experientia (Basel)"},{"key":"10.1124\/pr.58.3.2_REF10","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1096\/fj.05-3995fje","article-title":"The endocannabinoid system drives neural progenitor proliferation","volume":"19","author":"Aguado","year":"2005","journal-title":"FASEB J"},{"key":"10.1124\/pr.58.3.2_REF11","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1523\/JNEUROSCI.3101-05.2006","article-title":"The endocannabinoid system promotes astroglial differentiation by acting on neural progenitor cells","volume":"26","author":"Aguado","year":"2006","journal-title":"J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF12","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0301-0082(02)00080-1","article-title":"Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids","volume":"68","author":"Alger","year":"2002","journal-title":"Prog Neurobiol"},{"key":"10.1124\/pr.58.3.2_REF13","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1535-7597.2004.04501.x","article-title":"Endocannabinoids and their implications for epilepsy","volume":"4","author":"Alger","year":"2004","journal-title":"Epilepsy Curr"},{"key":"10.1124\/pr.58.3.2_REF14","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1136\/gut.2003.036350","article-title":"Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse","volume":"53","author":"Allen","year":"2005","journal-title":"Gut"},{"key":"10.1124\/pr.58.3.2_REF15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11060-004-5950-2","article-title":"Cannabinoids selectively inhibit proliferation and induce death of cultured human glioblastoma multiforme cells","volume":"74","author":"Allister","year":"2005","journal-title":"J Neurooncol"},{"key":"10.1124\/pr.58.3.2_REF16","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1056\/NEJM199810293391808","article-title":"Medical management of glaucoma","volume":"339","author":"Alward","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1124\/pr.58.3.2_REF17","doi-asserted-by":"crossref","unstructured":"Amaya F, Shimosato G, Kawasaki Y, Hashimoto S, Tanaka Y, and Ji RR (2006) Induction of CB(1) cannabinoid receptor by inflammation in primary afferent neurons facilitates antihyperalgesic effect of peripheral CB(1) agonist. Pain, in press.","DOI":"10.1016\/j.pain.2006.04.001"},{"key":"10.1124\/pr.58.3.2_REF18","first-page":"14","article-title":"Anticonvulsant effect of cannabidiol","volume":"69","author":"Ames","year":"1986","journal-title":"S Afr Med J"},{"key":"10.1124\/pr.58.3.2_REF19","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/0006-8993(95)00645-7","article-title":"The cannabinoid agonists WIN 55,212-2 and CP 55,940 attenuate rotational behavior induced by a dopamine D1 but not a D2 agonist in rats with unilateral lesions of the nigrostriatal pathway","volume":"691","author":"Anderson","year":"1995","journal-title":"Brain Res"},{"key":"10.1124\/pr.58.3.2_REF20","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/S0140-6736(87)92620-1","article-title":"Cannabis and schizophrenia: a longitudinal study of Swedish conscripts","volume":"2","author":"Andreasson","year":"1987","journal-title":"Lancet"},{"key":"10.1124\/pr.58.3.2_REF21","first-page":"2083","article-title":"Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial","volume":"289","author":"Appel","year":"2003","journal-title":"J Am Med Assoc"},{"key":"10.1124\/pr.58.3.2_REF22","first-page":"253","article-title":"The cannabinoids: therapeutic potentials","volume":"9","author":"Archer","year":"1974","journal-title":"Annu Rev Med Chem"},{"key":"10.1124\/pr.58.3.2_REF23","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0091-3057(01)00578-0","article-title":"Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters","volume":"70","author":"Arevalo","year":"2001","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pr.58.3.2_REF24","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1523\/JNEUROSCI.23-07-02511.2003","article-title":"Therapeutic action of cannabinoids in a murine model of multiple sclerosis","volume":"23","author":"Arevalo-Martin","year":"2003","journal-title":"J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF25","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s002130050326","article-title":"Selective inhibition of sucrose and ethanol intake by SR141716, an antagonist of central cannabinoid (CB1) receptors","volume":"132","author":"Arnone","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1124\/pr.58.3.2_REF26","doi-asserted-by":"crossref","first-page":"8432","DOI":"10.1523\/JNEUROSCI.1289-05.2005","article-title":"Cannabinoid action depends on phosphorylation of dopamine- and cAMP-regulated phosphoprotein of 32 kDa at the protein kinase A site in striatal projection neurons","volume":"25","author":"Andersson","year":"2005","journal-title":"J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF27","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/bja\/83.4.637","article-title":"Adverse effects of cannabis and cannabinoids","volume":"83","author":"Ashton","year":"1999","journal-title":"Br J Anaesth"},{"key":"10.1124\/pr.58.3.2_REF28","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/0269881105051541","article-title":"Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential","volume":"19","author":"Ashton","year":"2005","journal-title":"J Psychopharmacol"},{"key":"10.1124\/pr.58.3.2_REF29","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1365-2125.1981.tb01294.x","article-title":"The seed and the soil: effect of dosage, personality and starting state on the response to \u03949 tetrahydrocannabinol in man","volume":"12","author":"Ashton","year":"1981","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF30","first-page":"540","article-title":"Preliminary trial of carisoprodol in multiple sclerosis","volume":"192","author":"Ashworth","year":"1964","journal-title":"Practitioner"},{"key":"10.1124\/pr.58.3.2_REF31","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S1090-3801(03)00084-3","article-title":"Are oral cannabinoids safe and effective in refractory neuropathic pain?","volume":"8","author":"Attal","year":"2004","journal-title":"Eur J Pain"},{"key":"10.1124\/pr.58.3.2_REF32","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.nbd.2005.07.008","article-title":"Endocannabinoids affect neurological and cognitive function in thioacetamide-induced hepatic encephalopathy in mice","volume":"1","author":"Avraham","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1124\/pr.58.3.2_REF33","first-page":"H520","article-title":"Is there a role for anandamide in cardiovascular regulation? Insights from studies of endocannabinoid metabolism","volume":"289","author":"Awumey","year":"2005","journal-title":"Am J Physiol"},{"key":"10.1124\/pr.58.3.2_REF34","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1101\/lm.53303","article-title":"Activation of the cannabinoid receptor type 1 decreases glutamatergic and GABAergic synaptic transmission in the lateral amygdala of the mouse","volume":"10","author":"Azad","year":"2003","journal-title":"Learn Mem"},{"key":"10.1124\/pr.58.3.2_REF35","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1517\/13543784.12.4.561","article-title":"The therapeutic potential of cannabis in multiple sclerosis","volume":"12","author":"Baker","year":"2003","journal-title":"Expert Opin Invest Drugs"},{"key":"10.1124\/pr.58.3.2_REF36","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/35003583","article-title":"Cannabinoids control spasticity and tremor in a multiple sclerosis model","volume":"404","author":"Baker","year":"2000","journal-title":"Nature (Lond)"},{"key":"10.1124\/pr.58.3.2_REF37","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1096\/fj.00-0399fje","article-title":"Endocannabinoids control spasticity in a multiple sclerosis model","volume":"15","author":"Baker","year":"2001","journal-title":"FASEB J"},{"key":"10.1124\/pr.58.3.2_REF38","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s00213-005-0251-9","article-title":"Role of the cannabinoid system in the effects induced by nicotine an anxiety-like behaviour in mice","volume":"184","author":"Balerio","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1124\/pr.58.3.2_REF39","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/sj.tpj.6500352","article-title":"(AAT)n repeat in the cannabinoid receptor gene (CNR1): association with cocaine addiction in an African-Caribbean population","volume":"6","author":"Ballon","year":"2006","journal-title":"Pharmacogenonics J"},{"key":"10.1124\/pr.58.3.2_REF40","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.pnpbp.2004.05.021","article-title":"Neuropsychopharmacology and the genetics of schizophrenia: a history of the diagnosis of schizophrenia","volume":"28","author":"Ban","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1124\/pr.58.3.2_REF41","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/sj.bjp.0704829","article-title":"Direct inhibition by cannabinoids of human 5-HT3A receptors: probable involvement of an allosteric modulatory site","volume":"137","author":"Barann","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF42","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrd1330","article-title":"Neurodegenerative diseases and oxidative stress","volume":"3","author":"Barnham","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/pr.58.3.2_REF43","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/BF02815406","article-title":"Neuroprotective activity of HU-211, a novel NMDA antagonist, in global ischemia in gerbils","volume":"23","author":"Bar-Joseph","year":"1994","journal-title":"Mol Chem Neuropathol"},{"key":"10.1124\/pr.58.3.2_REF44","first-page":"47","article-title":"The effects of marijuana on human sleep patterns","volume":"8","author":"Barratt","year":"1974","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pr.58.3.2_REF45","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1093\/jnci\/90.16.1198","article-title":"Histopathologic and molecular alterations in bronchial epithelium in habitual smokers of marijuana, cocaine, and\/or tobacco","volume":"90","author":"Barsky","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1124\/pr.58.3.2_REF46","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0006-8993(98)01072-5","article-title":"Down-regulation of cannabinoid receptor agonist-stimulated [35S]GTP\u03b3S binding in synaptic plasma membrane from chronic ethanol exposed mice","volume":"815","author":"Basavarajappa","year":"1999","journal-title":"Brain Res"},{"key":"10.1124\/pr.58.3.2_REF47","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1054\/plef.2001.0352","article-title":"Neuromodulatory role of the endocannabinoid signaling system in alcoholism: an overview","volume":"66","author":"Basavarajappa","year":"2002","journal-title":"Prostaglandins Leukotrienes Essent Fatty Acids"},{"key":"10.1124\/pr.58.3.2_REF48","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.neuropharm.2005.12.005","article-title":"Increased ethanol consumption and preference and decreased sensitivity in female FAAH knockout mice","volume":"50","author":"Basavarajappa","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.58.3.2_REF49","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/00001756-199904060-00010","article-title":"Characterization of the hypnotic properties of oleamide","volume":"10","author":"Basile","year":"1999","journal-title":"Neuroreport"},{"key":"10.1124\/pr.58.3.2_REF50","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/89953","article-title":"Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis","volume":"7","author":"B\u00e1tkai","year":"2001","journal-title":"Nat Med"},{"key":"10.1124\/pr.58.3.2_REF51","first-page":"H595","article-title":"Cannabinoid antagonist SR141716 inhibits endotoxic hypotension by a cardiac mechanism not involving CB1 or CB2 receptors","volume":"287","author":"B\u00e1tkai","year":"2004","journal-title":"Am J Physiol"},{"key":"10.1124\/pr.58.3.2_REF52","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1161\/01.CIR.0000143230.23252.D2","article-title":"Endocannabinoids acting at CB1 receptors regulate cardiovascular function in hypertension","volume":"110","author":"B\u00e1tkai","year":"2004","journal-title":"Circulation"},{"key":"10.1124\/pr.58.3.2_REF53","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0749-0704(03)00014-9","article-title":"Traumatic brain injury in infants and children: mechanisms of secondary damage and treatment in the intensive care unit","volume":"19","author":"Bayir","year":"2003","journal-title":"Crit Care Clin"},{"key":"10.1124\/pr.58.3.2_REF54","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0885-3924(94)00117-4","article-title":"Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS","volume":"10","author":"Beal","year":"1995","journal-title":"J Pain Symptom Manage"},{"key":"10.1124\/pr.58.3.2_REF55","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0885-3924(97)00038-9","article-title":"Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia","volume":"14","author":"Beal","year":"1997","journal-title":"J Pain Symptom Manage"},{"key":"10.1124\/pr.58.3.2_REF56","doi-asserted-by":"crossref","first-page":"46188","DOI":"10.1074\/jbc.M307258200","article-title":"G protein-coupled endothelial receptor for atypical cannabinoid ligands modulates a Ca2+-dependent K+ current","volume":"278","author":"Begg","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.58.3.2_REF57","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pharmthera.2004.11.005","article-title":"Evidence for novel cannabinoid receptors","volume":"106","author":"Begg","year":"2005","journal-title":"Pharmacol Ther"},{"key":"10.1124\/pr.58.3.2_REF58","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1093\/brain\/awf180","article-title":"Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation","volume":"125","author":"Behrens","year":"2002","journal-title":"Brain"},{"key":"10.1124\/pr.58.3.2_REF59","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0304-3940(01)01591-9","article-title":"Activation of CB1 cannabinoid receptors in rat hippocampal slices inhibits potassium-evoked cholecystokinin release, a possible mechanism contributing to the spatial memory defects produced by cannabinoids","volume":"301","author":"Beinfeld","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.1124\/pr.58.3.2_REF60","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF02815084","article-title":"HU-211, a nonpsychotropic cannabinoid, improves neurological signs and reduces brain damage after severe forebrain ischemia in rats","volume":"25","author":"Belayev","year":"1995","journal-title":"Mol Chem Neuropathol"},{"key":"10.1124\/pr.58.3.2_REF61","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/0006-8993(95)01127-9","article-title":"Post-ischemic administration of HU-211, a novel non-competitive NMDA antagonist, protects against blood-brain barrier disruption in photochemical cortical infarction in rats: a quantitative study","volume":"702","author":"Belayev","year":"1995","journal-title":"Brain Res"},{"key":"10.1124\/pr.58.3.2_REF62","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1161\/01.STR.26.12.2313","article-title":"HU-211, a novel noncompetitive N-methyl-d-aspartate antagonist, improves neurological deficit and reduces infarct volume after reversible focal cerebral ischemia in the rat","volume":"26","author":"Belayev","year":"1995","journal-title":"Stroke"},{"key":"10.1124\/pr.58.3.2_REF63","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1126\/science.277.5329.1094","article-title":"Functional role of high-affinity anandamide transport, as revealed by selective inhibition","volume":"277","author":"Beltramo","year":"1997","journal-title":"Science (Wash DC)"},{"key":"10.1124\/pr.58.3.2_REF64","doi-asserted-by":"crossref","first-page":"11136","DOI":"10.1523\/JNEUROSCI.23-35-11136.2003","article-title":"Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer\u2019s disease brains","volume":"23","author":"Benito","year":"2003","journal-title":"J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF65","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/cpt1975183287","article-title":"Cardiovascular effects of prolonged delta-9-tetrahydrocannabinol ingestion","volume":"18","author":"Benowitz","year":"1975","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/pr.58.3.2_REF65a","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0014-2999(98)00392-6","article-title":"An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity","volume":"353","author":"Ben-Shabat","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF67","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1124\/mol.63.4.908","article-title":"The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa\/fa rats and in cultured adipocyte cells","volume":"63","author":"Bensaid","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF68","doi-asserted-by":"crossref","first-page":"PL125","DOI":"10.1016\/S0024-3205(98)00324-5","article-title":"Effects of cannabinoid receptor ligands on LPS-induced pulmonary inflammation in mice","volume":"63","author":"Berdyshev","year":"1998","journal-title":"Life Sci"},{"key":"10.1124\/pr.58.3.2_REF69","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1046\/j.1471-4159.2003.02244.x","article-title":"Massive accumulation of N-acylethanolamines after stroke: cell signalling in acute cerebral ischemia?","volume":"88","author":"Berger","year":"2004","journal-title":"J Neurochem"},{"key":"10.1124\/pr.58.3.2_REF70","doi-asserted-by":"crossref","first-page":"19115","DOI":"10.1073\/pnas.0509494102","article-title":"Endocannabinoids regulate interneuron migration and morphogenesis by transactivating the TrkB receptor","volume":"102","author":"Berghuis","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.58.3.2_REF71","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1526-4637.2006.00085.x","article-title":"Experience with the synthetic cannabinoid nabilone in chronic noncancer pain","volume":"7","author":"Berlach","year":"2006","journal-title":"Pain Med"},{"key":"10.1124\/pr.58.3.2_REF72","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.pain.2004.09.013","article-title":"Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial","volume":"112","author":"Berman","year":"2004","journal-title":"Pain"},{"key":"10.1124\/pr.58.3.2_REF73","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00213-002-1144-9","article-title":"Involvement of the opioid system in the anxiolytic-like effects induced by Delta(9)-tetrahydrocannabinol.\u03949-tetrahydrocannabinol","volume":"163","author":"Berrendero","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pr.58.3.2_REF74","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/syn.1075","article-title":"Changes in cannabinoid CB1 receptors in striatal and cortical regions of rats with experimental allergic encephalomyelitis, an animal model of multiple sclerosis","volume":"41","author":"Berrendero","year":"2001","journal-title":"Synapse"},{"key":"10.1124\/pr.58.3.2_REF75","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0163-7258(02)00257-7","article-title":"Tetrahydrocannabinol and endocannabinoids in feeding and appetite","volume":"95","author":"Berry","year":"2002","journal-title":"Pharmacol Ther"},{"key":"10.1124\/pr.58.3.2_REF76","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/35086062","article-title":"Pathophysiology of levodopa-induced dyskinesia: potential for new therapies","volume":"2","author":"Bezard","year":"2001","journal-title":"Nat Rev Neurosci"},{"key":"10.1124\/pr.58.3.2_REF77","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1200\/JCO.2001.19.2.464","article-title":"Solid cancers after bone marrow transplantation","volume":"19","author":"Bhatia","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1124\/pr.58.3.2_REF78","first-page":"H181","article-title":"Improved techniques for cardiovascular monitoring in rats as applied during endotoxemia","volume":"254","author":"Biber","year":"1988","journal-title":"Am J Physiol"},{"key":"10.1124\/pr.58.3.2_REF79","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.2337\/diabetes.54.5.1314","article-title":"Effects of diet and genetic background on sterol regulatory element-binding protein-1c, stearoyl-CoA desaturase 1, and the development of the metabolic syndrome","volume":"54","author":"Biddinger","year":"2005","journal-title":"Diabetes"},{"key":"10.1124\/pr.58.3.2_REF80","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1521-6616(03)00064-0","article-title":"Ajulemic acid, a nonpsychoactive cannabinoid acid, induces apoptosis in human T lymphocytes","volume":"108","author":"Bidinger","year":"2003","journal-title":"Clin Immunol"},{"key":"10.1124\/pr.58.3.2_REF81","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1365-2362.2004.01331.x","article-title":"Vasodilator mRNA levels are increased in the livers of portal hypertensive NO-synthase 3-deficient mice","volume":"34","author":"Biecker","year":"2004","journal-title":"Eur J Clin Investig"},{"key":"10.1124\/pr.58.3.2_REF82","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.2174\/1381612043384196","article-title":"Cannabinoids as neuroprotective agents in traumatic brain injury","volume":"10","author":"Biegon","year":"2004","journal-title":"Curr Pharm Des"},{"key":"10.1124\/pr.58.3.2_REF83","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nm0602-547","article-title":"Targeting the endocannabinoid system in cancer therapy: a call for further research","volume":"8","author":"Bifulco","year":"2002","journal-title":"Nat Med"},{"key":"10.1124\/pr.58.3.2_REF84","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1096\/fj.01-0320fje","article-title":"Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth","volume":"15","author":"Bifulco","year":"2001","journal-title":"FASEB J"},{"key":"10.1124\/pr.58.3.2_REF85","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1096\/fj.04-1754fje","article-title":"A new strategy to block tumor growth by inhibiting endocannabinoid inactivation","volume":"18","author":"Bifulco","year":"2004","journal-title":"FASEB J"},{"key":"10.1124\/pr.58.3.2_REF86","doi-asserted-by":"crossref","first-page":"15670","DOI":"10.1073\/pnas.0504640102","article-title":"Early age-related cognitive impairment in mice lacking cannabinoid CB1 receptors","volume":"102","author":"Bilkei-Gorzo","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.58.3.2_REF87","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1096\/fj.05-4743fje","article-title":"Increasing cannabinoid levels by pharmacological and genetic manipulation delay disease progression in SOD1 mice","volume":"20","author":"Bilsland","year":"2006","journal-title":"FASEB J"},{"key":"10.1124\/pr.58.3.2_REF88","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1476-5381.1973.tb08236.x","article-title":"Reduction by 9-tetrahydrocannabinol in the blood pressure of hypertensive rats bearing regenerated adrenal glands","volume":"48","author":"Birmingham","year":"1973","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF89","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1006\/bbrc.1999.0254","article-title":"Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function","volume":"256","author":"Bisogno","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/pr.58.3.2_REF90","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1006\/abbi.1999.1410","article-title":"Biosynthesis and inactivation of N-arachidonoylethanolamine (anandamide) and N-docosahexaenoylethanolamine in bovine retina","volume":"370","author":"Bisogno","year":"1999","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/pr.58.3.2_REF91","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","article-title":"Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide","volume":"134","author":"Bisogno","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF92","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1083\/jcb.200305129","article-title":"Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain","volume":"163","author":"Bisogno","year":"2003","journal-title":"J Cell Biol"},{"key":"10.1124\/pr.58.3.2_REF93","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.pbb.2005.01.027","article-title":"The endocannabinoid signaling system: biochemical aspects","volume":"81","author":"Bisogno","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pr.58.3.2_REF94","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1074\/jbc.272.6.3315","article-title":"Biosynthesis, uptake and degradation of anandamide and palmitoylethanolamide in leukocytes","volume":"272","author":"Bisogno","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.58.3.2_REF94a","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1042\/bj3510817","article-title":"N-Acyl-dopamines: novel synthetic CB1 cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo","volume":"351","author":"Bisogno","year":"2000","journal-title":"Biochem J"},{"key":"10.1124\/pr.58.3.2_REF94ab","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1006\/bbrc.1998.8874","article-title":"Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase","volume":"248","author":"Bisogno","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/pr.58.3.2_REF94abc","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1096\/fj.02-0795fje","article-title":"Inhibition of tumor angiogenesis by cannabinoids","volume":"17","author":"Bl\u00e1zquez","year":"2003","journal-title":"FASEB J"},{"key":"10.1124\/pr.58.3.2_REF94abcd","doi-asserted-by":"crossref","first-page":"5617","DOI":"10.1158\/0008-5472.CAN-03-3927","article-title":"Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas","volume":"64","author":"Bl\u00e1zquez","year":"2004","journal-title":"Cancer Res"},{"key":"10.1124\/pr.58.3.2_REF99","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0083-6729(08)60985-1","article-title":"Effects of cannabinoids on reproduction and development","volume":"36","author":"Bloch","year":"1978","journal-title":"Vitam Horm"},{"key":"10.1124\/pr.58.3.2_REF100","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0022-3565(25)30767-6","article-title":"9-Nor-9\u03b2-hydroxyhexahydrocannabinol a cannabinoid with potent antinociceptive activity: comparisons with morphine","volume":"200","author":"Bloom","year":"1977","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.58.3.2_REF101","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2174\/138161280404221010152220","article-title":"Oleamide: an endogenous sleep-inducing lipid and prototypical member of a new class of biological signaling molecules","volume":"4","author":"Boger","year":"1998","journal-title":"Curr Pharm Des"},{"key":"10.1124\/pr.58.3.2_REF102","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1021\/jm049614v","article-title":"Discovery of a potent, selective, and efficacious class of reversible \u03b1-ketoheterocycle inhibitors of fatty acid amide hydrolase effective as analgesics","volume":"48","author":"Boger","year":"2005","journal-title":"J Med Chem"},{"key":"10.1124\/pr.58.3.2_REF103","doi-asserted-by":"crossref","first-page":"4810","DOI":"10.1073\/pnas.95.9.4810","article-title":"Chemical requirements for inhibition of gap junction communication by the biologically active lipid oleamide","volume":"95","author":"Boger","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.58.3.2_REF104","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/00005344-200304000-00020","article-title":"Cannabinoids acting on CB1 receptors decrease contractile performance in human atrial muscle","volume":"41","author":"Bonz","year":"2003","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF105","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.pbb.2004.02.020","article-title":"Functional responses to the cannabinoid agonist WIN 55,212-2 in neonatal rats of both genders: influence of weaning","volume":"78","author":"Borcel","year":"2004","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pr.58.3.2_REF106","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0952-3278(96)90100-3","article-title":"Cerebrodiene, arachidonylethanolamide, and hybrid structures: potential for interaction with brain cannabinoid receptors","volume":"55","author":"Boring","year":"1996","journal-title":"Prostaglandins Leukotrienes Essent Fatty Acids"},{"key":"10.1124\/pr.58.3.2_REF107","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1590\/S1516-31802004000300007","article-title":"Possible hepatotoxicity of chronic marijuana usage","volume":"122","author":"Borini","year":"2004","journal-title":"Sao Paulo Med J"},{"key":"10.1124\/pr.58.3.2_REF108","doi-asserted-by":"crossref","unstructured":"Bortolato M, Campolongo P, Mangieri RA, Scattoni ML, Frau R, Trezza V, La Rana G, Russo R, Calignano A, Gessa GL, et al. (2006) Anxiolytic-like properties of the anandamide transport inhibitor AM404. Neuropsychopharmacology, in press.","DOI":"10.1038\/sj.npp.1301061"},{"key":"10.1124\/pr.58.3.2_REF109","doi-asserted-by":"crossref","first-page":"20397","DOI":"10.1074\/jbc.274.29.20397","article-title":"Regulation of peripheral cannabinoid receptor CB2 phosphorylation by the inverse agonist SR 144528: implications for receptor biological responses","volume":"274","author":"Bouaboula","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.58.3.2_REF110","doi-asserted-by":"crossref","first-page":"22330","DOI":"10.1074\/jbc.272.35.22330","article-title":"A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1: evidence for a new model of receptor\/ligand interactions","volume":"272","author":"Bouaboula","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.58.3.2_REF111","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/S0024-3205(02)02474-8","article-title":"Contribution of endocannabinoids in the endothelial protection afforded by ischemic preconditioning in the isolated rat heart","volume":"72","author":"Bouchard","year":"2003","journal-title":"Life Sci"},{"key":"10.1124\/pr.58.3.2_REF112","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1126\/science.1076535","article-title":"Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling","volume":"298","author":"Bracey","year":"2002","journal-title":"Science (Wash DC)"},{"key":"10.1124\/pr.58.3.2_REF113","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.phrs.2004.07.009","article-title":"3,4-Methylenedioxymethamphetamine-induced conditioned place preference (CPP) is mediated by endocannabinoid system","volume":"51","author":"Braida","year":"2005","journal-title":"Pharmacol Res"},{"key":"10.1124\/pr.58.3.2_REF114","first-page":"227","article-title":"Intracerebral self-administration of the cannabinoid receptor agonist CP 55,940 in the rat: interaction with the opioid system","volume":"413","author":"Braida","year":"2001","journal-title":"Neuroscience"},{"key":"10.1124\/pr.58.3.2_REF115","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/sj.bjp.0704825","article-title":"Role of the endocannabinoid system in MDMA intracerebral self-administration in rats","volume":"136","author":"Braida","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF116","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1017\/S0033291700042938","article-title":"Hallucinogenic drugs as precipitants of schizophrenia","volume":"4","author":"Breakey","year":"1974","journal-title":"Psychol Med"},{"key":"10.1124\/pr.58.3.2_REF117","doi-asserted-by":"crossref","first-page":"82s","DOI":"10.1002\/j.1552-4604.2002.tb06007.x","article-title":"Short-term effects of cannabinoids on immune phenotype and function in HIV-1-infected patients","volume":"42","author":"Bredt","year":"2002","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF118","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0026-895X(24)23059-5","article-title":"Evidence for a new G protein-coupled cannabinoid receptor in mouse brain","volume":"60","author":"Breivogel","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF119","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/S0022-3565(24)36967-8","article-title":"Regional differences in cannabinoid receptor\/G-protein coupling in rat brain","volume":"282","author":"Breivogel","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.58.3.2_REF120","first-page":"446","article-title":"The effect of orally and rectally administered \u03949-tetrahydrocannabinol on spasticity: a pilot study with 2 patients","volume":"34","author":"Brenneisen","year":"1996","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1124\/pr.58.3.2_REF121","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/sj.bjp.0704110","article-title":"The synthetic cannabinoid WIN55,212-2 attenuates hyperalgesia and allodynia in a rat model of neuropathic pain","volume":"133","author":"Bridges","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF122","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0024-3205(82)90416-7","article-title":"Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty","volume":"31","author":"Britton","year":"1982","journal-title":"Life Sci"},{"key":"10.1124\/pr.58.3.2_REF123","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S1471-4892(02)00011-5","article-title":"CB1 cannabinoid receptor signalling in Parkinson\u2019s disease","volume":"3","author":"Brotchie","year":"2003","journal-title":"Curr Opin Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF124","unstructured":"Brown A and Wise A (2003) inventors, GlaxoSmithKline, assignee. Identification of modulators of gpr55 activity. U.S. patent 20030113814. Jun 19, 2003."},{"key":"10.1124\/pr.58.3.2_REF125","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/0002-9394(77)90732-2","article-title":"Pupil size after use of marijuana and alcohol","volume":"83","author":"Brown","year":"1977","journal-title":"Am J Ophthalmol"},{"key":"10.1124\/pr.58.3.2_REF126","doi-asserted-by":"crossref","first-page":"90S","DOI":"10.1002\/j.1552-4604.2002.tb06008.x","article-title":"Endocrine effects of marijuana","volume":"42","author":"Brown","year":"2002","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF127","first-page":"108","article-title":"Soft cannabinoid analogues as potential anti-glaucoma agents","volume":"57","author":"Buchwald","year":"2002","journal-title":"Pharmazie"},{"key":"10.1124\/pr.58.3.2_REF128","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0014-2999(00)00211-9","article-title":"Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB2 receptor","volume":"396","author":"Buckley","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF129","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0304-3959(03)00331-2","article-title":"Lack of analgesic efficacy of oral \u0394-9-tetrahydrocannabinol in postoperative pain","volume":"106","author":"Buggy","year":"2003","journal-title":"Pain"},{"key":"10.1124\/pr.58.3.2_REF130","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/0028-3908(82)90071-5","article-title":"Effects of acute \u03949-THC administration on EEG and EEG power spectra in the rat","volume":"21","author":"Buonamici","year":"1982","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.58.3.2_REF131","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1523\/JNEUROSCI.5404-03.2004","article-title":"Expression of cannabinoid CB1 receptors by vagal afferent neurons is inhibited by cholecystokinin","volume":"24","author":"Burdyga","year":"2004","journal-title":"J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF132","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3181\/00379727-210-43926","article-title":"Differential inhibition of RAW264.7 macrophage tumoricidal activity by \u03949tetrahydrocannabinol: differential inhibition of RAW264.7 macrophage tumoricidal activity by \u03949tetrahydrocannabinol","volume":"210","author":"Burnette-Curley","year":"1995","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1124\/pr.58.3.2_REF133","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1345\/aph.1G217","article-title":"Cannabinoid analgesia as a potential new therapeutic option in the treatment of chronic pain","volume":"40","author":"Burns","year":"2006","journal-title":"Ann Pharmacother"},{"key":"10.1124\/pr.58.3.2_REF134","doi-asserted-by":"crossref","first-page":"E143","DOI":"10.1208\/aapsj070115","article-title":"Ajulemic acid (IP-751): synthesis, proof of principle, toxicity studies, and clinical trials","volume":"7","author":"Burstein","year":"2005","journal-title":"AAPS J"},{"key":"10.1124\/pr.58.3.2_REF135","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.2174\/1381612003399473","article-title":"Ajulemic acid (CT3): a potent analog of the acid metabolites of THC","volume":"6","author":"Burstein","year":"2000","journal-title":"Curr Pharm Des"},{"key":"10.1124\/pr.58.3.2_REF136","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1021\/jm00095a007","article-title":"Synthetic nonpsychotropic cannabinoids with potent antiinflammatory, analgesic, and leukocyte antiadhesion activities","volume":"35","author":"Burstein","year":"1992","journal-title":"J Med Chem"},{"key":"10.1124\/pr.58.3.2_REF137","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0024-3205(98)00256-2","article-title":"Analgesic effects of 1\u2032,1\u2032 dimethylheptyl-\u03948-THC-11-oic acid (CT3) in mice","volume":"63","author":"Burstein","year":"1998","journal-title":"Life Sci"},{"key":"10.1124\/pr.58.3.2_REF138","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.lfs.2004.04.010","article-title":"Ajulemic acid: a novel cannabinoid produces analgesia without a \u201chigh.\u201d","volume":"75","author":"Burstein","year":"2004","journal-title":"Life Sci"},{"key":"10.1124\/pr.58.3.2_REF139","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF00422507","article-title":"Analgesic activity of \u03949-tetrahydrocannabinol in the rat and mouse","volume":"25","author":"Buxbaum","year":"1972","journal-title":"Psychopharmacology"},{"key":"10.1124\/pr.58.3.2_REF140","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/0024-3205(94)90122-8","article-title":"Inhibition of macrophage inducible protein expression by \u0394-9-tetrahydrocannabinol","volume":"54","author":"Cabral","year":"1994","journal-title":"Life Sci"},{"key":"10.1124\/pr.58.3.2_REF141","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3181\/00379727-182-42325","article-title":"Effect of \u03949-tetrahydrocannabinol on herpes simplex virus type 2 vaginal infection in the guinea pig","volume":"182","author":"Cabral","year":"1986","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1124\/pr.58.3.2_REF142","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/0024-3205(95)00190-H","article-title":"Anandamide inhibits macrophage-mediated killing of tumor necrosis factor-sensitive cells","volume":"56","author":"Cabral","year":"1995","journal-title":"Life Sci"},{"key":"10.1124\/pr.58.3.2_REF143","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1523\/JNEUROSCI.17-04-01226.1997","article-title":"Occurrence and biosynthesis of endogenous cannabinoid precursor N-arachidonoyl phosphatidylethanolamine in rat brain","volume":"17","author":"Cadas","year":"1997","journal-title":"J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF144","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/sj.npp.1300848","article-title":"Cannabinoid modulation of opiate reinforcement through the ventral striatopallidal pathway","volume":"31","author":"Caill\u00e9","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.58.3.2_REF145","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0014-2999(02)01487-5","article-title":"Cannabinoid CB1 receptor blockade enhances the protective effect of melanocortins in hemorrhagic shock in the rat","volume":"441","author":"Cainazzo","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF146","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/35040576","article-title":"Bidirectional control of airway responsiveness by endogenous cannabinoids","volume":"408","author":"Calignano","year":"2000","journal-title":"Nature (Lond)"},{"key":"10.1124\/pr.58.3.2_REF147","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/S0014-2999(97)01297-1","article-title":"Potentiation of anandamide hypotension by the transport inhibitor: AM404","volume":"337","author":"Calignano","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF148","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/28393","article-title":"Control of pain initiation by endogenous cannabinoids","volume":"394","author":"Calignano","year":"1998","journal-title":"Nature (Lond)"},{"key":"10.1124\/pr.58.3.2_REF149","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0091-3057(95)00050-7","article-title":"Serotonin-3 receptor and ethanol-stimulated dopamine release in the nucleus accumbens","volume":"51","author":"Campbell","year":"1995","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pr.58.3.2_REF150","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/bmj.323.7303.13","article-title":"Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review","volume":"323","author":"Campbell","year":"2001","journal-title":"BMJ"},{"key":"10.1124\/pr.58.3.2_REF151","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1079\/BJN20041256","article-title":"Potential modulation of plasma ghrelin and glucagon-like peptide-1 by anorexigenoc cannabinoid compounds, SR141716A (rimonabant) and oleoylethanolamide","volume":"92","author":"Cani","year":"2004","journal-title":"Br J Nutr"},{"key":"10.1124\/pr.58.3.2_REF152","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1101\/lm.77904","article-title":"CB1 cannabinoid receptors modulate kinase and phosphatase activity during extinction of conditioned fear in mice","volume":"11","author":"Cannich","year":"2004","journal-title":"Learn Mem"},{"key":"10.1124\/pr.58.3.2_REF153","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1053\/j.gastro.2005.06.018","article-title":"Fatty acid amide hydrolase controls mouse intestinal motility in vivo","volume":"129","author":"Capasso","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1124\/pr.58.3.2_REF154","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/1097-0142(19900901)66:5<1005::AID-CNCR2820660535>3.0.CO;2-H","article-title":"Marijuana smoking and carcinoma of the tongue: is there an association?","volume":"66","author":"Caplan","year":"1990","journal-title":"Cancer"},{"key":"10.1124\/pr.58.3.2_REF155","first-page":"1","article-title":"Anticonvulsant activity of four oxygenated cannabidiol derivatives","volume":"12","author":"Carlini","year":"1975","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF156","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1567-5769(01)00147-3","article-title":"Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation","volume":"2","author":"Carlisle","year":"2002","journal-title":"Int Immunopharmacol"},{"key":"10.1124\/pr.58.3.2_REF157","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ccr.2006.03.005","article-title":"The stress-regulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells","volume":"9","author":"Carracedo","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1124\/pr.58.3.2_REF158","doi-asserted-by":"crossref","first-page":"7895","DOI":"10.1073\/pnas.0511232103","article-title":"Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression","volume":"103","author":"Carrier","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.58.3.2_REF159","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1177\/104990910101800411","article-title":"Marijuana in the management of amyotrophic lateral sclerosis","volume":"18","author":"Carter","year":"2001","journal-title":"Am J Hosp Palliat Care"},{"key":"10.1124\/pr.58.3.2_REF160","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1172\/JCI200316116","article-title":"Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors","volume":"111","author":"Casanova","year":"2003","journal-title":"J Clin Investig"},{"key":"10.1124\/pr.58.3.2_REF161","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0028-3908(02)00118-1","article-title":"Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence","volume":"43","author":"Castane","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.58.3.2_REF162","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0014-2999(02)02830-3","article-title":"Differential distribution of functional cannabinoid CB1 receptors in the mouse gastroenteric tract","volume":"459","author":"Casu","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF163","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1476-5381.1992.tb14321.x","article-title":"Cannabinoid receptor agonists inhibit Ca current in NG108-15 neuroblastoma cells via a pertussis toxin-sensitive mechanism","volume":"106","author":"Caulfield","year":"1992","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF164","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0014-2999(72)90027-1","article-title":"Parasympatholytic activity of (-)-9-trans-tetrahydrocannabinol in mongrel dogs","volume":"19","author":"Cavero","year":"1972","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF165","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.neuroscience.2005.03.006","article-title":"Subthalamic nucleus lesion reverses motor abnormalities and striatal glutamatergic overactivity in experimental parkinsonism","volume":"133","author":"Centonze","year":"2005","journal-title":"Neuroscience"},{"key":"10.1124\/pr.58.3.2_REF166","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0031-9384(04)00302-6","article-title":"Cannabinoid (CB)1 receptor antagonist, AM 251, causes a sustained reduction of daily food intake in the rat","volume":"82","author":"Chambers","year":"2003","journal-title":"Physiol Behav"},{"key":"10.1124\/pr.58.3.2_REF167","doi-asserted-by":"crossref","first-page":"942","DOI":"10.3109\/00365529709011206","article-title":"Prognostic value of plasma endotoxin levels in patients with cirrhosis","volume":"32","author":"Chan","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"10.1124\/pr.58.3.2_REF168","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/sj.bjp.0706699","article-title":"Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms","volume":"148","author":"Chang","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF169","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s002130050518","article-title":"Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats","volume":"135","author":"Chaperon","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1124\/pr.58.3.2_REF170","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1038\/sj.bjp.0702758","article-title":"The cannabinoid CB1 receptor antagonist, SR141716A, selectively facilitates nociceptive responses of dorsal horn neurones in the rat","volume":"127","author":"Chapman","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF171","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0306-4522(00)00241-4","article-title":"Lack of response suppression follows repeated ventral tegmental cannabinoid administration: an in vitro electrophysiological study","volume":"99","author":"Cheer","year":"2000","journal-title":"Neuroscience"},{"key":"10.1124\/pr.58.3.2_REF172","doi-asserted-by":"crossref","first-page":"7033","DOI":"10.1093\/emboj\/20.24.7033","article-title":"Direct inhibition of T-type calcium channels by the endogenous cannabinoid anandamide","volume":"20","author":"Chemin","year":"2001","journal-title":"EMBO (Eur Mol Biol Organ) J"},{"key":"10.1124\/pr.58.3.2_REF173","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.bbrc.2005.03.095","article-title":"Finding of endocannabinoids in human eye tissues: implications for glaucoma","volume":"330","author":"Chen","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/pr.58.3.2_REF174","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/BF02245916","article-title":"\u03949-Tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely moving rats, as measured by intracerebral microdialysis","volume":"102","author":"Chen","year":"1990","journal-title":"Psychopharmacology"},{"key":"10.1124\/pr.58.3.2_REF175","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0896-6273(03)00499-9","article-title":"Long-term plasticity of endocannabinoid signaling induced by developmental febrile seizures","volume":"39","author":"Chen","year":"2003","journal-title":"Neuron"},{"key":"10.1124\/pr.58.3.2_REF176","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.brainres.2003.12.004","article-title":"Synergistic effects of cannabinoid inverse agonist AM251 and opioid antagonist nalmefene on food intake in mice","volume":"999","author":"Chen","year":"2004","journal-title":"Brain Res"},{"key":"10.1124\/pr.58.3.2_REF177","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0022-3565(24)39301-2","article-title":"Cannabinoids protect cells from oxidative cell death: a receptor-independent mechanism","volume":"293","author":"Chen","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.58.3.2_REF178","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s00210-002-0684-1","article-title":"Selective versus non-selective suppression of nitric oxide synthase on regional hemodynamics in rats with or without LPS-induced endotoxemia","volume":"367","author":"Cheng","year":"2003","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF179","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/hmg\/ddh216","article-title":"Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug use","volume":"13","author":"Chiang","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1124\/pr.58.3.2_REF180","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1001\/archopht.121.1.87","article-title":"Effect of WIN 55212-2, a cannabinoid receptor agonist, on aqueous humor dynamics in monkeys","volume":"121","author":"Chien","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1124\/pr.58.3.2_REF181","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1528-1157.1979.tb04816.x","article-title":"The influence of cannabidiol and \u03949-tetrahydrocannabinol on cobalt epilepsy in rats","volume":"20","author":"Chiu","year":"1979","journal-title":"Epilepsia"},{"key":"10.1124\/pr.58.3.2_REF182","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1001\/archpsyc.1974.01760070014002","article-title":"Psychotic reactions following cannabis use in East Indians","volume":"30","author":"Chopra","year":"1974","journal-title":"Arch Gen Psychiatry"},{"key":"10.1124\/pr.58.3.2_REF183","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1111\/j.1460-9568.2005.04056.x","article-title":"The Cannabinoid CB1 receptor antagonism reduces conditioned reinstatement of ethanol-seeking behavior in rats","volume":"21","author":"Cippitelli","year":"2005","journal-title":"Eur J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF184","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1210\/endo-115-1-427","article-title":"Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats","volume":"115","author":"Clark","year":"1984","journal-title":"Endocrinology"},{"key":"10.1124\/pr.58.3.2_REF185","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0304-3959(01)00454-7","article-title":"CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain","volume":"96","author":"Clayton","year":"2002","journal-title":"Pain"},{"key":"10.1124\/pr.58.3.2_REF186","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1523\/JNEUROSCI.23-09-03916.2003","article-title":"Increased seizure susceptibility and proconvulsant activity of anandamide in mice lacking fatty acid amide hydrolase","volume":"23","author":"Clement","year":"2003","journal-title":"J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF187","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/ana.410130616","article-title":"Tetrahydrocannabinol for tremor in multiple sclerosis","volume":"13","author":"Clifford","year":"1983","journal-title":"Ann Neurol"},{"key":"10.1124\/pr.58.3.2_REF188","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/sj.npp.1300541","article-title":"Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: reversal by the cannabinoid (CB1) receptor antagonist rimonabant (SR141716)","volume":"30","author":"Cohen","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.58.3.2_REF189","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00008877-200209000-00018","article-title":"SR141716, a central cannabinoid (CB1) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats","volume":"13","author":"Cohen","year":"2002","journal-title":"Behav Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF190","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0091-3057(82)90418-X","article-title":"Effects of marihuana cannabinoids on seizure activity in cobalt-epileptic rats","volume":"16","author":"Colasanti","year":"1982","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pr.58.3.2_REF191","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/0306-3623(84)90202-7","article-title":"Ocular hypotension, ocular toxicity, and neurotoxicity in response to marihuana extract and cannabidiol","volume":"15","author":"Colasanti","year":"1984","journal-title":"Gen Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF192","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0014-4835(84)90013-7","article-title":"Intraocular pressure, ocular toxicity and neurotoxicity after administration of cannabinol or cannabigerol","volume":"39","author":"Colasanti","year":"1984","journal-title":"Exp Eye Res"},{"key":"10.1124\/pr.58.3.2_REF193","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0014-4835(84)90139-8","article-title":"Intraocular pressure, ocular toxicity and neurotoxicity after administration of \u03949-tetrahydrocannabinol or cannabichromene","volume":"38","author":"Colasanti","year":"1984","journal-title":"Exp Eye Res"},{"key":"10.1124\/pr.58.3.2_REF194","doi-asserted-by":"crossref","first-page":"PL113","DOI":"10.1016\/S0024-3205(98)00322-1","article-title":"Appetite suppression and weight loss after the cannabinoid antagonist SR 141716","volume":"63","author":"Colombo","year":"1998","journal-title":"Life Sci"},{"key":"10.1124\/pr.58.3.2_REF195","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/oxfordjournals.alcalc.a008368","article-title":"Reduction of voluntary ethanol intake in ethanol preferring sP rats by the cannabinoid antagonist SR141716A","volume":"33","author":"Colombo","year":"1998","journal-title":"Alcohol Alcohol"},{"key":"10.1124\/pr.58.3.2_REF196","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s002130100887","article-title":"Stimulation of voluntary ethanol intake by cannabinoid receptor agonists in ethanol-preferring sP rats","volume":"159","author":"Colombo","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1124\/pr.58.3.2_REF197","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.pbb.2005.01.022","article-title":"Endocannabinoid system and alcohol addiction: pharmacological studies","volume":"81","author":"Colombo","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pr.58.3.2_REF198","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ejphar.2004.03.065","article-title":"Suppression by baclofen of the stimulation of alcohol intake induced by morphine and WIN 55,212-2 in alcohol-preferring rats","volume":"492","author":"Colombo","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF199","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0140-6736(02)08220-X","article-title":"Multiple sclerosis","volume":"359","author":"Compston","year":"2002","journal-title":"Lancet"},{"key":"10.1124\/pr.58.3.2_REF200","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1006\/nbdi.1998.0220","article-title":"Brain cannabinoid systems as targets for the therapy of neurological disorders","volume":"5","author":"Consroe","year":"1998","journal-title":"Neurobiol Dis"},{"key":"10.1124\/pr.58.3.2_REF201","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/0091-3057(91)90386-G","article-title":"Controlled clinical trial of cannabidiol in Huntington\u2019s disease","volume":"40","author":"Consroe","year":"1991","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pr.58.3.2_REF202","doi-asserted-by":"crossref","first-page":"428S","DOI":"10.1002\/j.1552-4604.1981.tb02623.x","article-title":"Antiepileptic potential of cannabidiol analogs","volume":"21","author":"Consroe","year":"1981","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF203","first-page":"59","article-title":"Anticonvulsant and neurotoxic effects of tetrahydrocannabinol stereoisomers","volume":"79","author":"Consroe","year":"1987","journal-title":"NIDA Res Monogr"},{"key":"10.1124\/pr.58.3.2_REF204","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000112901","article-title":"The perceived effects of smoked cannabis on patients with multiple sclerosis","volume":"38","author":"Consroe","year":"1997","journal-title":"Eur Neurol"},{"key":"10.1124\/pr.58.3.2_REF205","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0022-3565(25)30824-4","article-title":"Cannabidiol-antiepileptic drug comparisons and interactions in experimentally induced seizures in rats","volume":"201","author":"Consroe","year":"1977","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.58.3.2_REF206","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/jama.1975.03260160054015","article-title":"Anticonvulsant nature of marihuana smoking","volume":"234","author":"Consroe","year":"1975","journal-title":"J Am Med Assoc"},{"key":"10.1124\/pr.58.3.2_REF207","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ygyno.2003.12.040","article-title":"Arachidonyl ethanolamide induces apoptosis of uterine cervix cancer cells via aberrantly expressed vanilloid receptor-1","volume":"93","author":"Contassot","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1124\/pr.58.3.2_REF208","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1093\/jnen\/63.9.956","article-title":"Arachidonylethanolamide induces apoptosis of human glioma cells through vanilloid receptor-1","volume":"63","author":"Contassot","year":"2004","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1124\/pr.58.3.2_REF209","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1528-1157.1978.tb05011.x","article-title":"Antiepileptic and prophylactic effects of tetrahydrocannabinols in amygdaloid kindled rats","volume":"19","author":"Corcoran","year":"1978","journal-title":"Epilepsia"},{"key":"10.1124\/pr.58.3.2_REF210","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2174\/1389557054368790","article-title":"The role of cannabinoid system on immune modulation: therapeutic implications on CNS inflammation","volume":"5","author":"Correa","year":"2005","journal-title":"Mini Rev Med Chem"},{"key":"10.1124\/pr.58.3.2_REF211","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s002109900135","article-title":"Inhibitory effect of the cannabinoid receptor agonist WIN 55,212-2 on pentagastrin-induced gastric acid secretion in the anaesthetized rat","volume":"360","author":"Coruzzi","year":"1999","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF212","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0166-4328(00)00311-9","article-title":"Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse","volume":"118","author":"Cossu","year":"2001","journal-title":"Behav Brain Res"},{"key":"10.1124\/pr.58.3.2_REF213","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s00210-004-0871-3","article-title":"Oral anti-inflammatory activity of cannabidiol, a non-psychoactive constituent of cannabis, in acute carrageenan-induced inflammation in the rat paw","volume":"369","author":"Costa","year":"2004","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF214","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/sj.bjp.0705587","article-title":"Repeated treatment with the synthetic cannabinoid WIN 55,212-2 reduces both hyperalgesia and production of pronociceptive mediators in a rat model of neuropathic pain","volume":"141","author":"Costa","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF215","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1172\/JCI17725","article-title":"The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis","volume":"112","author":"Cota","year":"2003","journal-title":"J Clin Investig"},{"key":"10.1124\/pr.58.3.2_REF216","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/cne.10270","article-title":"Localisation of cannabinoid CB1 receptor immunoreactivity in the guinea pig and rat myenteric plexus","volume":"448","author":"Coutts","year":"2002","journal-title":"J Comp Neurol"},{"key":"10.1124\/pr.58.3.2_REF217","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.coph.2004.05.007","article-title":"The gastrointestinal pharmacology of cannabinoids: an update","volume":"4","author":"Coutts","year":"2004","journal-title":"Curr Opin Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF218","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1038\/sj.bjp.0701301","article-title":"Inhibition by cannabinoid receptor agonists of acetylcholine release from the guinea-pig myenteric plexus","volume":"121","author":"Coutts","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF219","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejphar.2004.04.022","article-title":"The antinociceptive effect of \u03949-tetrahydrocannabinol in the arthritic rat","volume":"493","author":"Cox","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF220","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1126\/science.7901908","article-title":"Oxidative stress, glutamate, and neurodegenerative disorders","volume":"262","author":"Coyle","year":"1993","journal-title":"Science (Wash DC)"},{"key":"10.1124\/pr.58.3.2_REF221","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1038\/sj.bjp.0704651","article-title":"The sleep hormone oleamide modulates inhibitory ionotropic receptors in mammalian CNS in vitro","volume":"135","author":"Coyne","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF222","doi-asserted-by":"crossref","first-page":"9371","DOI":"10.1073\/pnas.161191698","article-title":"Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase","volume":"98","author":"Cravatt","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.58.3.2_REF223","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/384083a0","article-title":"Molecular characterization of an enzyme that degrades neuromodulatory fattyacid amides","volume":"384","author":"Cravatt","year":"1996","journal-title":"Nature (Lond)"},{"key":"10.1124\/pr.58.3.2_REF224","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1126\/science.7770779","article-title":"Chemical characterization of a family of brain lipids that induce sleep","volume":"268","author":"Cravatt","year":"1995","journal-title":"Science (Wash DC)"},{"key":"10.1124\/pr.58.3.2_REF225","doi-asserted-by":"crossref","first-page":"10821","DOI":"10.1073\/pnas.0401292101","article-title":"Functional disassociation of the central and peripheral fatty acid amide signaling systems","volume":"101","author":"Cravatt","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.58.3.2_REF226","first-page":"191","article-title":"Effects of tetrahydrocannabinol on arterial and intraocular hypertension","volume":"17","author":"Crawford","year":"1979","journal-title":"Int J Clin Pharmacol Biopharm"},{"key":"10.1124\/pr.58.3.2_REF227","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/0091-3057(93)90230-Q","article-title":"Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents","volume":"46","author":"Crawley","year":"1993","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pr.58.3.2_REF228","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/sj.bjp.0705412","article-title":"Role of cannabinoid CB1 receptors and tumor necrosis factor-\u03b1 in the gut and systemic anti-inflammatory activity of SR 141716 (rimonabant) in rodents","volume":"140","author":"Croci","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF229","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/01.icu.0000156136.20570.eb","article-title":"Glaucoma medication and aqueous humor dynamics","volume":"16","author":"Crowston","year":"2005","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1124\/pr.58.3.2_REF230","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2165\/00023210-200317030-00004","article-title":"Therapeutic potential of cannabinoids in CNS disease","volume":"17","author":"Croxford","year":"2003","journal-title":"CNS Drugs"},{"key":"10.1124\/pr.58.3.2_REF231","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1172\/JCI200317652","article-title":"Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R+WIN55,212","volume":"111","author":"Croxford","year":"2003","journal-title":"J Clin Investig"},{"key":"10.1124\/pr.58.3.2_REF232","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jneuroim.2005.04.023","article-title":"Cannabinoids and the immune system: potential for the treatment of inflammatory diseases?","volume":"166","author":"Croxford","year":"2005","journal-title":"J Neuroimmunol"},{"key":"10.1124\/pr.58.3.2_REF233","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2174\/1570161054368616","article-title":"Role of oxidative and nitrosative stress, longevity genes and poly(ADP-ribose) polymerase in cardiovascular dysfunction associated with aging","volume":"3","author":"Csiszar","year":"2005","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF234","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000307682","article-title":"Action of \u0394-9-tetrahydrocannabinol on ophthalmotonus","volume":"172","author":"Cuendet","year":"1976","journal-title":"Ophthalmologica"},{"key":"10.1124\/pr.58.3.2_REF235","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000137430","article-title":"Chronic administration of cannabidiol to healthy volunteers and epileptic patients","volume":"21","author":"Cunha","year":"1980","journal-title":"Pharmacology"},{"key":"10.1124\/pr.58.3.2_REF236","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jchemneu.2006.01.005","article-title":"A novel population of progenitor cells expressing cannabinoid receptors in the subependymal layer of the adult normal and Huntington\u2019s disease human brain","volume":"31","author":"Curtis","year":"2006","journal-title":"J Chem Neuroanat"},{"key":"10.1124\/pr.58.3.2_REF237","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0022-3565(24)35067-0","article-title":"1\u2032,1\u2032-Dimethylheptyl-\u0394-8-tetrahydrocannabinol-11-oic acid: a novel, orally effective cannabinoid with analgesic and antiinflammatory properties","volume":"291","author":"Dajani","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.58.3.2_REF238","unstructured":"Dale LC and Anthenelli RM (2004) Rimonabant as an aid to smoking cessation in smokers motivated to quit: results from a U.S. Multicenter Study\u2014STRATUS U.S. Trial, in Proceedings of the Annual Scientific Session of the American College of Cardiology; 2004 March 7-10; New Orleans, LA."},{"key":"10.1124\/pr.58.3.2_REF239","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/hup.560","article-title":"Comorbid cannabis use and panic disorder: short term and long term follow-up study","volume":"19","author":"Dannon","year":"2004","journal-title":"Hum Psychopharmacol"},{"key":"10.1124\/pr.58.3.2_REF240","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1096\/fj.05-4943fje","article-title":"Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation","volume":"20","author":"D\u2019Argenio","year":"2006","journal-title":"FASEB J"},{"key":"10.1124\/pr.58.3.2_REF241","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0893-133X(00)00197-4","article-title":"\u03949-Tetrahydrocannabinol and synthetic cannabinoids prevent emesis produced by the cannabinoid CB1 receptor antagonist\/inverse agonist SR 141716A","volume":"24","author":"Darmani","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.58.3.2_REF242","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0091-3057(01)00531-7","article-title":"\u0394-9-Tetrahydrocannabinol differentially suppresses cisplatin-induced emesis and indices of motor function via cannabinoid CB1 receptors in the least shrew","volume":"69","author":"Darmani","year":"2001","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pr.58.3.2_REF243","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1073\/pnas.92.10.4332","article-title":"Cannabinoid ligand-receptor signaling in the mouse uterus","volume":"92","author":"Das","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.58.3.2_REF244","doi-asserted-by":"crossref","first-page":"48973","DOI":"10.1074\/jbc.M305697200","article-title":"A predominant role for inhibition of the adenylate cyclase\/protein kinase A pathway in ERK activation by cannabinoid receptor 1 in N1E-115 neuroblastoma cells","volume":"278","author":"Davis","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.58.3.2_REF245","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0306-4522(00)00552-2","article-title":"Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use","volume":"103","author":"Dean","year":"2001","journal-title":"Neuroscience"},{"key":"10.1124\/pr.58.3.2_REF246","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.brainres.2004.02.016","article-title":"Involvement of vanilloid-like receptors in the effects of anandamide on motor behavior and nigrostriatal dopaminergic activity: in vivo and in vitro evidence","volume":"1007","author":"de Lago","year":"2004","journal-title":"Brain Res"},{"key":"10.1124\/pr.58.3.2_REF247","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.euroneuro.2005.06.001","article-title":"UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington\u2019s disease and multiple sclerosis, but fails to delay\/arrest the progression of different motor-related disorders","volume":"16","author":"de Lago","year":"2006","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1124\/pr.58.3.2_REF248","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0014-2999(02)01996-9","article-title":"UCM707, a potent and selective inhibitor of endocannabinoid uptake, potentiates hypokinetic and antinociceptive effects of anandamide","volume":"449","author":"de Lago","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF249","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ejphar.2003.11.027","article-title":"In vivo pharmacological actions of two novel inhibitors of anandamide cellular uptake","volume":"484","author":"de Lago","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF249a","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.brainres.2005.05.024","article-title":"Arvanil, a hybrid endocannabinoid and vanilloid compound, behaves as an antihyperkinetic agent in a rat model of Huntington\u2019s disease","volume":"1050","author":"de Lago","year":"2005","journal-title":"Brain Res"},{"key":"10.1124\/pr.58.3.2_REF251","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1476-511X-2-5","article-title":"Endocannabinoid signalling in the blood of patients with schizophrenia","volume":"2","author":"De Marchi","year":"2003","journal-title":"Lipids Health Dis"},{"key":"10.1124\/pr.58.3.2_REF251a","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0014-5793(00)02082-2","article-title":"Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity","volume":"483","author":"De Petrocellis","year":"2000","journal-title":"FEBS Lett"},{"key":"10.1124\/pr.58.3.2_REF253","doi-asserted-by":"crossref","first-page":"8375","DOI":"10.1073\/pnas.95.14.8375","article-title":"The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation","volume":"95","author":"De Petrocellis","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.58.3.2_REF254","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.tips.2005.06.002","article-title":"Cannabinoid CB1 receptors control conditioned drug seeking","volume":"26","author":"De Vries","year":"2005","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/pr.58.3.2_REF255","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/nm1001-1151","article-title":"A cannabinoid mechanism of relapse to cocaine seeking","volume":"7","author":"De Vries","year":"2001","journal-title":"Nat Med"},{"key":"10.1124\/pr.58.3.2_REF256","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.neuropharm.2004.11.012","article-title":"The modulation of Ca2+ and K+ channels but not changes in cAMP signaling contribute to the inhibition of glutamate release by cannabinoid receptors in cerebrocortical nerve terminals","volume":"48","author":"del Carmen Godino","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.58.3.2_REF257","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0306-4522(00)00157-3","article-title":"Cannabinoid receptor messenger RNA levels decrease in a subset of neurons of the lateral striatum, cortex and hippocampus of transgenic Huntington\u2019s disease mice","volume":"98","author":"Denovan-Wright","year":"2000","journal-title":"Neuroscience"},{"key":"10.1124\/pr.58.3.2_REF258","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1046\/j.1471-4159.2001.00333.x","article-title":"Cannabinoids activate p38 mitogen-activated protein kinases through CB1 receptors in hippocampus","volume":"77","author":"Derkinderen","year":"2001","journal-title":"J Neurochem"},{"key":"10.1124\/pr.58.3.2_REF259","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s002130100804","article-title":"SR141716, a CB1 receptor antagonist, decreases the sensitivity to the reinforcing effects of electrical brain stimulation in rats","volume":"157","author":"Deroche-Gamonet","year":"2001","journal-title":"Psychoharmacology"},{"key":"10.1124\/pr.58.3.2_REF260","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1056\/NEJMoa044537","article-title":"Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia","volume":"353","author":"Despr\u00e9s","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1124\/pr.58.3.2_REF260a","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1006\/bbrc.1997.6072","article-title":"Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor","volume":"231","author":"Deutsch","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/pr.58.3.2_REF260ab","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0006-2952(96)00830-1","article-title":"Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidase","volume":"53","author":"Deutsch","year":"1997","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF263","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0026-895X(25)09876-1","article-title":"Determination and characterization of a cannabinoid receptor in rat brain","volume":"34","author":"Devane","year":"1988","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF264","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science (Wash DC)"},{"key":"10.1124\/pr.58.3.2_REF265","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0031-6997(25)06864-4","article-title":"Cannabinoid pharmacology","volume":"38","author":"Dewey","year":"1986","journal-title":"Pharmacol Rev"},{"key":"10.1124\/pr.58.3.2_REF266","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1113\/jphysiol.2005.097477","article-title":"Activity-dependent release and actions of endocannabinoids in the rat hypothalamic supraoptic nucleus","volume":"569","author":"Di","year":"2005","journal-title":"J Physiol (Lond)"},{"key":"10.1124\/pr.58.3.2_REF266a","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.1523\/JNEUROSCI.23-12-04850.2003","article-title":"Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism","volume":"23","author":"Di","year":"2003","journal-title":"J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF268","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1210\/en.2005-0610","article-title":"Rapid glucocorticoid-mediated endocannabinoid release and opposing regulation of glutamate and \u03b3-aminobutyric acid inputs to hypothalamic magnocellular neurons","volume":"146","author":"Di","year":"2005","journal-title":"Endocrinology"},{"key":"10.1124\/pr.58.3.2_REF269","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1517\/13543784.12.1.39","article-title":"Cannabinoids for gastrointestinal diseases: potential therapeutic applications","volume":"12","author":"Di Carlo","year":"2003","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1124\/pr.58.3.2_REF269a","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1189\/jlb.0703303","article-title":"Cannabinoid CB2 receptor activation reduces mouse myocardial ischemia-reperfusion injury: involvement of cytokine\/chemokines and PMN","volume":"75","author":"Di Filippo","year":"2004","journal-title":"J Leukoc Biol"},{"key":"10.1124\/pr.58.3.2_REF271","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrd1495","article-title":"The endocannabinoid system and its therapeutic exploitation","volume":"3","author":"Di Marzo","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/pr.58.3.2_REF271a","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1006\/bbrc.2001.4354","article-title":"Highly selective CB1 cannabinoid receptor ligands and novel CB1\/VR1 vanilloid receptor \u201chybrid\u201d ligands","volume":"281","author":"Di Marzo","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/pr.58.3.2_REF273","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/372686a0","article-title":"Formation and inactivation of endogenous cannabinoid anandamide in central neurons","volume":"372","author":"Di Marzo","year":"1994","journal-title":"Nature (Lond)"},{"key":"10.1124\/pr.58.3.2_REF274","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/35071088","article-title":"Leptin-regulated endocannabinoids are involved in maintaining food intake","volume":"410","author":"Di Marzo","year":"2001","journal-title":"Nature (Lond)"},{"key":"10.1124\/pr.58.3.2_REF275","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1096\/fasebj.14.10.1432","article-title":"Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson\u2019s disease","volume":"14","author":"Di Marzo","year":"2000","journal-title":"FASEB J"},{"key":"10.1124\/pr.58.3.2_REF276","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nn1457","article-title":"Endocannabinoid control of food intake and energy balance","volume":"8","author":"Di Marzo","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.1124\/pr.58.3.2_REF277","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1146\/annurev.med.57.011205.135648","article-title":"Plant, synthetic, and endogenous cannabinoids in medicine","volume":"57","author":"Di Marzo","year":"2006","journal-title":"Annu Rev Med"},{"key":"10.1124\/pr.58.3.2_REF278","doi-asserted-by":"crossref","first-page":"10819","DOI":"10.1073\/pnas.152334899","article-title":"Brain monoglyceride lipase participating in endocannabinoid inactivation","volume":"99","author":"Dinh","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.58.3.2_REF279","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0009-3084(02)00150-0","article-title":"A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation","volume":"121","author":"Dinh","year":"2002","journal-title":"Chem Phys Lipids"},{"key":"10.1124\/pr.58.3.2_REF280","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/gut.2004.051599","article-title":"Increased anandamide induced relaxation in mesenteric arteries of cirrhotic rats: role of cannabinoid and vanilloid receptors","volume":"54","author":"Domenicali","year":"2005","journal-title":"Gut"},{"key":"10.1124\/pr.58.3.2_REF281","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/BF02971741","article-title":"On the physical and medicinal qualities of Indian hemp (Cannabis indica)","volume":"26","author":"Donovan","year":"1845","journal-title":"Dublin J Med Sci"},{"key":"10.1124\/pr.58.3.2_REF282","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1046\/j.1460-9568.2000.00101.x","article-title":"Activation of spinal cannabinoid 1 receptors inhibits C-fibre driven hyperexcitable neuronal responses and increases [35S]GTP\u03b3S binding in the dorsal horn of the spinal cord of noninflamed and inflamed rats","volume":"12","author":"Drew","year":"2000","journal-title":"Eur J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF283","unstructured":"Drmota T, Greasley P, and Groblewski T (2004) inventors, AstraZeneca, assignee. Screening assays for cannabinoid-ligand-type modulators of GPR55. World Intellectual Property Organization patent application PCT\/GB2004\/000571. 2004 Sept 2."},{"key":"10.1124\/pr.58.3.2_REF284","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.2174\/0929867033456387","article-title":"Cannabinoids: mechanisms and therapeutic applications in the CNS","volume":"10","author":"Drysdale","year":"2003","journal-title":"Curr Med Chem"},{"key":"10.1124\/pr.58.3.2_REF285","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.biopsych.2004.12.006","article-title":"\u0394-9-Tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction","volume":"57","author":"D\u2019Souza","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pr.58.3.2_REF286","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/sj.npp.1300496","article-title":"The psychotomimetic effects of intravenous \u0394-9-tetrahydrocannabinol in healthy individuals: implications for psychosis","volume":"29","author":"D\u2019Souza","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.58.3.2_REF287","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF00426661","article-title":"\u03949-Tetrahydrocannabinol sensitization of the rat brain to direct cholinergic stimulation","volume":"60","author":"Duncan","year":"1979","journal-title":"Psychopharmacology"},{"key":"10.1124\/pr.58.3.2_REF288","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1365-2036.2005.02648.x","article-title":"Review article: endocannabinoids and their receptors in the enteric nervous system","volume":"22","author":"Duncan","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1124\/pr.58.3.2_REF289","first-page":"175","article-title":"The perceived effects of marijuana on spinal cord injured males","volume":"12","author":"Dunn","year":"1974","journal-title":"Paraplegia"},{"key":"10.1124\/pr.58.3.2_REF290","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.pain.2005.03.037","article-title":"Antihyperalgesic properties of the cannabinoid CT-3 in chronic neuropathic and inflammatory pain states in the rat","volume":"116","author":"Dyson","year":"2005","journal-title":"Pain"},{"key":"10.1124\/pr.58.3.2_REF291","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s00213-005-0199-9","article-title":"Effect of cannabinoid CB1 receptor antagonist SR-141716A on ethanol self-administration and ethanol-seeking behavior in rats","volume":"183","author":"Economidou","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1124\/pr.58.3.2_REF292","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1023\/B:NEON.0000024746.87666.ed","article-title":"The risk for malignant primary adult-onset glioma in a large, multiethnic, managed-care cohort: cigarette smoking and other lifestyle behaviors","volume":"68","author":"Efird","year":"2004","journal-title":"J Neurooncol"},{"key":"10.1124\/pr.58.3.2_REF293","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neuron.2005.11.027","article-title":"The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells","volume":"49","author":"Eljaschewitsch","year":"2006","journal-title":"Neuron"},{"key":"10.1124\/pr.58.3.2_REF294","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cellsig.2004.05.011","article-title":"Cannabinoids down-regulate PI3K\/Akt and Erk signalling pathways and activate proapoptotic function of Bad protein","volume":"17","author":"Ellert-Miklaszewska","year":"2005","journal-title":"Cell Signal"},{"key":"10.1124\/pr.58.3.2_REF295","first-page":"439","article-title":"Complex partial seizure symptoms affected by marijuana abuse","volume":"51","author":"Ellison","year":"1990","journal-title":"J Clin Psychiatry"},{"key":"10.1124\/pr.58.3.2_REF296","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1111\/j.1460-9568.2004.03690.x","article-title":"Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naive rats and in rat models of inflammatory and neuropathic pain","volume":"20","author":"Elmes","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF297","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2353\/ajpath.2006.050500","article-title":"Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes","volume":"168","author":"El-Remessy","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1124\/pr.58.3.2_REF298","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/S0002-9440(10)63558-4","article-title":"Neuroprotective effect of (-)\u03949-tetrahydrocannabinol and cannabidiol in N-methyl-d-aspartate-induced retinal neurotoxicity: involvement of peroxynitrite","volume":"163","author":"El-Remessy","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1124\/pr.58.3.2_REF299","doi-asserted-by":"crossref","first-page":"472S","DOI":"10.1002\/j.1552-4604.1981.tb02627.x","article-title":"Cannabinoids in glaucoma: a primary screening procedure","volume":"21","author":"ElSohly","year":"1981","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF300","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3109\/02713688409000797","article-title":"Cannabinoids in glaucoma. II: the effect of different cannabinoids on intraocular pressure of the rabbit","volume":"3","author":"ElSohly","year":"1984","journal-title":"Curr Eye Res"},{"key":"10.1124\/pr.58.3.2_REF301","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0091-3057(96)00426-1","article-title":"Towards a cannabinoid hypothesis of schizophrenia: cognitive impairments due to dysregulation of the endogenous cannabinoid system","volume":"56","author":"Emrich","year":"1997","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pr.58.3.2_REF302","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.2337\/diabetes.54.10.2838","article-title":"Activation of the peripheral endocannabinoid system in human obesity","volume":"54","author":"Engeli","year":"2005","journal-title":"Diabetes"},{"key":"10.1124\/pr.58.3.2_REF303","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/archneur.62.3.353","article-title":"Molecular pathogenesis of Parkinson disease","volume":"62","author":"Eriksen","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1124\/pr.58.3.2_REF304","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00001756-199312000-00013","article-title":"HU-211, a non-psychotropic cannabinoid, rescues cortical neurones from excitatory amino acid toxicity in culture","volume":"5","author":"Eshhar","year":"1993","journal-title":"Neuroreport"},{"key":"10.1124\/pr.58.3.2_REF305","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0014-2999(95)00271-L","article-title":"Neuroprotective and antioxidant activities of HU-211, a novel NMDA receptor antagonist","volume":"283","author":"Eshhar","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF306","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2174\/1570161054368580","article-title":"Role of nitrosative stress and activation of poly(ADP-ribose) polymerase-1 in cardiovascular failure associated with septic and hemorrhagic shock","volume":"3","author":"Evgenov","year":"2005","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF307","doi-asserted-by":"crossref","first-page":"377S","DOI":"10.1002\/j.1552-4604.1981.tb02617.x","article-title":"The efficacy and safety of nabilone (a synthetic cannabinoid) in the treatment of anxiety","volume":"21","author":"Fabre","year":"1981","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF308","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0306-4522(02)00017-9","article-title":"Anatomical substrates of orexin-dopamine interactions: lateral hypothalamic projections to the ventral tegmental area","volume":"111","author":"Fadel","year":"2002","journal-title":"Neuroscience"},{"key":"10.1124\/pr.58.3.2_REF309","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/01.wco.0000044767.39452.bf","article-title":"Neuroprotection and traumatic brain injury: theoretical option or realistic proposition","volume":"15","author":"Faden","year":"2002","journal-title":"Curr Opin Neurol"},{"key":"10.1124\/pr.58.3.2_REF310","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1152\/jn.1995.73.2.907","article-title":"Cannabinoid agonists inhibit the activation of 5-HT3 receptors in rat nodose ganglion neurons","volume":"73","author":"Fan","year":"1995","journal-title":"J Neurophysiol"},{"key":"10.1124\/pr.58.3.2_REF311","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1017\/S095252380320208X","article-title":"Biphasic modulation of voltage-dependent currents of retinal cones by cannabinoid CB1 receptor agonist WIN 55212-2","volume":"20","author":"Fan","year":"2003","journal-title":"Vis Neurosci"},{"key":"10.1124\/pr.58.3.2_REF312","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.pbb.2005.01.031","article-title":"Endocannabinoid system and opioid addiction: behavioural aspects","volume":"81","author":"Fattore","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pr.58.3.2_REF313","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0166-4328(99)00059-5","article-title":"CB1 cannabinoid receptor agonist WIN 55,212-2 decreases cocaine self-administration in rats","volume":"104","author":"Fattore","year":"1999","journal-title":"Behav Brain Res"},{"key":"10.1124\/pr.58.3.2_REF314","doi-asserted-by":"crossref","first-page":"8756","DOI":"10.1073\/pnas.0400997101","article-title":"Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172","volume":"101","author":"Fegley","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.58.3.2_REF314a","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0022-3565(24)37189-7","article-title":"LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulation","volume":"284","author":"Felder","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.58.3.2_REF314ab","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0026-895X(25)10492-6","article-title":"Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors","volume":"48","author":"Felder","year":"1995","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF317","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/cpt1976196782","article-title":"Effects of marijuana extract and tetrahydrocannabinol on electroencephalographic sleep patterns","volume":"19","author":"Feinberg","year":"1976","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/pr.58.3.2_REF318","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/cpt1975174458","article-title":"Effects of high dosage \u0394-9-tetrahydrocannabinol on sleep patterns in man","volume":"17","author":"Feinberg","year":"1975","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/pr.58.3.2_REF319","first-page":"430","article-title":"Rimonabant Sanofi-Synthelabo","volume":"5","author":"Fernandez","year":"2004","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1124\/pr.58.3.2_REF320","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.nbd.2004.10.015","article-title":"Cannabinoid CB1 antagonists possess antiparkinsonian efficacy only in rats with very severe nigral lesion in experimental parkinsonism","volume":"18","author":"Fernandez-Espejo","year":"2005","journal-title":"Neurobiol Dis"},{"key":"10.1124\/pr.58.3.2_REF321","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1478-3231.2004.0945.x","article-title":"Circulating endogenous cannabinoid anandamide and portal, systemic and renal hemodynamics in cirrhosis","volume":"24","author":"Fernandez-Rodriguez","year":"2004","journal-title":"Liver Int"},{"key":"10.1124\/pr.58.3.2_REF322","series-title":"Cannabinoids","first-page":"479","article-title":"Cannabinoid control of motor function at the basal ganglia","author":"Fernandez-Ruiz","year":"2005"},{"key":"10.1124\/pr.58.3.2_REF323","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1046\/j.1460-9568.2003.02896.x","article-title":"Effects of levodopa on endocannabinoid levels in rat basal ganglia: implications for the treatment of levodopa-induced dyskinesias","volume":"18","author":"Ferrer","year":"2003","journal-title":"Eur J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF324","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/S0022-3565(25)39607-2","article-title":"\u03949-Tetrahydrocannabinol inhibition of tumor necrosis factor-\u03b1: suppression of post-translational events","volume":"267","author":"Fischer-Stenger","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.58.3.2_REF325","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/dev.420160207","article-title":"The ontogeny of \u0394-9-tetrahydrocannabinol responsiveness in the rabbit","volume":"16","author":"Fish","year":"1983","journal-title":"Dev Psychobiol"},{"key":"10.1124\/pr.58.3.2_REF326","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/oxfordjournals.jhered.a109475","article-title":"Inheritance of \u03949-tetrahydrocannabinol seizure susceptibility in rabbits","volume":"72","author":"Fish","year":"1981","journal-title":"J Hered"},{"key":"10.1124\/pr.58.3.2_REF327","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0376-8716(93)80001-U","article-title":"Behavioral effects of cocaine alone and in combination of ethanol and marijuana in humans","volume":"32","author":"Foltin","year":"1993","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/pr.58.3.2_REF328","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/sj.bjp.0704565","article-title":"Evidence of a novel site mediating anandamide-induced negative inotropic and coronary vasodilator responses in rat isolated hearts","volume":"135","author":"Ford","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF328a","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s00213-005-0015-6","article-title":"Cannabinoid CB1 receptors are involved in motivational effects of nicotine in rats","volume":"181","author":"Forget","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1124\/pr.58.3.2_REF330","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF00915771","article-title":"Analgesic and antiinflammatory activity of constituents of Cannabis sativa L","volume":"12","author":"Formukong","year":"1988","journal-title":"Inflammation"},{"key":"10.1124\/pr.58.3.2_REF331","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/sj.bjp.0705608","article-title":"Oleamide: a member of the endocannabinoid family?","volume":"141","author":"Fowler","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF332","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0006-2952(03)00392-7","article-title":"Inhibition of C6 glioma cell proliferation by anandamide, 1-arachidonoylglycerol, and by a water soluble phosphate ester of anandamide: variability in response and involvement of arachidonic acid","volume":"66","author":"Fowler","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF333","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2004.03.048","article-title":"Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis\u2014a difficult issue to handle","volume":"492","author":"Fowler","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF334","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1517\/13543784.14.6.695","article-title":"Therapeutic potential of cannabinoid receptor agonists as analgesic agents","volume":"14","author":"Fox","year":"2005","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1124\/pr.58.3.2_REF335","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0304-3959(00)00474-7","article-title":"The role of central and peripheral cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain","volume":"92","author":"Fox","year":"2001","journal-title":"Pain"},{"key":"10.1124\/pr.58.3.2_REF336","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1212\/01.WNL.0000118203.67138.3E","article-title":"The effect of cannabis on tremor in patients with multiple sclerosis","volume":"62","author":"Fox","year":"2004","journal-title":"Neurology"},{"key":"10.1124\/pr.58.3.2_REF337","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/mds.10289","article-title":"Stimulation of cannabinoid receptors reduces levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate model of Parkinson\u2019s disease","volume":"17","author":"Fox","year":"2002","journal-title":"Mov Disord"},{"key":"10.1124\/pr.58.3.2_REF338","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/mds.1280","article-title":"Randomised, double-blind, placebo-controlled trial to assess the potential of cannabinoid receptor stimulation in the treatment of dystonia","volume":"17","author":"Fox","year":"2002","journal-title":"Mov Disord"},{"key":"10.1124\/pr.58.3.2_REF339","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0091-3057(00)00359-2","article-title":"Effects of Sr141716A, a central cannabinoid receptor antagonist, on food-maintained responding","volume":"67","author":"Freedland","year":"2000","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pr.58.3.2_REF340","first-page":"277","article-title":"Effects of SR141716A on ethanol and sucrose self-administration","volume":"25","author":"Freedland","year":"2001","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1124\/pr.58.3.2_REF341","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0006-8993(02)03999-9","article-title":"Functional consequences of the acute administration of the cannabinoid receptor antagonist, SR141716A, in cannabinoid-naive and -tolerant animals: a quantitative 2-[14C]deoxyglucose study","volume":"962","author":"Freedland","year":"2003","journal-title":"Brain Res"},{"key":"10.1124\/pr.58.3.2_REF342","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1001\/jama.1972.03200100074027","article-title":"Effects of marihuana on sleeping states","volume":"220","author":"Freemon","year":"1972","journal-title":"J Am Med Assoc"},{"key":"10.1124\/pr.58.3.2_REF343","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0376-8716(82)90036-9","article-title":"The effect of chronically administered \u0394-9-tetrahydrocannabinol upon the polygraphically monitored sleep of normal volunteers","volume":"10","author":"Freemon","year":"1982","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/pr.58.3.2_REF344","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0304-3940(97)00278-4","article-title":"\u03949-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors","volume":"226","author":"French","year":"1997","journal-title":"Neurosci Lett"},{"key":"10.1124\/pr.58.3.2_REF345","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1152\/physrev.00004.2003","article-title":"Role of endogenous cannabinoids in synaptic signaling","volume":"83","author":"Freund","year":"2003","journal-title":"Physiol Rev"},{"key":"10.1124\/pr.58.3.2_REF346","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ejphar.2004.07.033","article-title":"The endocannabinoid-CB1 receptor system during gestation and postnatal development","volume":"500","author":"Fride","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF347","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/153537020523000401","article-title":"Endocannabinoids and food intake: newborn suckling and appetite regulation in adulthood","volume":"230","author":"Fride","year":"2005","journal-title":"Exp Biol Med"},{"key":"10.1124\/pr.58.3.2_REF348","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0014-2999(03)01295-0","article-title":"Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: evidence for a \u201cCB3\u201d receptor","volume":"461","author":"Fride","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF349","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0014-2999(93)90468-W","article-title":"Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent","volume":"231","author":"Fride","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF350","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1097\/00001756-200210280-00001","article-title":"The endocannabinoid system: function in survival of the embryo, the newborn and the neuron","volume":"13","author":"Fride","year":"2002","journal-title":"Neuroreport"},{"key":"10.1124\/pr.58.3.2_REF351","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/978-1-4615-1951-5_15","article-title":"Marijuana, receptors and immunomodulation","volume":"373","author":"Friedman","year":"1995","journal-title":"Adv Exp Med Biol"},{"key":"10.1124\/pr.58.3.2_REF352","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nature01921","article-title":"Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-\u03b1","volume":"425","author":"Fu","year":"2003","journal-title":"Nature (Lond)"},{"key":"10.1124\/pr.58.3.2_REF353","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1478-3231.2005.01180.x","article-title":"Endocannabinoids and liver disease\u2014review","volume":"25","author":"Gabbay","year":"2005","journal-title":"Liver Int"},{"key":"10.1124\/pr.58.3.2_REF354","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0014-2999(99)00170-3","article-title":"Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist","volume":"370","author":"Gallate","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF355","doi-asserted-by":"crossref","first-page":"R5","DOI":"10.1016\/S0014-2999(00)00653-1","article-title":"2-Arachidonylglycerol, an endogenous cannabinoid, inhibits tumor necrosis factor-\u03b1 production in murine macrophages, and in mice","volume":"406","author":"Gallily","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF356","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1124\/mol.62.6.1385","article-title":"Mechanism of extracellular signal-regulated kinase activation by the CB1 cannabinoid receptor","volume":"62","author":"Galve-Roperh","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF357","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/73171","article-title":"Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation","volume":"6","author":"Galve-Roperh","year":"2000","journal-title":"Nat Med"},{"key":"10.1124\/pr.58.3.2_REF358","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.neuropharm.2005.04.017","article-title":"Cannabinoids augment the release of neuropeptide Y in the rat hypothalamus","volume":"49","author":"Gamber","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.58.3.2_REF359","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/039463200501800103","article-title":"Cannabinoid receptors and their relationships with neuropsychiatric disorders","volume":"18","author":"Gambi","year":"2005","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF360","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1210\/en.2004-1672","article-title":"Regulation of gonadotropin-releasing hormone secretion by cannabinoids","volume":"146","author":"Gammon","year":"2005","journal-title":"Endocrinology"},{"key":"10.1124\/pr.58.3.2_REF361","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1021\/ja01062a046","article-title":"Isolation, structure and partial synthesis of an active constituent of hashish","volume":"86","author":"Gaoni","year":"1964","journal-title":"J Am Chem Soc"},{"key":"10.1124\/pr.58.3.2_REF362","first-page":"G14","article-title":"Systemic and portal hemodynamic effects of anandamide","volume":"280","author":"Garcia","year":"2001","journal-title":"Am J Physiol"},{"key":"10.1124\/pr.58.3.2_REF363","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/sj.bjp.0704100","article-title":"Regional haemodynamic responses to the cannabinoid agonist, WIN 55212-2, in conscious, normotensive rats, and in hypertensive, transgenic rats","volume":"133","author":"Gardiner","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF364","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1038\/sj.bjp.0704649","article-title":"Complex regional haemodynamic effects of anandamide in conscious rats","volume":"135","author":"Gardiner","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF365","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/sj.bjp.0704750","article-title":"Influence of the CB1 receptor antagonist, AM 251, on the regional haemodynamic effects of WIN-55212-2 or HU 210 in conscious rats","volume":"136","author":"Gardiner","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF366","first-page":"H2280","article-title":"Involvement of CB1-receptors and \u03b2-adrenoceptors in the regional hemodynamic responses to lipopolysaccharide infusion in conscious rats","volume":"288","author":"Gardiner","year":"2005","journal-title":"Am J Physiol"},{"key":"10.1124\/pr.58.3.2_REF367","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.pbb.2005.01.032","article-title":"Endocannabinoid signaling system and brain reward: emphasis on dopamine","volume":"81","author":"Gardner","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pr.58.3.2_REF368","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/BF02431546","article-title":"Facilitation of brain stimulation reward by 9-tetrahydrocannabinol.\u03949-tetrahydrocannabinol","volume":"96","author":"Gardner","year":"1988","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pr.58.3.2_REF368a","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0960-894X(95)00573-C","article-title":"Structure activity relationships of tetrahydrocannabinol analogues on human cannabinoid receptors","volume":"6","author":"Gareau","year":"1996","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/pr.58.3.2_REF370","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/sj.bjp.0706331","article-title":"Role of endocannabinoids in the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats","volume":"146","author":"Gaskari","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF371","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0024-3205(97)00690-5","article-title":"Binding of the non-classical cannabinoid CP 55,940, and the diarylpyrazole AM251 to rodent brain cannabinoid receptors","volume":"61","author":"Gatley","year":"1997","journal-title":"Life Sci"},{"key":"10.1124\/pr.58.3.2_REF372","first-page":"H2085","article-title":"Cannabinoid CB1 receptor of cat cerebral arterial muscle functions to inhibit L-type Ca2+ channel current","volume":"266","author":"Gebremedhin","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1124\/pr.58.3.2_REF373","first-page":"23","article-title":"A pilot study of safety and tolerability of \u0394 9-THC (Marinol) treatment for ALS","volume":"3","author":"Gelinas","year":"2002","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"10.1124\/pr.58.3.2_REF374","first-page":"A27","article-title":"Anxiolytic and anxiogenic effects of the cannabinoid agonist CP 55,940 in animal tests of anxiety","volume":"17","author":"Genn","year":"2003","journal-title":"J Psychopharmacology"},{"key":"10.1124\/pr.58.3.2_REF375","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.pbb.2003.12.019","article-title":"Unconditioned and conditioned anxiogenic effects of the cannabinoid receptor agonist CP 55,940 in the social interaction test","volume":"77","author":"Genn","year":"2004","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pr.58.3.2_REF376","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.forsciint.2004.06.027","article-title":"Long-term intracerebral inflammatory response after traumatic brain injury","volume":"146","author":"Gentleman","year":"2004","journal-title":"Forensic Sci Int"},{"key":"10.1124\/pr.58.3.2_REF377","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1530-0277.1990.tb00499.x","article-title":"Corticotropin-releasing factor is altered in brains of animals with high preference for ethanol","volume":"14","author":"George","year":"1990","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1124\/pr.58.3.2_REF378","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1152\/jn.2001.85.1.468","article-title":"CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum","volume":"85","author":"Gerdeman","year":"2001","journal-title":"J Neurophysiol"},{"key":"10.1124\/pr.58.3.2_REF379","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/sj.bjp.0705466","article-title":"Emerging roles for endocannabinoids in long-term synaptic plasticity","volume":"140","author":"Gerdeman","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF380","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0166-2236(03)00065-1","article-title":"It could be habit forming: drugs of abuse and striatal synaptic plasticity","volume":"26","author":"Gerdeman","year":"2003","journal-title":"Trends Neurosci"},{"key":"10.1124\/pr.58.3.2_REF381","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nn832","article-title":"Postsynaptic endocannabinoid release is critical to long-term depression in the striatum","volume":"5","author":"Gerdeman","year":"2002","journal-title":"Nat Neurosci"},{"key":"10.1124\/pr.58.3.2_REF382","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1567-5769(01)00200-4","article-title":"Effect of the cannabinoid receptor ligand, WIN 55,212-2, on superoxide anion and TNF-\u03b1 production by human mononuclear cells","volume":"2","author":"Germain","year":"2002","journal-title":"Int Immunopharmacol"},{"key":"10.1124\/pr.58.3.2_REF383","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s002100000360","article-title":"Cannabinoid CB1-mediated inhibition of stress-induced gastric ulcers in rats","volume":"363","author":"Germano","year":"2001","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF384","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s00213-006-0327-1","article-title":"Lack of tolerance to the suppressing effect of rimonabant on chocolate intake in rats","volume":"185","author":"Gessa","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1124\/pr.58.3.2_REF385","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1523\/JNEUROSCI.22-03-01146.2002","article-title":"Motivational effects of cannabinoids are mediated by \u03bc-opioid and \u03ba-opioid receptors","volume":"22","author":"Ghozland","year":"2002","journal-title":"J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF386","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/S0022-3565(25)13092-9","article-title":"Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN 55212-2, and is potentiated by the cannabinoid antagonist, SR 141716A","volume":"277","author":"Gifford","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.58.3.2_REF386a","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1034\/j.1600-0773.2003.930202.x","article-title":"The CB1 cannabinoid receptor agonist, HU-210, reduces levodopa-induced rotations in 6-hydroxydopamine-lesioned rats","volume":"93","author":"Gilgun-Sherki","year":"2003","journal-title":"Pharmacol Toxicol"},{"key":"10.1124\/pr.58.3.2_REF388","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1016\/S0024-3205(03)00668-4","article-title":"The cannabinoid agonist WIN 55,212-2 increases nociception threshold in cholestatic rats: implications for the treatment of the pruritus of cholestasis","volume":"73","author":"Gingold","year":"2003","journal-title":"Life Sci"},{"key":"10.1124\/pr.58.3.2_REF389","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/379606a0","article-title":"Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter","volume":"379","author":"Giros","year":"1996","journal-title":"Nature (Lond)"},{"key":"10.1124\/pr.58.3.2_REF390","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1038\/sj.npp.1300558","article-title":"Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms","volume":"29","author":"Giuffrida","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.58.3.2_REF391","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/7268","article-title":"Dopamine activation of endogenous cannabinoid signaling in dorsal striatum","volume":"2","author":"Giuffrida","year":"1999","journal-title":"Nat Neurosci"},{"key":"10.1124\/pr.58.3.2_REF392","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1006\/phrs.1999.0560","article-title":"The cannabinoid agonist HU210 modifies behavioural responses to novelty and stress","volume":"41","author":"Giuliani","year":"2000","journal-title":"Pharmacol Res"},{"key":"10.1124\/pr.58.3.2_REF393","doi-asserted-by":"crossref","first-page":"4269","DOI":"10.1073\/pnas.0730816100","article-title":"Evidence against the presence of an anandamide transporter","volume":"100","author":"Glaser","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.58.3.2_REF394","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.lfs.2005.05.007","article-title":"Anandamide transport: a critical review","volume":"77","author":"Glaser","year":"2005","journal-title":"Life Sci"},{"key":"10.1124\/pr.58.3.2_REF395","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0278-5846(01)00162-2","article-title":"The role of cannabinoids in neurodegenerative diseases","volume":"25","author":"Glass","year":"2001","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1124\/pr.58.3.2_REF396","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1460-9568.1997.tb01390.x","article-title":"Modulation of neurotransmission by cannabinoids in the basal ganglia","volume":"9","author":"Glass","year":"1997","journal-title":"Eur J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF397","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0306-4522(96)00428-9","article-title":"Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain","volume":"77","author":"Glass","year":"1997","journal-title":"Neuroscience"},{"key":"10.1124\/pr.58.3.2_REF398","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0306-4522(00)00008-7","article-title":"The pattern of neurodegeneration in Huntington\u2019s disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington\u2019s disease","volume":"97","author":"Glass","year":"2000","journal-title":"Neuroscience"},{"key":"10.1124\/pr.58.3.2_REF399","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0306-4522(93)90352-G","article-title":"Loss of cannabinoid receptors in the substantia nigra in Huntington\u2019s disease","volume":"56","author":"Glass","year":"1993","journal-title":"Neuroscience"},{"key":"10.1124\/pr.58.3.2_REF400","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.1523\/JNEUROSCI.17-14-05327.1997","article-title":"Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor","volume":"17","author":"Glass","year":"1997","journal-title":"J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF401","first-page":"1362","article-title":"Agonist selective regulation of G proteins by cannabinoid CB1 and CB2 receptors","volume":"56","author":"Glass","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF402","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0306-4522(03)00595-5","article-title":"Delayed onset of Huntington\u2019s disease in mice in an enriched environment correlates with delayed loss of cannabinoid CB1 receptors","volume":"123","author":"Glass","year":"2004","journal-title":"Neuroscience"},{"key":"10.1124\/pr.58.3.2_REF403","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF00434401","article-title":"A single dose study of nabilone, a synthetic cannabinoid","volume":"71","author":"Glass","year":"1980","journal-title":"Psychopharmacology"},{"key":"10.1124\/pr.58.3.2_REF404","doi-asserted-by":"crossref","first-page":"18620","DOI":"10.1073\/pnas.0509591102","article-title":"Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis","volume":"102","author":"Gobbi","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.58.3.2_REF404a","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.febslet.2004.12.065","article-title":"Inhibition of N- and P\/Q-type Ca2+ channels by cannabinoid receptors in single cerebrocortical nerve terminals","volume":"579","author":"Godino","year":"2005","journal-title":"FEBS Lett"},{"key":"10.1124\/pr.58.3.2_REF406","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/sj.bjp.0705839","article-title":"Presynaptic cannabinoid CB1 receptors are involved in the inhibition of the neurogenic vasopressor response during septic shock in pithed rats","volume":"142","author":"Godlewski","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF407","doi-asserted-by":"crossref","first-page":"36527","DOI":"10.1074\/jbc.M205797200","article-title":"Cannabinoids protect astrocytes from ceramide-induced apoptosis through the phosphatidylinositol 3-kinase\/protein kinase B pathway","volume":"277","author":"G\u00f3mez Del Pulgar","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.58.3.2_REF408","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1042\/bj3470369","article-title":"The CB1 cannabinoid receptor is coupled to the activation of protein kinase B\/Akt","volume":"347","author":"G\u00f3mez Del Pulgar","year":"2000","journal-title":"Biochem J"},{"key":"10.1124\/pr.58.3.2_REF409","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1042\/bj3630183","article-title":"De novo-synthesized ceramide is involved in cannabinoid-induced apoptosis","volume":"363","author":"G\u00f3mez Del Pulgar","year":"2002","journal-title":"Biochem J"},{"key":"10.1124\/pr.58.3.2_REF410","doi-asserted-by":"crossref","first-page":"9612","DOI":"10.1523\/JNEUROSCI.22-21-09612.2002","article-title":"A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding","volume":"22","author":"Gomez","year":"2002","journal-title":"J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF411","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.brainres.2005.11.035","article-title":"Cannabinoid CB2 receptors: immunohistochemical localization in rat brain","volume":"1071","author":"Gong","year":"2006","journal-title":"Brain Res"},{"key":"10.1124\/pr.58.3.2_REF412","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0026-895X(24)26516-0","article-title":"Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide","volume":"57","author":"Gonsiorek","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF413","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0006-8993(02)03344-9","article-title":"Changes in endocannabinoid content in the brain of rats chronically exposed to nicotine, ethanol or cocaine","volume":"954","author":"Gonzalez","year":"2002","journal-title":"Brain Res"},{"key":"10.1124\/pr.58.3.2_REF414","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.brainres.2005.04.010","article-title":"Cannabinoid CB1 receptors in the basal ganglia and motor response to activation or blockade of these receptors in parkin-null mice","volume":"1046","author":"Gonzalez","year":"2005","journal-title":"Brain Res"},{"key":"10.1124\/pr.58.3.2_REF415","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.brainres.2005.12.014","article-title":"Effects of rimonabant, a selective cannabinoid CB1 receptor antagonist, in a rat model of Parkinson\u2019s disease","volume":"1073-1074","author":"Gonzalez","year":"2006","journal-title":"Brain Res"},{"key":"10.1124\/pr.58.3.2_REF415a","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0006-2952(98)00314-1","article-title":"Enzymes of porcine brain hydrolyzing 2-arachidonoylglycerol, an endogenous ligand of cannabinoid receptors","volume":"57","author":"Goparaju","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF417","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0014-5793(97)01603-7","article-title":"Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand","volume":"422","author":"Goparaju","year":"1998","journal-title":"FEBS Lett"},{"key":"10.1124\/pr.58.3.2_REF418","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1046\/j.1528-1157.2001.19301.x","article-title":"Alcohol and marijuana: effects on epilepsy and use by patients with epilepsy","volume":"42","author":"Gordon","year":"2001","journal-title":"Epilepsia"},{"key":"10.1124\/pr.58.3.2_REF419","doi-asserted-by":"crossref","first-page":"754.e1","DOI":"10.1016\/j.ahj.2005.11.006","article-title":"The cannabinoid CB1 receptor antagonist rimonabant attenuates the hypotensive effect of smoked marijuana in male smokers","volume":"151","author":"Gorelick","year":"2006","journal-title":"Am Heart J"},{"key":"10.1124\/pr.58.3.2_REF420","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00002030-199201000-00018","article-title":"Dronabinol effects on weight in patients with HIV infection","volume":"6","author":"Gorter","year":"1992","journal-title":"AIDS"},{"key":"10.1124\/pr.58.3.2_REF420a","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0968-0896(01)00088-8","article-title":"Stereochemical selectivity of methanandamides for the CB1 and CB2 cannabinoid receptors and their metabolic stability","volume":"9","author":"Goutopoulos","year":"2001","journal-title":"Bioorg Med Chem"},{"key":"10.1124\/pr.58.3.2_REF422","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0014-4835(77)90259-7","article-title":"Cannabinoid action on the eye as mediated through the central nervous system and local adrenergic activity","volume":"24","author":"Green","year":"1977","journal-title":"Exp Eye Res"},{"key":"10.1124\/pr.58.3.2_REF423","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0014-4835(77)90260-3","article-title":"Cannabinoid penetration and chronic effects in the eye","volume":"24","author":"Green","year":"1977","journal-title":"Exp Eye Res"},{"key":"10.1124\/pr.58.3.2_REF424","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000055673","article-title":"Interaction between \u0394-9-tetrahydrocannabinol and indomethacin","volume":"33","author":"Green","year":"2001","journal-title":"Ophthalmic Res"},{"key":"10.1124\/pr.58.3.2_REF425","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/0014-4835(73)90142-5","article-title":"Effect of 1-tetrahydrocannabinol on aqueous dynamics and ciliary body permeability in the rabbit","volume":"15","author":"Green","year":"1973","journal-title":"Exp Eye Res"},{"key":"10.1124\/pr.58.3.2_REF426","first-page":"422","article-title":"Antagonism of arachidonic acid-induced ocular effects by \u03941-tetrahydrocannabinol","volume":"13","author":"Green","year":"1974","journal-title":"Investig Ophthalmol"},{"key":"10.1124\/pr.58.3.2_REF427","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/clpt.1994.33","article-title":"Short-term effects of smoking marijuana on balance in patients with multiple sclerosis and normal volunteers","volume":"55","author":"Greenberg","year":"1994","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/pr.58.3.2_REF428","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF00427475","article-title":"Effects of marijuana use on body weight and energy intake in humans","volume":"49","author":"Greenberg","year":"1976","journal-title":"Psychopharmacology"},{"key":"10.1124\/pr.58.3.2_REF429","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1126\/science.294.5544.1024","article-title":"The neurobiology of slow synaptic transmission","volume":"294","author":"Greengard","year":"2001","journal-title":"Science (Wash DC)"},{"key":"10.1124\/pr.58.3.2_REF429a","unstructured":"Grenard P, Julien B, Tran Van Nhieu J, Li L, Ledent C, Mallat A, and Lotersztajn S (2004) Reduced fibrosis in mice invalidated for CB1 receptor, in Proceedings of the 2004 Symposium on the Cannabinoids; 2004 June 22-27; Peastum, Italy. p 60, International Cannabinoid Research Society, Burlington, VT."},{"key":"10.1124\/pr.58.3.2_REF431","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0009-3084(02)00161-5","article-title":"Assessment of cannabinoid induced gene changes: tolerance and neuroprotection","volume":"121","author":"Grigorenko","year":"2002","journal-title":"Chem Phys Lipids"},{"key":"10.1124\/pr.58.3.2_REF432","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.yexcr.2005.10.024","article-title":"Anandamide inhibits adhesion and migration of breast cancer cells","volume":"312","author":"Grimaldi","year":"2006","journal-title":"Exp Cell Res"},{"key":"10.1124\/pr.58.3.2_REF433","series-title":"Marihuana: The Forbidden Medicine","first-page":"1","article-title":"The history of cannabis","author":"Grinspoon","year":"1993"},{"key":"10.1124\/pr.58.3.2_REF434","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/02791072.1998.10399687","article-title":"The use of cannabis as a mood stabilizer in bipolar disorder: anecdotal evidence and the need for clinical research","volume":"30","author":"Grinspoon","year":"1998","journal-title":"J Psychoact Drugs"},{"key":"10.1124\/pr.58.3.2_REF435","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2165\/00003088-200342040-00003","article-title":"Pharmacokinetics and pharmacodynamics of cannabinoids","volume":"42","author":"Grotenhermen","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/pr.58.3.2_REF436","first-page":"14","article-title":"Pharmacology of cannabinoids","volume":"25","author":"Grotenhermen","year":"2004","journal-title":"Neuro Endocrinol Lett"},{"key":"10.1124\/pr.58.3.2_REF437","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00051316","article-title":"Parents\u2019 use of cocaine and marijuana and increased risk of rhabdomyosarcoma in their children","volume":"4","author":"Grufferman","year":"1993","journal-title":"Cancer Causes Control"},{"key":"10.1124\/pr.58.3.2_REF438","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1517\/13543784.11.10.1365","article-title":"The therapeutic potential of the cannabinoids in neuroprotection","volume":"11","author":"Grundy","year":"2002","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1124\/pr.58.3.2_REF439","doi-asserted-by":"crossref","first-page":"6900","DOI":"10.1523\/JNEUROSCI.22-16-06900.2002","article-title":"Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission","volume":"22","author":"Gubellini","year":"2002","journal-title":"J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF440","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1136\/gut.2005.076372","article-title":"Neural contractions in colonic strips from patients with diverticulosis: role of endocannabinoids and substance P","volume":"55","author":"Guagnini","year":"2006","journal-title":"Gut"},{"key":"10.1124\/pr.58.3.2_REF441","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/BF02244012","article-title":"Antianxiety effect of cannabidiol in the elevated plus-maze","volume":"100","author":"Guimaraes","year":"1990","journal-title":"Psychopharmacology"},{"key":"10.1124\/pr.58.3.2_REF442","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0306-3623(94)90027-2","article-title":"Anxiolytic effect of cannabidiol derivatives in the elevated plus-maze","volume":"25","author":"Guimaraes","year":"1994","journal-title":"Gen Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF443","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.neuropharm.2005.12.002","article-title":"Antihyperalgesic effects of local injections of anandamide, ibuprofen, rofecoxib and their combinations in a model of neuropathic pain","volume":"50","author":"Guindon","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.58.3.2_REF444","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.pain.2005.12.007","article-title":"Local interactions between anandamide, an endocannabinoid, and ibuprofen, a nonsteroidal anti-inflammatory drug, in acute and inflammatory pain","volume":"121","author":"Guindon","year":"2006","journal-title":"Pain"},{"key":"10.1124\/pr.58.3.2_REF445","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1460-9568.2004.03428.x","article-title":"Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala","volume":"20","author":"Gulyas","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF446","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1124\/mol.65.3.665","article-title":"Endocannabinoids modulate N-type calcium channels and G-protein-coupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons","volume":"65","author":"Guo","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF447","doi-asserted-by":"crossref","first-page":"23429","DOI":"10.1074\/jbc.C500168200","article-title":"N-Acylphosphatidylethanolamine-hydrolyzing phospholipase D is an important determinant of uterine anandamide levels during implantation","volume":"280","author":"Guo","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.58.3.2_REF448","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nrc1188","article-title":"Cannabinoids: potential anticancer agents","volume":"3","author":"Guzm\u00e1n","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1124\/pr.58.3.2_REF449","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0163-7258(02)00256-5","article-title":"Cannabinoids and cell fate","volume":"95","author":"Guzm\u00e1n","year":"2002","journal-title":"Pharmacol Ther"},{"key":"10.1124\/pr.58.3.2_REF450","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0028-3908(02)00157-0","article-title":"Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers","volume":"43","author":"H\u00e1jos","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.58.3.2_REF451","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0306-4522(01)00287-1","article-title":"Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus","volume":"106","author":"H\u00e1jos","year":"2001","journal-title":"Neuroscience"},{"key":"10.1124\/pr.58.3.2_REF452","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1001\/archpsyc.1972.01750260016003","article-title":"Marihuana use and psychiatric illness","volume":"27","author":"Halikas","year":"1972","journal-title":"Arch Gen Psychiatry"},{"key":"10.1124\/pr.58.3.2_REF453","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/S0140-6736(98)05021-1","article-title":"Adverse effects of cannabis","volume":"352","author":"Hall","year":"1998","journal-title":"Lancet"},{"key":"10.1124\/pr.58.3.2_REF454","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1470-2045(05)70024-3","article-title":"Cannabinoids and cancer: causation, remediation, and palliation","volume":"6","author":"Hall","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1124\/pr.58.3.2_REF455","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/09595230412331324554","article-title":"Cannabis use and psychotic disorders: an update","volume":"23","author":"Hall","year":"2004","journal-title":"Drug Alcohol Rev"},{"key":"10.1124\/pr.58.3.2_REF456","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1046\/j.1460-9568.2002.02192.x","article-title":"The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety","volume":"16","author":"Haller","year":"2002","journal-title":"Eur J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF457","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1111\/j.1460-9568.2004.03293.x","article-title":"Context-dependent effects of CB1 cannabinoid gene disruption on anxiety-like and social behaviour in mice","volume":"19","author":"Haller","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF458","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01.fbp.0000135704.56422.40","article-title":"CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents","volume":"15","author":"Haller","year":"2004","journal-title":"Behav Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF459","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0140-6736(98)05429-4","article-title":"Analgesic effect of the cannabinoid analogue nabilone is not mediated by opioid receptors","volume":"353","author":"Hamann","year":"1999","journal-title":"Lancet"},{"key":"10.1124\/pr.58.3.2_REF460","doi-asserted-by":"crossref","first-page":"8268","DOI":"10.1073\/pnas.95.14.8268","article-title":"Cannabidiol and (-)\u03949-tetrahydrocannabinol are neuroprotective antioxidants","volume":"95","author":"Hampson","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.58.3.2_REF461","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1749-6632.2000.tb06193.x","article-title":"Neuroprotective antioxidants from marijuana","volume":"899","author":"Hampson","year":"2000","journal-title":"Ann NY Acad Sci"},{"key":"10.1124\/pr.58.3.2_REF462","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1152\/jn.2000.84.5.2356","article-title":"Cannabinoid and \u03ba opioid receptors reduce potassium K current via activation of Gs proteins in cultured hippocampal neurons","volume":"84","author":"Hampson","year":"2000","journal-title":"J Neurophysiol"},{"key":"10.1124\/pr.58.3.2_REF463","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1046\/j.1471-4159.2001.00006.x","article-title":"Accumulation of the anandamide precursor and other N-acylethanolamine phospholipids in infant rat models of in vivo necrotic and apoptotic neuronal death","volume":"76","author":"Hansen","year":"2001","journal-title":"J Neurochem"},{"key":"10.1124\/pr.58.3.2_REF464","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1046\/j.1471-4159.2001.00542.x","article-title":"Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration","volume":"78","author":"Hansen","year":"2001","journal-title":"J Neurochem"},{"key":"10.1124\/pr.58.3.2_REF465","doi-asserted-by":"crossref","unstructured":"Hansson AC, Bermudez-Silva FJ, Malinen H, Hyytia P, Sanchez-Vera I, Rimondini R, Rodriguez de Fonseca F, Kunos G, Sommer WH, and Heilig M (2006) Genetic impairment of frontocortical endocannabinoid degradation and high alcohol preference. Neuropsychopharmacology, in press.","DOI":"10.1038\/sj.npp.1301034"},{"key":"10.1124\/pr.58.3.2_REF465a","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1073\/pnas.061029898","article-title":"2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor","volume":"98","author":"Hanus","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.58.3.2_REF467","doi-asserted-by":"crossref","first-page":"14228","DOI":"10.1073\/pnas.96.25.14228","article-title":"HU-308: a specific agonist for CB2, a peripheral cannabinoid receptor","volume":"96","author":"Hanus","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.58.3.2_REF468","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0014-2999(00)00059-5","article-title":"Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice","volume":"392","author":"Hao","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF469","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nature04071","article-title":"A role for lateral hypothalamic orexin neurons in reward seeking","volume":"437","author":"Harris","year":"2005","journal-title":"Nature (Lond)"},{"key":"10.1124\/pr.58.3.2_REF470","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0006-8993(02)03245-6","article-title":"Downregulation of cannabinoid-1 (CB-1) receptors in specific extrahypothalamic regions of rats with dietary obesity: a role for endogenous cannabinoids in driving appetite for palatable food?","volume":"952","author":"Harrold","year":"2002","journal-title":"Brain Res"},{"key":"10.1124\/pr.58.3.2_REF471","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1079\/BJN2003942","article-title":"The cannabinoid system: a role in both the homeostatic and hedonic control of eating?","volume":"90","author":"Harrold","year":"2003","journal-title":"Br J Nutr"},{"key":"10.1124\/pr.58.3.2_REF472","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1158\/0008-5472.CAN-03-3720","article-title":"Cannabinoids induce cancer cell proliferation via tumor necrosis factor \u03b1-converting enzyme (TACE\/ADAM17)-mediated transactivation of the epidermal growth factor receptor","volume":"64","author":"Hart","year":"2004","journal-title":"Cancer Res"},{"key":"10.1124\/pr.58.3.2_REF473","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1365-2125.1978.tb01667.x","article-title":"Bronchodilator effect of \u03941-tetrahydrocannabinol","volume":"5","author":"Hartley","year":"1978","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF474","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S0140-6736(04)16901-8","article-title":"Pathogenetic mechanisms of parkin in Parkinson\u2019s disease","volume":"364","author":"Hattori","year":"2004","journal-title":"Lancet"},{"key":"10.1124\/pr.58.3.2_REF475","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1097\/00001756-200410250-00016","article-title":"Cannabidiol prevents infarction via the non-CB1 cannabinoid receptor mechanism","volume":"15","author":"Hayakawa","year":"2004","journal-title":"Neuroreport"},{"key":"10.1124\/pr.58.3.2_REF476","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1211\/0022357011777891","article-title":"Protective effects of cannabinoid receptor agonists against cocaine and other convulsant-induced toxic behavioural symptoms","volume":"53","author":"Hayase","year":"2001","journal-title":"J Pharm Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF477","first-page":"596","article-title":"Protective effects of cannabinoid receptor ligands analogous to anandamide against cocaine toxicity","volume":"36","author":"Hayase","year":"2001","journal-title":"Nihon Arukoru Yakubutsu Igakkai Zasshi"},{"key":"10.1124\/pr.58.3.2_REF478","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/S0006-2952(99)00274-9","article-title":"Allosteric regulation by oleamide of the binding properties of 5-hydroxytryptamine7 receptors","volume":"58","author":"Hedlund","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF479","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/BF00441953","article-title":"Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models","volume":"98","author":"Heilig","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1124\/pr.58.3.2_REF480","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1359-6446(05)03417-3","article-title":"Cannabinoid therapeutics: high hopes for the future","volume":"10","author":"Hensen","year":"2005","journal-title":"Drug Discov Today"},{"key":"10.1124\/pr.58.3.2_REF481","series-title":"Pharmacology of Cannabis","article-title":"Ocular effects of marijuana","author":"Hepler","year":"1976"},{"key":"10.1124\/pr.58.3.2_REF482","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1001\/jama.1971.03190100074024","article-title":"Marihuana smoking and intraocular pressure","volume":"217","author":"Hepler","year":"1971","journal-title":"J Am Med Assoc"},{"key":"10.1124\/pr.58.3.2_REF483","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/0002-9394(72)90741-6","article-title":"Pupillary constriction after marijuana smoking","volume":"74","author":"Hepler","year":"1972","journal-title":"Am J Ophthalmol"},{"key":"10.1124\/pr.58.3.2_REF484","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0006-8993(91)90096-E","article-title":"Neuronal localization of cannabinoid receptors and second messengers in mutant mouse cerebellum","volume":"552","author":"Herkenham","year":"1991","journal-title":"Brain Res"},{"key":"10.1124\/pr.58.3.2_REF485","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1523\/JNEUROSCI.11-02-00563.1991","article-title":"Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study","volume":"11","author":"Herkenham","year":"1991","journal-title":"J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF486","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1073\/pnas.87.5.1932","article-title":"Cannabinoid receptor localization in brain","volume":"87","author":"Herkenham","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.58.3.2_REF487","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neulet.2004.10.080","article-title":"Coexpression of the cannabinoid receptor type 1 with the corticotrophin-releasing hormone receptor type 1 in distinct regions of the adult mouse forebrain","volume":"375","author":"Hermann","year":"2005","journal-title":"Neurosci Lett"},{"key":"10.1124\/pr.58.3.2_REF488","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/j.yexcr.2006.03.009","article-title":"The CB(2) cannabinoid receptor signals apoptosis via ceramide-dependent activation of the mitochondrial intrinsic pathway","volume":"312","author":"Herrera","year":"2006","journal-title":"Exp Cell Res"},{"key":"10.1124\/pr.58.3.2_REF489","doi-asserted-by":"crossref","first-page":"5084","DOI":"10.1016\/j.febslet.2005.08.021","article-title":"p38 MAPK is involved in CB2 receptor-induced apoptosis of human leukaemia cells","volume":"579","author":"Herrera","year":"2005","journal-title":"FEBS Lett"},{"key":"10.1124\/pr.58.3.2_REF490","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0304-3940(96)13308-5","article-title":"The analgesic effects of R(+)-WIN 55,212-2 mesylate a high affinity cannabinoid agonist, in a rat model of neuropathic pain","volume":"221","author":"Herzberg","year":"1997","journal-title":"Neurosci Lett"},{"key":"10.1124\/pr.58.3.2_REF491","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/hep.20733","article-title":"Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C","volume":"42","author":"Hezode","year":"2005","journal-title":"Hepatology"},{"key":"10.1124\/pr.58.3.2_REF492","doi-asserted-by":"crossref","first-page":"23731","DOI":"10.1074\/jbc.M212369200","article-title":"Hypersensitization of the Orexin 1 receptor by the CB1 receptor: evidence for cross-talk blocked by the specific CB1 antagonist, SR141716","volume":"278","author":"Hilairet","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.58.3.2_REF493","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0014-2999(03)01343-8","article-title":"Antiobesity effects of chronic cannabinoid CB1 receptor antagonist treatment in diet-induced obese mice","volume":"462","author":"Hildebrandt","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF494","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/sj.bjp.0705155","article-title":"Endocannabinoids as mediators in the heart: a potential target for therapy of remodelling after myocardial infarction?","volume":"138","author":"Hiley","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF495","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1017\/S1464793103006201","article-title":"Cannabinoid pharmacology in the cardiovascular system: potential protective mechanisms through lipid signaling","volume":"79","author":"Hiley","year":"2004","journal-title":"Biol Rev Camb Philos Soc"},{"key":"10.1124\/pr.58.3.2_REF496","doi-asserted-by":"crossref","unstructured":"Hill MN, Ho WS, Sinopoli KJ, Viau V, Hillard CJ, and Gorzalka BB (2006) Involvement of the endocannabinoid system in the ability of long-term tricyclic antidepressant treatment to suppress stress-induced activation of the hypothalamicpituitary-adrenal axis. Neuropsychopharmacology, in press.","DOI":"10.1038\/sj.npp.1301092"},{"key":"10.1124\/pr.58.3.2_REF497","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/sj.npp.1300601","article-title":"Downregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress","volume":"30","author":"Hill","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.58.3.2_REF498","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0022-3565(24)39035-4","article-title":"Endocannabinoids and vascular function","volume":"294","author":"Hillard","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.58.3.2_REF499","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0009-3084(00)00191-2","article-title":"The movement of N-arachidonolethanolamide (anandamide) across cellular membranes","volume":"108","author":"Hillard","year":"2000","journal-title":"Chem Phys Lipids"},{"key":"10.1124\/pr.58.3.2_REF500","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/sj.bjp.0705468","article-title":"Cellular accumulation of anandamide: consensus and controversy","volume":"140","author":"Hillard","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF500a","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0022-3565(24)38289-8","article-title":"Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1)","volume":"289","author":"Hillard","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.58.3.2_REF502","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0003-9993(96)90073-8","article-title":"Functional outcome measures to assess interventions for spasticity","volume":"77","author":"Hinderer","year":"1996","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1124\/pr.58.3.2_REF503","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/sj.bjp.0706710","article-title":"Cannabinoid 1 (CB1 receptors coupled to cholinergic motorneurones inhibit neurogenic circular muscle contractility in the human colon","volume":"148","author":"Hinds","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF504","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1124\/mol.104.002618","article-title":"Up-regulation of cyclooxygenase-2 expression is involved in R(+)-methanandamide-induced apoptotic death of human neuroglioma cells","volume":"66","author":"Hinz","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF505","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/sj.bjp.0705160","article-title":"Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric artery","volume":"138","author":"Ho","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF506","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0006-8993(98)01321-3","article-title":"Pre- and postsynaptic distribution of cannabinoid and mu opioid receptors in rat spinal cord","volume":"822","author":"Hohmann","year":"1999","journal-title":"Brain Res"},{"key":"10.1124\/pr.58.3.2_REF507","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1124\/jpet.103.060079","article-title":"Selective activation of cannabinoid CB2 receptors suppresses hyperalgesia evoked by intradermal capsaicin","volume":"308","author":"Hohmann","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.58.3.2_REF508","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0304-3940(98)00534-5","article-title":"Regulation of cannabinoid and mu opioid receptors in rat lumbar spinal cord following neonatal capsaicin treatment","volume":"252","author":"Hohmann","year":"1998","journal-title":"Neurosci Lett"},{"key":"10.1124\/pr.58.3.2_REF509","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0306-4522(99)00220-1","article-title":"Cannabinoid receptors undergo axonal flow in sensory nerves","volume":"92","author":"Hohmann","year":"1999","journal-title":"Neuroscience"},{"key":"10.1124\/pr.58.3.2_REF510","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/(SICI)1098-2396(200007)37:1<71::AID-SYN8>3.0.CO;2-K","article-title":"Localization of cannabinoid CB1 receptor mRNA in neuronal subpopulations of rat striatum: a double-label in situ hybridization study","volume":"37","author":"Hohmann","year":"2000","journal-title":"Synapse"},{"key":"10.1124\/pr.58.3.2_REF511","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/0024-3205(95)00196-D","article-title":"Inhibition of noxious stimulus-evoked activity of spinal cord dorsal horn neurons by the cannabinoid WIN 55,212-2","volume":"56","author":"Hohmann","year":"1995","journal-title":"Life Sci"},{"key":"10.1124\/pr.58.3.2_REF512","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/nature03658","article-title":"An endocannabinoid mechanism for stress-induced analgesia","volume":"435","author":"Hohmann","year":"2005","journal-title":"Nature (Lond)"},{"key":"10.1124\/pr.58.3.2_REF513","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3940(98)00802-7","article-title":"Cannabinoid modulation of wide dynamic range neurons in the lumbar dorsal horn of the rat by spinally administered WIN55,212-2","volume":"257","author":"Hohmann","year":"1998","journal-title":"Neurosci Let"},{"key":"10.1124\/pr.58.3.2_REF513a","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1152\/jn.1999.81.2.575","article-title":"Cannabinoid suppression of noxious heatevoked activity in wide dynamic range neurons in the lumbar dorsal horn of the rat","volume":"81","author":"Hohmann","year":"1999","journal-title":"J Neurophysiol"},{"key":"10.1124\/pr.58.3.2_REF515","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2044.1997.139-az0132.x","article-title":"Pain relief with oral cannabinoids in familial Mediterranean fever","volume":"52","author":"Holdcroft","year":"1997","journal-title":"Anaesthesia"},{"key":"10.1124\/pr.58.3.2_REF516","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/cpt197112144","article-title":"Hunger and appetite after single doses of marijuana, alcohol and dextroamphetamine","volume":"12","author":"Hollister","year":"1971","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/pr.58.3.2_REF517","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000136462","article-title":"Structure-activity relationships in man of cannabis constituents, and homologs and metabolites of \u03949-tetrahydrocannabinol","volume":"11","author":"Hollister","year":"1974","journal-title":"Pharmacology"},{"key":"10.1124\/pr.58.3.2_REF518","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0031-6997(25)06862-0","article-title":"Health aspects of cannabis","volume":"38","author":"Hollister","year":"1986","journal-title":"Pharmacol Rev"},{"key":"10.1124\/pr.58.3.2_REF519","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1097\/00000542-200605000-00021","article-title":"A multicenter dose-escalation study of the analgesic and adverse effects of an oral cannabis extract (Cannador) for postoperative pain management","volume":"104","author":"Holdcroft","year":"2006","journal-title":"Anesthesiology"},{"key":"10.1124\/pr.58.3.2_REF520","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/16501970510027321","article-title":"Neurotrauma Task Force on Mild Traumatic Brain Injury of the WHO Collaborating Centre: summary of the WHO Collaborating Centre for Neurotrauma Task Force on mild traumatic brain injury","volume":"37","author":"Holm","year":"2005","journal-title":"J Rehabil Med"},{"key":"10.1124\/pr.58.3.2_REF521","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0896-6273(00)80642-X","article-title":"Seizures in the developing brain: perhaps not so benign after all","volume":"21","author":"Holmes","year":"1998","journal-title":"Neuron"},{"key":"10.1124\/pr.58.3.2_REF522","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1212\/WNL.63.7_suppl_2.S7","article-title":"The comparative effects of medical therapies for Parkinson\u2019s disease","volume":"63","author":"Horn","year":"2004","journal-title":"Neurology"},{"key":"10.1124\/pr.58.3.2_REF523","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/sj.npp.1300568","article-title":"CB1 receptor knockout mice display reduced ethanol-induced conditioned place preference and increased striatal dopamine D2 receptors","volume":"30","author":"Houchi","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.58.3.2_REF524","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0006-8993(00)01981-8","article-title":"Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, \u03949-THC and anandamide","volume":"857","author":"Houser","year":"2000","journal-title":"Brain Res"},{"key":"10.1124\/pr.58.3.2_REF525","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/sj.bjp.0705881","article-title":"Efficacy in CB1 receptor-mediated signal transduction","volume":"142","author":"Howlett","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF526","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/pr.54.2.161","article-title":"International Union of Pharmacology. XXVII. Classification of cannabinoid receptors","volume":"54","author":"Howlett","year":"2002","journal-title":"Pharmacol Rev"},{"issue":"Suppl 1","key":"10.1124\/pr.58.3.2_REF527","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.neuropharm.2004.07.030","article-title":"Cannabinoid physiology and pharmacology: 30 years of progress","volume":"47","author":"Howlett","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.58.3.2_REF528","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/oby.2004.160","article-title":"Diet-induced changes in stearoyl-CoA desaturase 1 expression in obesity-prone and -resistant mice","volume":"12","author":"Hu","year":"2004","journal-title":"Obes Res"},{"key":"10.1124\/pr.58.3.2_REF528a","doi-asserted-by":"crossref","first-page":"8400","DOI":"10.1073\/pnas.122196999","article-title":"An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors","volume":"99","author":"Huang","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.58.3.2_REF530","doi-asserted-by":"crossref","first-page":"10311","DOI":"10.1523\/JNEUROSCI.23-32-10311.2003","article-title":"Mediation of amphetamine-induced long-term depression of synaptic transmission by CB1 cannabinoid receptors in the rat amygdala","volume":"23","author":"Huang","year":"2003","journal-title":"J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF531","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1523\/JNEUROSCI.21-07-02413.2001","article-title":"Leptin-induced nuclear translocation of STAT3 immunoreactivity in hypothalamic nuclei involved in body weight regulation","volume":"21","author":"H\u00fcbschle","year":"2001","journal-title":"J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF531a","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1016\/S0968-0896(99)00219-9","article-title":"3-(1\u2032,1\u2032-Dimethylbutyl)-1-deoxy-\u03948-THC and related compounds: synthesis of selective ligands for the CB2 receptor","volume":"7","author":"Huffman","year":"1999","journal-title":"Bioorg Med Chem"},{"key":"10.1124\/pr.58.3.2_REF533","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1046\/j.1471-4159.2003.01576.x","article-title":"Cannabinoid CB1 receptor knockout mice exhibit markedly reduced voluntary alcohol consumption and lack alcohol-induced dopamine release in the nucleus accumbens","volume":"84","author":"Hungund","year":"2003","journal-title":"J Neurochem"},{"key":"10.1124\/pr.58.3.2_REF534","doi-asserted-by":"crossref","first-page":"10529","DOI":"10.1073\/pnas.1834309100","article-title":"Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS","volume":"100","author":"Ibrahim","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.58.3.2_REF535","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1073\/pnas.0409888102","article-title":"CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids","volume":"102","author":"Ibrahim","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.58.3.2_REF536","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.pain.2005.12.018","article-title":"CB2 cannabinoid receptor mediation of antinociception","volume":"122","author":"Ibrahim","year":"2006","journal-title":"Pain"},{"key":"10.1124\/pr.58.3.2_REF537","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nm1255","article-title":"Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors","volume":"11","author":"Idris","year":"2005","journal-title":"Nat Med"},{"key":"10.1124\/pr.58.3.2_REF538","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/380255a0","article-title":"Voltage-dependent modulation of N-type calcium channels by G-protein \u03b2\u03b3 subunits","volume":"380","author":"Ikeda","year":"1996","journal-title":"Nature (Lond)"},{"key":"10.1124\/pr.58.3.2_REF539","first-page":"943","article-title":"Nabilone, a cannabinol derivative, in the treatment of anxiety neurosis","volume":"29","author":"Ilaria","year":"1981","journal-title":"Curr Ther Res"},{"key":"10.1124\/pr.58.3.2_REF540","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0006-8993(01)02932-8","article-title":"Immunohistochemical characterization of localization of long-form leptin receptor (OB-Rb) in neurochemically defined cells in the ovine hypothalamus","volume":"920","author":"Iqbal","year":"2001","journal-title":"Brain Res"},{"key":"10.1124\/pr.58.3.2_REF541","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1111\/j.1476-5381.1996.tb15639.x","article-title":"Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves","volume":"118","author":"Ishac","year":"1996","journal-title":"Br J Pharmacol"},{"issue":"Pt 3","key":"10.1124\/pr.58.3.2_REF542","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1113\/jphysiol.2005.094219","article-title":"Retrograde endocannabinoid regulation of GABAergic inhibition in the rat dentate gyrus granule cell","volume":"567","author":"Isokawa","year":"2005","journal-title":"J Physiol (Lond)"},{"key":"10.1124\/pr.58.3.2_REF543","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1471-4159.2003.02327.x","article-title":"Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on \u03b2-amyloid-induced toxicity in PC12 cells","volume":"89","author":"Iuvone","year":"2004","journal-title":"J Neurochem"},{"key":"10.1124\/pr.58.3.2_REF544","series-title":"The Science of Marijuana","author":"Iversen","year":"2000"},{"key":"10.1124\/pr.58.3.2_REF544a","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0022-3565(24)38760-9","article-title":"In vitro and in vivo pharmacological characterization of JTE-907, a novel selective ligand for cannabinoid CB2 receptor","volume":"296","author":"Iwamura","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.58.3.2_REF546","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0016-5085(03)00892-8","article-title":"An endogenous cannabinoid tone attenuates cholera toxin-induced fluidaccumulation in mice","volume":"125","author":"Izzo","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1124\/pr.58.3.2_REF547","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/sj.bjp.0704293","article-title":"Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation","volume":"134","author":"Izzo","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF548","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1471-4892(01)00102-3","article-title":"The gastrointestinal pharmacology of cannabinoids","volume":"1","author":"Izzo","year":"2001","journal-title":"Curr Opin Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF549","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1002\/mds.20214","article-title":"\u03949-Tetrahydrocannabinol improves motor control in a patient with musician\u2019s dystonia","volume":"19","author":"Jabusch","year":"2004","journal-title":"Mov Disord"},{"key":"10.1124\/pr.58.3.2_REF550","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jns.2005.03.002","article-title":"Cannabinoids and neuroprotection in CNS inflammatory disease","volume":"233","author":"Jackson","year":"2005","journal-title":"J Neurol Sci"},{"key":"10.1124\/pr.58.3.2_REF551","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.neuroscience.2005.02.045","article-title":"Cannabinoid-receptor 1 null mice are susceptible to neurofilament damage and caspase 3 activation","volume":"134","author":"Jackson","year":"2005","journal-title":"Neuroscience"},{"key":"10.1124\/pr.58.3.2_REF552","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/S0006-2952(00)00492-5","article-title":"Serum-dependent effects of tamoxifen and cannabinoids upon C6 glioma cell viability","volume":"60","author":"Jacobsson","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF553","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/sj.bjp.0706510","article-title":"Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models","volume":"147","author":"Jayamanne","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF554","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/sj.bjp.0704379","article-title":"Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats","volume":"134","author":"Jamshidi","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF555","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0041-008X(03)00010-3","article-title":"Attenuation of the ovalbumin-induced allergic airway response by cannabinoid treatment in A\/J mice","volume":"188","author":"Jan","year":"2003","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF556","doi-asserted-by":"crossref","first-page":"14136","DOI":"10.1073\/pnas.96.24.14136","article-title":"Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors","volume":"96","author":"J\u00e1rai","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.58.3.2_REF556a","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1046\/j.1471-4159.2000.0742597.x","article-title":"Structure-activity relationships among N-arachidonylethanolamine (Anandamide) head group analogues for the anandamide transporter","volume":"74","author":"Jarrahian","year":"2000","journal-title":"J Neurochem"},{"key":"10.1124\/pr.58.3.2_REF558","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0163-7258(02)00259-0","article-title":"Cannabinoids in the treatment of glaucoma","volume":"95","author":"Jarvinen","year":"2002","journal-title":"Pharmacol Ther"},{"key":"10.1124\/pr.58.3.2_REF559","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1096\/fj.04-3177fje","article-title":"The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance","volume":"19","author":"Jbilo","year":"2005","journal-title":"FASEB J"},{"key":"10.1124\/pr.58.3.2_REF560","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1172\/JCI25509","article-title":"Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects","volume":"115","author":"Jiang","year":"2005","journal-title":"J Clin Investig"},{"key":"10.1124\/pr.58.3.2_REF561","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/hep.20714","article-title":"Endocannabinoids and liver disease","volume":"41","author":"Jimenez","year":"2005","journal-title":"Hepatology"},{"key":"10.1124\/pr.58.3.2_REF562","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/1531-8249(200008)48:2<257::AID-ANA18>3.0.CO;2-P","article-title":"CB1 cannabinoid receptor induction in experimental stroke","volume":"48","author":"Jin","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1124\/pr.58.3.2_REF563","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1523\/JNEUROSCI.19-10-03773.1999","article-title":"Distinct domains of the CB1 cannabinoid receptor mediate desensitization and internalization","volume":"19","author":"Jin","year":"1999","journal-title":"J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF564","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.neuron.2005.10.021","article-title":"Integration of endocannabinoid and leptin signaling in an appetite-related neural circuit","volume":"48","author":"Jo","year":"2005","journal-title":"Neuron"},{"key":"10.1124\/pr.58.3.2_REF565","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0304-3959(01)00336-0","article-title":"Cannabinoids attenuate capsaicin-evoked hyperalgesia through spinal and peripheral mechanisms","volume":"93","author":"Johanek","year":"2001","journal-title":"Pain"},{"key":"10.1124\/pr.58.3.2_REF566","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.pain.2004.02.020","article-title":"Activation of peripheral cannabinoid receptors attenuates cutaneous hyperalgesia produced by a heat injury","volume":"109","author":"Johanek","year":"2004","journal-title":"Pain"},{"key":"10.1124\/pr.58.3.2_REF567","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1192\/bjp.178.2.116","article-title":"Psychiatric effects of cannabis","volume":"178","author":"Johns","year":"2001","journal-title":"Br J Psychiatry"},{"key":"10.1124\/pr.58.3.2_REF568","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1523\/JNEUROSCI.12-02-00483.1992","article-title":"Opioids excite dopamine neurons by hyperpolarization of local interneurons","volume":"12","author":"Johnson","year":"1992","journal-title":"J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF569","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1139\/y75-140","article-title":"Epileptiform seizures in domestic fowl. V. The anticonvulsant activity of \u03949-tetrahydrocannabinol","volume":"53","author":"Johnson","year":"1975","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF570","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0006-2952(74)90435-3","article-title":"Relative pharmacological potency in mice of optical isomers of \u03941-tetrahydrocannabinol","volume":"23","author":"Jones","year":"1974","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF571","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1517\/14728222.7.6.749","article-title":"Cannabinoid receptor systems: therapeutic targets for tumour intervention","volume":"7","author":"Jones","year":"2003","journal-title":"Expert Opin Ther Targets"},{"key":"10.1124\/pr.58.3.2_REF572","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00204-002-0435-6","article-title":"AM404 and VDM 11 non-specifically inhibit C6 glioma cell proliferation at concentrations used to block the cellular accumulation of the endocannabinoid anandamide","volume":"77","author":"Jonsson","year":"2003","journal-title":"Arch Toxicol"},{"key":"10.1124\/pr.58.3.2_REF573","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/nature02282","article-title":"Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1","volume":"427","author":"Jordt","year":"2004","journal-title":"Nature (Lond)"},{"key":"10.1124\/pr.58.3.2_REF574","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00262-004-0509-9","article-title":"Anandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytes","volume":"53","author":"Joseph","year":"2004","journal-title":"Cancer Immunol Immunother"},{"key":"10.1124\/pr.58.3.2_REF575","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0008-6363(02)00268-7","article-title":"Endocannabinoids are implicated in the infarct size-reducing effect conferred by heat stress preconditioning in isolated rat hearts","volume":"55","author":"Joyeux","year":"2002","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pr.58.3.2_REF576","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ceca.2005.10.005","article-title":"Cannabinoid receptors regulate Ca2+ signals and insulin secretion in pancreatic \u03b2-cell","volume":"39","author":"Juan-Pico","year":"2005","journal-title":"Cell Calcium"},{"key":"10.1124\/pr.58.3.2_REF577","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1053\/j.gastro.2004.12.050","article-title":"Antifibrogenic role of the cannabinoid receptor CB2 in the liver","volume":"128","author":"Julien","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1124\/pr.58.3.2_REF578","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/bja\/aei106","article-title":"Effects of AM281, a cannabinoid antagonist, on systemic haemodynamics, internal carotid artery blood flow and mortality in septic shock in rats","volume":"94","author":"Kadoi","year":"2005","journal-title":"Br J Anaesth"},{"key":"10.1124\/pr.58.3.2_REF579","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1097\/01.CCM.0000187010.14426.CC","article-title":"Cannabinoid antagonist AM 281 reduces mortality rate and neurologic dysfunction after cecal ligation and puncture in rats","volume":"33","author":"Kadoi","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1124\/pr.58.3.2_REF580","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1745-9974-2-2","article-title":"Effect of N-arachidonoyl-(2-methyl-4-hydroxyphenyl) amine (VDM11), an anandamide transporter inhibitor, on capsaicin-induced cough in mice","volume":"2","author":"Kamei","year":"2006","journal-title":"Cough"},{"key":"10.1124\/pr.58.3.2_REF581","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1161\/01.CIR.53.4.703","article-title":"The effects of delta-9-tetrahydrocannabinol (cannabis) on cardiac performance with and without beta blockade","volume":"53","author":"Kanakis","year":"1976","journal-title":"Circulation"},{"key":"10.1124\/pr.58.3.2_REF582","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.taap.2004.09.013","article-title":"Inhibition of leukocyte function and interleukin-2 gene expression by 2-methylarachidonyl-(2\u2032-fluoroethyl)amide, a stable congener of the endogenous cannabinoid receptor ligand anandamide","volume":"205","author":"Kaplan","year":"2005","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF583","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/0028-3908(84)90052-2","article-title":"Interaction between \u0394-9-tetrahydrocannabinol and kindling by electrical and chemical stimuli in mice","volume":"23","author":"Karler","year":"1984","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.58.3.2_REF584","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0028-3908(86)90240-6","article-title":"Prolonged CNS hyperexcitability in mice after a single exposure to \u0394-9-tetrahydrocannabinol","volume":"25","author":"Karler","year":"1986","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.58.3.2_REF585","doi-asserted-by":"crossref","first-page":"437S","DOI":"10.1002\/j.1552-4604.1981.tb02624.x","article-title":"The cannabinoids as potential antiepileptics","volume":"21","author":"Karler","year":"1981","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF586","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1093\/hmg\/ddi370","article-title":"The cannabinoid receptor type 2 (CNR2) gene is associated with human osteoporosis","volume":"14","author":"Karsak","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1124\/pr.58.3.2_REF587","first-page":"S383","article-title":"The cannabinoid CB2 receptor: a potential target for the treatment of osteoporosis","volume":"19","author":"Karsak","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1124\/pr.58.3.2_REF588","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1001\/jama.290.13.1757","article-title":"Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial","volume":"290","author":"Karst","year":"2003","journal-title":"J Am Med Assoc"},{"key":"10.1124\/pr.58.3.2_REF589","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/nm803","article-title":"Modulation of anxiety through blockade of anandamide hydrolysis","volume":"9","author":"Kathuria","year":"2003","journal-title":"Nat Med"},{"key":"10.1124\/pr.58.3.2_REF590","doi-asserted-by":"crossref","first-page":"9506","DOI":"10.1523\/JNEUROSCI.21-23-09506.2001","article-title":"Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission","volume":"21","author":"Katona","year":"2001","journal-title":"J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF591","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1523\/JNEUROSCI.19-11-04544.1999","article-title":"Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons","volume":"19","author":"Katona","year":"1999","journal-title":"J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF592","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1124\/mol.104.006882","article-title":"Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk?","volume":"67","author":"Kearn","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF593","first-page":"474","article-title":"Grand mal convulsions subsequent to marijuana use: case report","volume":"28","author":"Keeler","year":"1967","journal-title":"Dis Nerv Syst"},{"key":"10.1124\/pr.58.3.2_REF594","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11914-003-0011-x","article-title":"Burden of osteoporosis and fractures","volume":"1","author":"Keen","year":"2003","journal-title":"Curr Osteoporos Rep"},{"key":"10.1124\/pr.58.3.2_REF595","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/0304-4165(73)90335-8","article-title":"The effects of \u03941-tetrahydrocannabinol on cyclic AMP levels in WI-38 fibroblasts","volume":"320","author":"Kelly","year":"1973","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/pr.58.3.2_REF596","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1046\/j.1460-9568.2003.02957.x","article-title":"Activation of peripheral cannabinoid CB1 receptors inhibits mechanically evoked responses of spinal neurons in noninflamed rats and rats with hindpaw inflammation","volume":"18","author":"Kelly","year":"2003","journal-title":"Eur J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF596a","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1021\/jm960152y","article-title":"Head group analogs of arachidonylethanolamide, the endogenous cannabinoid ligand","volume":"39","author":"Khanolkar","year":"1996","journal-title":"J Med Chem"},{"key":"10.1124\/pr.58.3.2_REF598","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1111\/j.1460-9568.2004.03285.x","article-title":"Involvement of brain-derived neurotrophic factor in cannabinoid receptor-dependent protection against excitotoxicity","volume":"19","author":"Khaspekov","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF599","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0165-5728(03)00045-6","article-title":"Immunomodulatory effects of orally administered cannabinoids in multiple sclerosis","volume":"137","author":"Killestein","year":"2003","journal-title":"J Neuroimmunol"},{"key":"10.1124\/pr.58.3.2_REF600","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1212\/WNL.58.9.1404","article-title":"Safety, tolerability, and efficacy of orally administered cannabinoids in MS","volume":"58","author":"Killestein","year":"2002","journal-title":"Neurology"},{"key":"10.1124\/pr.58.3.2_REF601","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/01.wco.0000169741.29535.cc","article-title":"Current trials in multiple sclerosis: established evidence and future hopes","volume":"18","author":"Killestein","year":"2005","journal-title":"Curr Opin Neurol"},{"key":"10.1124\/pr.58.3.2_REF602","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-200464010-00001","article-title":"Cannabinoids in multiple sclerosis: do they have a therapeutic role?","volume":"64","author":"Killestein","year":"2004","journal-title":"Drugs"},{"key":"10.1124\/pr.58.3.2_REF603","doi-asserted-by":"crossref","first-page":"19970","DOI":"10.1074\/jbc.M402165200","article-title":"C75, a fatty acid synthase inhibitor, reduces food intake via hypothalamic AMP-activated protein kinase","volume":"279","author":"Kim","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.58.3.2_REF604","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nn1262","article-title":"Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus","volume":"7","author":"Kim","year":"2004","journal-title":"Nat Neurosci"},{"key":"10.1124\/pr.58.3.2_REF605","doi-asserted-by":"crossref","first-page":"10182","DOI":"10.1523\/JNEUROSCI.22-23-10182.2002","article-title":"Activation of muscarinic acetylcholine receptors enhances the release of endogenous cannabinoids in the hippocampus","volume":"22","author":"Kim","year":"2002","journal-title":"J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF606","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1124\/jpet.104.079509","article-title":"Involvement of protein kinase A in cannabinoid receptor-mediated protection from oxidative neuronal injury","volume":"313","author":"Kim","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.58.3.2_REF607","series-title":"Cannabinoids","first-page":"147","article-title":"Cannabinoids and medicine: eating disorders, nausea and emesis","author":"Kirkham","year":"2004"},{"key":"10.1124\/pr.58.3.2_REF608","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00008877-200509000-00004","article-title":"Endocannabinoids in the regulation of appetite and body weight","volume":"16","author":"Kirkham","year":"2005","journal-title":"Behav Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF609","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1079\/095442201108729141","article-title":"Endogenous cannabinoids and appetite","volume":"14","author":"Kirkham","year":"2001","journal-title":"Nutr Res Rev"},{"key":"10.1124\/pr.58.3.2_REF610","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s002130000596","article-title":"Synergistic effects of opioid and cannabinoid antagonists on food intake","volume":"159","author":"Kirkham","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1124\/pr.58.3.2_REF611","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/sj.bjp.0704767","article-title":"Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol","volume":"136","author":"Kirkham","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF612","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nri1602","article-title":"Cannabinoid-based drugs as anti-inflammatory therapeutics","volume":"5","author":"Klein","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1124\/pr.58.3.2_REF613","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0165-5728(97)00226-9","article-title":"Marijuana, immunity and infection","volume":"83","author":"Klein","year":"1998","journal-title":"J Neuroimmunol"},{"key":"10.1124\/pr.58.3.2_REF614","first-page":"1","article-title":"The cannabinoid system and cytokine network","volume":"225","author":"Klein","year":"2000","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1124\/pr.58.3.2_REF615","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1189\/jlb.0303101","article-title":"The cannabinoid system and immune modulation","volume":"74","author":"Klein","year":"2003","journal-title":"J Leukoc Biol"},{"key":"10.1124\/pr.58.3.2_REF616","doi-asserted-by":"crossref","first-page":"6461","DOI":"10.4049\/jimmunol.164.12.6461","article-title":"\u03949-Tetrahydrocannabinol treatment suppresses immunity and early IFN-\u03b3, IL-12, and IL-12 receptor \u03b2 2 responses to Legionella pneumophila infection","volume":"164","author":"Klein","year":"2000","journal-title":"J Immunol"},{"key":"10.1124\/pr.58.3.2_REF617","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S1474-4422(03)00558-1","article-title":"American Stroke Association and European Stroke Initiative: management of acute ischaemic stroke: new guidelines from the American Stroke Association and European Stroke Initiative","volume":"2","author":"Klijn","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1124\/pr.58.3.2_REF618","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/00003246-200203000-00009","article-title":"Dexanabinol (HU-211) in the treatment of severe closed head injury: a randomized, placebo-controlled, phase II clinical trial","volume":"30","author":"Knoller","year":"2002","journal-title":"Crit Care Med"},{"key":"10.1124\/pr.58.3.2_REF619","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1021\/jm040042o","article-title":"Synthesis and antitumor activity of quinonoid derivatives of cannabinoids","volume":"47","author":"Kogan","year":"2004","journal-title":"J Med Chem"},{"key":"10.1124\/pr.58.3.2_REF620","doi-asserted-by":"crossref","first-page":"25196","DOI":"10.1074\/jbc.C500175200","article-title":"Cannabinoids and ghrelin have both central and peripheral metabolic effects via AMP-activated protein kinase","volume":"280","author":"Kola","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.58.3.2_REF621","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0165-6147(92)90060-J","article-title":"Drugs of abuse: anatomy, pharmacology and function of reward pathways","volume":"13","author":"Koob","year":"1992","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/pr.58.3.2_REF622","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0896-6273(00)80109-9","article-title":"Drug addiction: the yin and yang of hedonic homeostasis","volume":"16","author":"Koob","year":"1996","journal-title":"Neuron"},{"key":"10.1124\/pr.58.3.2_REF623","first-page":"499","article-title":"Stimulant and anxiogenic effects of corticotropin releasing factor","volume":"192","author":"Koob","year":"1985","journal-title":"Prog Clin Biol Res"},{"key":"10.1124\/pr.58.3.2_REF624","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0306-3623(80)90026-9","article-title":"The ocular effects of cannabinoids","volume":"11","author":"Korczyn","year":"1980","journal-title":"Gen Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF625","first-page":"76","article-title":"Antihypertensive effects of \u03949-tetrahydrocannabinol","volume":"233","author":"Kosersky","year":"1978","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1124\/pr.58.3.2_REF625a","doi-asserted-by":"crossref","first-page":"22937","DOI":"10.1016\/S0021-9258(17)31599-5","article-title":"Inhibitors of arachidonoyl ethanolamide hydrolysis","volume":"269","author":"Koutek","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.58.3.2_REF627","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0896-6273(01)00246-X","article-title":"Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells","volume":"29","author":"Kreutzer","year":"2001","journal-title":"Neuron"},{"key":"10.1124\/pr.58.3.2_REF628","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/29993","article-title":"Hypothalamic CART is a new anorectic peptide regulated by leptin","volume":"393","author":"Kristensen","year":"1998","journal-title":"Nature (Lond)"},{"key":"10.1124\/pr.58.3.2_REF629","first-page":"560","article-title":"Increase of the heart arrhythmogenic resistance and decrease of the myocardialnecrosis zone during activation of cannabinoid receptors","volume":"88","author":"Krylatov","year":"2002","journal-title":"Ross Fiziol Zh Im I M Sechenova"},{"key":"10.1124\/pr.58.3.2_REF630","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s10517-005-0344-9","article-title":"Cannabinoid receptor antagonists SR141716 and SR144528 exhibit properties of partial agonists in experiments on isolated perfused rat heart","volume":"139","author":"Krylatov","year":"2005","journal-title":"Bull Exp Biol Med"},{"key":"10.1124\/pr.58.3.2_REF631","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1023\/A:1012381914518","article-title":"Activation of type II cannabinoid receptors improves myocardial tolerance to arrhythmogenic effects of coronary occlusion and reperfusion","volume":"131","author":"Krylatov","year":"2001","journal-title":"Bull Exp Biol Med"},{"key":"10.1124\/pr.58.3.2_REF632","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1023\/A:1015574100494","article-title":"Endogenous cannabinoids improve myocardial resistance to arrhythmogenic effects of coronary occlusion and reperfusion: a possible mechanism","volume":"133","author":"Krylatov","year":"2002","journal-title":"Bull Exp Biol Med"},{"key":"10.1124\/pr.58.3.2_REF633","first-page":"6","article-title":"Anandamide and R-(+)-methanandamide prevent development of ischemic and reperfusion arrhythmia in rats by stimulation of CB2-receptors","volume":"65","author":"Krylatov","year":"2002","journal-title":"Eksp Klin Farmakol"},{"key":"10.1124\/pr.58.3.2_REF634","first-page":"782","article-title":"Parental occupation and childhood astrocytoma: results of a case-control study","volume":"52","author":"Kuijten","year":"1992","journal-title":"Cancer Res"},{"key":"10.1124\/pr.58.3.2_REF635","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s004410000261","article-title":"Localization of CB1-cannabinoid receptor immunoreactivity in the porcine enteric nervous system","volume":"302","author":"Kulkarni-Narla","year":"2000","journal-title":"Cell Tissue Res"},{"key":"10.1124\/pr.58.3.2_REF636","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0009-3084(02)00145-7","article-title":"The quest for a vascular endothelial cannabinoids receptor","volume":"121","author":"Kunos","year":"2002","journal-title":"Chem Phys Lipids"},{"key":"10.1124\/pr.58.3.2_REF637","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0009-3084(00)00194-8","article-title":"Endocannabinoids as cardiovascular modulators","volume":"108","author":"Kunos","year":"2000","journal-title":"Chem Phys Lipids"},{"key":"10.1124\/pr.58.3.2_REF638","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nm0704-678","article-title":"Cannabinoids cool the intestine","volume":"10","author":"Kunos","year":"2004","journal-title":"Nat Med"},{"key":"10.1124\/pr.58.3.2_REF639","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/08941930590905189","article-title":"2-Arachidonoylglycerol increases in ischemia-reperfusion injury of the rat liver","volume":"18","author":"Kurabayashi","year":"2005","journal-title":"J Investig Surg"},{"key":"10.1124\/pr.58.3.2_REF640","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/sj.bjp.0706195","article-title":"Central and peripheral components of the pressor effect of anandamide in urethane-anaesthetized rats","volume":"145","author":"Kwolek","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF641","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/sj.bjp.0703902","article-title":"Involvement of cannabinoids in the cardioprotection induced by lipopolysaccharide","volume":"132","author":"Lagneux","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF642","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0024-3205(02)02339-1","article-title":"Topically administered CB2-receptor agonist, JWH-133, does not decrease intraocular pressure (IOP) in normotensive rabbits","volume":"72","author":"Laine","year":"2003","journal-title":"Life Sci"},{"key":"10.1124\/pr.58.3.2_REF643","first-page":"3216","article-title":"Comparison of the enzymatic stability and intraocular pressure effects of 2-arachidonylglycerol and noladin ether, a novel putative endocannabinoid","volume":"43","author":"Laine","year":"2002","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1124\/pr.58.3.2_REF644","first-page":"393","article-title":"Effect of the enzyme inhibitor, phenylmethylsulfonyl fluoride, on the IOP profiles of topical anandamides","volume":"43","author":"Laine","year":"2002","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1124\/pr.58.3.2_REF645","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0022-3565(24)36714-X","article-title":"Cannabinoid-induced hypotension and bradycardia in rats mediated by CB1-like cannabinoid receptors","volume":"281","author":"Lake","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.58.3.2_REF646","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/01.HYP.29.5.1204","article-title":"Cardiovascular effects of anandamide in anesthetized and conscious normotensive and hypertensive rats","volume":"29","author":"Lake","year":"1997","journal-title":"Hypertension"},{"key":"10.1124\/pr.58.3.2_REF647","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/alcalc\/agh115","article-title":"Ethanol induces higher BEC in CB1 cannabinoid receptor knockout mice while decreasing ethanol preference","volume":"40","author":"Lallemand","year":"2004","journal-title":"Alcohol Alcohol"},{"key":"10.1124\/pr.58.3.2_REF647a","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.1208\/ps010204","article-title":"A design and synthesis of the CB1 selective cannabinoid antagonist AM281: a potential human SPECT ligand","volume":"1","author":"Lan","year":"1999","journal-title":"AAPS PharmSci"},{"key":"10.1124\/pr.58.3.2_REF647ab","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1021\/jm980363y","article-title":"Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists","volume":"42","author":"Lan","year":"1999","journal-title":"J Med Chem"},{"key":"10.1124\/pr.58.3.2_REF650","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0014-2999(02)02053-8","article-title":"Modulation of gastric emptying and gastrointestinal transit in rats through intestinal cannabinoid CB1 receptors","volume":"450","author":"Landi","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF651","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1021\/jm980461j","article-title":"Substrate specificity and stereoselectivity of rat brain microsomal anandamide amidohydrolase","volume":"42","author":"Lang","year":"1999","journal-title":"J Med Chem"},{"key":"10.1124\/pr.58.3.2_REF652","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1124\/jpet.105.100792","article-title":"Modulation of neuropathic and inflammatory pain by the endocannabinoid transport inhibitor AM404","volume":"317","author":"La Rana","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.58.3.2_REF653","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.291.5.605","article-title":"The new antiepileptic drugs: scientific review","volume":"291","author":"LaRoche","year":"2004","journal-title":"J Am Med Assoc"},{"key":"10.1124\/pr.58.3.2_REF654","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0006-8993(01)03403-5","article-title":"Loss of mRNA levels, binding and activation of GTP-binding proteins for cannabinoid CB1 receptors in the basal ganglia of a transgenic model of Huntington\u2019s disease","volume":"929","author":"Lastres-Becker","year":"2002","journal-title":"Brain Res"},{"key":"10.1124\/pr.58.3.2_REF655","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1046\/j.0953-816x.2001.01812.x","article-title":"Increased cannabinoid CB1 receptor binding and activation of GTP-binding proteins in the basal ganglia of patients with Parkinson\u2019s syndrome and of MPTP-treated marmosets","volume":"14","author":"Lastres-Becker","year":"2001","journal-title":"Eur J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF656","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1046\/j.1471-4159.2003.01595.x","article-title":"Compounds acting at the endocannabinoid and\/or endovanilloid systems reduce hyperkinesia in a rat model of Huntington\u2019s disease","volume":"84","author":"Lastres-Becker","year":"2003","journal-title":"J Neurochem"},{"key":"10.1124\/pr.58.3.2_REF657","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2174\/1568007033482751","article-title":"The endocannabinoid system and Huntington\u2019s disease","volume":"2","author":"Lastres-Becker","year":"2003","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"10.1124\/pr.58.3.2_REF658","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1097\/00001756-200107200-00017","article-title":"Changes in endocannabinoid transmission in the basal ganglia in a rat model of Huntington\u2019s disease","volume":"12","author":"Lastres-Becker","year":"2001","journal-title":"Neuroreport"},{"key":"10.1124\/pr.58.3.2_REF659","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/10298420290030514","article-title":"Loss of cannabinoid CB1 receptors in the basal ganglia in the late akinetic phase of rats with experimental Huntington\u2019s disease","volume":"4","author":"Lastres-Becker","year":"2002","journal-title":"Neurotox Res"},{"key":"10.1124\/pr.58.3.2_REF660","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.nbd.2004.11.009","article-title":"Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson\u2019s disease","volume":"19","author":"Lastres-Becker","year":"2005","journal-title":"Neurobiol Dis"},{"key":"10.1124\/pr.58.3.2_REF661","doi-asserted-by":"crossref","first-page":"19144","DOI":"10.1073\/pnas.0509588102","article-title":"The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq\/11 G proteins","volume":"102","author":"Lauckner","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.58.3.2_REF662","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0006-8993(01)02356-3","article-title":"Long term cerebroprotective effects of dexanabinol in a model of focal cerebral ischemia","volume":"901","author":"Lavie","year":"2001","journal-title":"Brain Res"},{"key":"10.1124\/pr.58.3.2_REF663","doi-asserted-by":"crossref","unstructured":"Laviolette SR and Grace AA (2006) The roles of cannabinoid and dopamine receptor systems in neural emotional learning circuits: implications for schizophrenia and addiction. Cell Mol Life Sci, in press.","DOI":"10.1007\/s00018-006-6027-5"},{"key":"10.1124\/pr.58.3.2_REF664","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1124\/mol.64.6.1334","article-title":"A novel synthetic cannabinoid derivative inhibits inflammatory liver damage via negative cytokine regulation","volume":"64","author":"Lavon","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF665","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0026-895X(25)10680-9","article-title":"The effects of \u03941-tetrahydrocannabinol and other cannabinoids on spin-labeled liposomes and their relationship to mechanisms of general anesthesia","volume":"11","author":"Lawrence","year":"1975","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF666","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1097\/00001756-200409150-00028","article-title":"Rimonabant, a CB1 antagonist, blocks nicotine-conditioned place preferences","volume":"15","author":"Le Foll","year":"2004","journal-title":"Neuroreport"},{"key":"10.1124\/pr.58.3.2_REF667","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1124\/jpet.104.077974","article-title":"Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence","volume":"312","author":"Le Foll","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.58.3.2_REF668","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1126\/science.283.5400.401","article-title":"Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice","volume":"283","author":"Ledent","year":"1999","journal-title":"Science (Wash DC)"},{"key":"10.1124\/pr.58.3.2_REF669","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2003.10.019","article-title":"Differential effects of the sleep-inducing lipid oleamide and cannabinoids on the induction of long-term potentiation in the CA1 neurons of the rat hippocampus in vitro","volume":"997","author":"Lees","year":"2004","journal-title":"Brain Res"},{"key":"10.1124\/pr.58.3.2_REF670","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/sj.bjp.0705607","article-title":"Oleamide is a selective endogenous agonist of rat and human CB1 cannabinoid receptors","volume":"141","author":"Leggett","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF671","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1161\/01.STR.0000079817.68944.1E","article-title":"Drug-induced hypothermia reduces ischemic damage: effects of the cannabinoid HU-210","volume":"34","author":"Leker","year":"2003","journal-title":"Stroke"},{"key":"10.1124\/pr.58.3.2_REF672","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0022-510X(98)00301-3","article-title":"Dexanabinol; a novel neuroprotective drug in experimental focal cerebral ischemia","volume":"162","author":"Leker","year":"1999","journal-title":"J Neurol Sci"},{"key":"10.1124\/pr.58.3.2_REF673","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1146\/annurev.pa.20.040180.001055","article-title":"Potential therapeutic usefulness of marijuana","volume":"20","author":"Lemberger","year":"1980","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/pr.58.3.2_REF674","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/sj.bjp.0705313","article-title":"Endocannabinoids protect the rat isolated heart against ischaemia","volume":"139","author":"Lepicier","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF675","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/0024-3205(95)00191-8","article-title":"Conditioned place preference induced by \u03949-tetrahydrocannabinol: comparison with cocaine, morphine and food reward","volume":"56","author":"Lepore","year":"1995","journal-title":"Life Sci"},{"key":"10.1124\/pr.58.3.2_REF676","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/ajmg.10038","article-title":"Schizophrenia and the cannabinoid receptor type 1 (CB1): association study using a single-base polymorphism in coding exon 1","volume":"105","author":"Leroy","year":"2001","journal-title":"Am J Med Genet"},{"key":"10.1124\/pr.58.3.2_REF677","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.euroneuro.2004.04.003","article-title":"Endogenous cannabinoids are not involved in cocaine reinforcement and development of cocaine-induced behavioral sensitization","volume":"15","author":"Lesscher","year":"2005","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1124\/pr.58.3.2_REF678","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1021\/bi060163l","article-title":"Inactivation of N-acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoids","volume":"45","author":"Leung","year":"2006","journal-title":"Biochemistry"},{"key":"10.1124\/pr.58.3.2_REF679","doi-asserted-by":"crossref","first-page":"895","DOI":"10.2165\/00023210-200418130-00005","article-title":"Cannabis-associated psychosis: current status of research","volume":"18","author":"Leweke","year":"2004","journal-title":"CNS Drugs"},{"key":"10.1124\/pr.58.3.2_REF680","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1097\/00001756-199906030-00008","article-title":"Elevated endogenous cannabinoids in schizophrenia","volume":"10","author":"Leweke","year":"1999","journal-title":"Neuroreport"},{"key":"10.1124\/pr.58.3.2_REF681","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nrn1648","article-title":"Cortical inhibitory neurons and schizophrenia","volume":"6","author":"Lewis","year":"2005","journal-title":"Nat Rev Neurosci"},{"key":"10.1124\/pr.58.3.2_REF682","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1161\/01.HYP.0000051641.58674.F7","article-title":"Anandamide-induced depressor effect in spontaneously hypertensive rats: role of the vanilloid receptor","volume":"41","author":"Li","year":"2003","journal-title":"Hypertension"},{"key":"10.1124\/pr.58.3.2_REF683","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2174\/1568007043336833","article-title":"Therapeutic potential of cannabinoids in trigeminal neuralgia","volume":"3","author":"Liang","year":"2004","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"10.1124\/pr.58.3.2_REF684","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1161\/CIRCULATIONAHA.105.537878","article-title":"Pathophysiology of coronary artery disease","volume":"111","author":"Libby","year":"2005","journal-title":"Circulation"},{"key":"10.1124\/pr.58.3.2_REF685","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1124\/jpet.104.069401","article-title":"Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: evidence for an unprecedented combination of potency and selectivity","volume":"311","author":"Lichtman","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.58.3.2_REF686","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0006-8993(91)90017-P","article-title":"Cannabinoid-induced antinociception is mediated by a spinal \u03b12-noradrenergic mechanism","volume":"559","author":"Lichtman","year":"1991","journal-title":"Brain Res"},{"key":"10.1124\/pr.58.3.2_REF687","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0022-3565(25)20242-7","article-title":"Spinal and supraspinal components of cannabinoid-induced antinociception","volume":"258","author":"Lichtman","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.58.3.2_REF688","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.pain.2004.01.022","article-title":"Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia","volume":"109","author":"Lichtman","year":"2004","journal-title":"Pain"},{"key":"10.1124\/pr.58.3.2_REF689","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/sj.bjp.0706418","article-title":"New potent and selective inhibitors of anandamide reuptake with antispastic activity in a mouse model of multiple sclerosis","volume":"147","author":"Ligresti","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF690","doi-asserted-by":"crossref","unstructured":"Ligresti A, Schiano Moriello A, Starowicz K, Matias I, Pisanti S, De Petrocellis L, Laezza C, Portella G, Bifulco M, and Di Marzo V (2006b) Anti-tumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. J Pharmacol Exp Ther, in press.","DOI":"10.1124\/jpet.106.105247"},{"key":"10.1124\/pr.58.3.2_REF690a","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.1021\/jm970257g","article-title":"Novel analogues of arachidonylethanolamide (anandamide): affinities for the CB1 and CB2 cannabinoid receptors and metabolic stability","volume":"41","author":"Lin","year":"1998","journal-title":"J Med Chem"},{"key":"10.1124\/pr.58.3.2_REF692","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1001\/archpsyc.1994.03950040017002","article-title":"Cannabis abuse and the course of recent-onset schizophrenic disorders","volume":"51","author":"Linszen","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"10.1124\/pr.58.3.2_REF693","doi-asserted-by":"crossref","first-page":"45034","DOI":"10.1074\/jbc.M306062200","article-title":"LPS induces anandamide synthesis in macrophages via CD14\/MAPK\/PI3K\/NF-\u03baB independently of platelet activating factor","volume":"278","author":"Liu","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.58.3.2_REF694","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1042\/bj3460835","article-title":"Functional CB1 cannabinoid receptors in human vascular endothelial cells","volume":"346","author":"Liu","year":"2000","journal-title":"Biochem J"},{"key":"10.1124\/pr.58.3.2_REF695","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1124\/mol.63.5.983","article-title":"Activation and binding of peroxisome proliferator-activated receptor gamma by synthetic cannabinoid ajulemic acid","volume":"63","author":"Liu","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF696","doi-asserted-by":"crossref","first-page":"13345","DOI":"10.1073\/pnas.0601832103","article-title":"Novel biosynthetic pathway for anandamide","volume":"103","author":"Liu","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.58.3.2_REF697","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1001\/archopht.1987.01060020099037","article-title":"Central nervous system and peripheral mechanisms in ocular hypotensive effect of cannabinoids","volume":"105","author":"Liu","year":"1987","journal-title":"Arch Ophthalmol"},{"key":"10.1124\/pr.58.3.2_REF698","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/sj.ijo.0802847","article-title":"Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lepob\/Lepob mice","volume":"29","author":"Liu","year":"2005","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1124\/pr.58.3.2_REF699","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.oraloncology.2003.08.015","article-title":"An analysis of risk factors for oral cancer in young people: a case-control study","volume":"40","author":"Llewellyn","year":"2004","journal-title":"Oral Oncol"},{"key":"10.1124\/pr.58.3.2_REF700","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1053\/j.gastro.2004.01.063","article-title":"Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences","volume":"126","author":"Loftus","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1124\/pr.58.3.2_REF701","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejphar.2004.04.039","article-title":"Cannabinoid agonists induce contractile responses through Gi\/o-dependent activation of phospholipase C in the bovine ciliary muscle","volume":"494","author":"Lograno","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF702","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.leukres.2005.01.014","article-title":"Targeting cannabinoid receptors to treat leukemia: role of cross-talk between extrinsic and intrinsic pathways in \u03949-tetrahydrocannabinol (THC)-induced apoptosis of Jurkat cells","volume":"29","author":"Lombard","year":"2005","journal-title":"Leuk Res"},{"key":"10.1124\/pr.58.3.2_REF703","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/sj.npp.1300838","article-title":"Cannabidiol reverses MK-801-induced disruption of prepulse inhibition in mice","volume":"31","author":"Long","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.58.3.2_REF704","doi-asserted-by":"crossref","first-page":"8245","DOI":"10.1523\/JNEUROSCI.2179-04.2004","article-title":"Long-lasting increase of alcohol relapse by the cannabinoid receptor agonist WIN 55,212-2 during alcohol deprivation","volume":"24","author":"Lopez-Moreno","year":"2005","journal-title":"J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF704a","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0223-5234(03)00045-X","article-title":"Design, synthesis and biological evaluation of new endocannabinoid transporter inhibitors","volume":"38","author":"Lopez-Rodriguez","year":"2003","journal-title":"Eur J Med Chem"},{"key":"10.1124\/pr.58.3.2_REF704ab","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1021\/jm015545y","article-title":"Design, synthesis and biological evaluation of novel arachidonic acid derivatives as highly potent and selective endocannabinoid transporter inhibitors","volume":"44","author":"Lopez-Rodriguez","year":"2001","journal-title":"J Med Chem"},{"key":"10.1124\/pr.58.3.2_REF707","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0006-8993(99)02422-1","article-title":"The effect of \u0394-9-tetrahydrocannabinol on forebrain ischemia in rat","volume":"857","author":"Louw","year":"2000","journal-title":"Brain Res"},{"key":"10.1124\/pr.58.3.2_REF708","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1017\/S0952523800171093","article-title":"Expression of CB2 cannabinoid receptor mRNA in adult rat retina","volume":"17","author":"Lu","year":"2000","journal-title":"Vis Neurosci"},{"key":"10.1124\/pr.58.3.2_REF709","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/0091-3057(94)90338-7","article-title":"Marihuana smoking increases plasma cocaine levels and subjective reports of euphoria in male volunteers","volume":"48","author":"Lukas","year":"1994","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pr.58.3.2_REF710","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/hep.1840080207","article-title":"Endotoxin levels measured by a chromatographic assay in portal, hepatic and peripheral blood in patients with cirrhosis","volume":"8","author":"Lumsden","year":"1988","journal-title":"Hepatology"},{"key":"10.1124\/pr.58.3.2_REF711","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/sj.bjp.0705931","article-title":"Marijuana and cannabinoid regulation of brain reward circuits","volume":"143","author":"Lupica","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF712","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1054\/plef.2001.0342","article-title":"Molecular biology of cannabinoid receptors","volume":"66","author":"Lutz","year":"2002","journal-title":"Prostaglandins Leukotrienes Essent Fatty Acids"},{"key":"10.1124\/pr.58.3.2_REF713","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.bcp.2004.07.007","article-title":"On-demand activation of the endocannabinoid system in the control of neuronal excitability and epileptiform seizures","volume":"68","author":"Lutz","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF714","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0165-5728(89)90075-1","article-title":"\u0394-9-Tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis","volume":"23","author":"Lyman","year":"1989","journal-title":"J Neuroimmunol"},{"key":"10.1124\/pr.58.3.2_REF715","first-page":"113","article-title":"Clinical trials in traumatic brain injury: current problems and future solutions","volume":"89","author":"Maas","year":"2004","journal-title":"Acta Neurochir Suppl"},{"key":"10.1124\/pr.58.3.2_REF716","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S1474-4422(05)70253-2","article-title":"Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial","volume":"5","author":"Maas","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1124\/pr.58.3.2_REF716a","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2174\/1568010023344878","article-title":"Endocannabinoid degradation, endotoxic shock and inflammation","volume":"1","author":"Maccarrone","year":"2002","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"10.1124\/pr.58.3.2_REF718","doi-asserted-by":"crossref","first-page":"13484","DOI":"10.1074\/jbc.275.18.13484","article-title":"Anandamide uptake by human endothelial cells and is regulation by nitric oxide","volume":"275","author":"Maccarrone","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.58.3.2_REF719","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/molehr\/8.2.188","article-title":"Low fatty acid amide hydrolase and high anandamide levels are associated with failure to achieve an ongoing pregnancy after IVF and embryo transfer","volume":"8","author":"Maccarrone","year":"2002","journal-title":"Mol Hum Reprod"},{"key":"10.1124\/pr.58.3.2_REF720","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1006\/abbi.2001.2500","article-title":"Lipopolysaccharide downregulates fatty acid amide hydrolase expression and increases anandamide levels in human peripheral lymphocytes","volume":"393","author":"Maccarrone","year":"2001","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/pr.58.3.2_REF721","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1046\/j.1471-4159.2003.01759.x","article-title":"Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism","volume":"85","author":"Maccarrone","year":"2003","journal-title":"J Neurochem"},{"key":"10.1124\/pr.58.3.2_REF722","doi-asserted-by":"crossref","first-page":"31938","DOI":"10.1074\/jbc.M005722200","article-title":"Anandamide induces apoptosis in human cells via vanilloid receptors: evidence for a protective role of cannabinoid receptors","volume":"275","author":"Maccarrone","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.58.3.2_REF723","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/S0140-6736(00)02115-2","article-title":"Relation between decreased anandamide hydrolase concentrations in human lymphocytes and miscarriage","volume":"355","author":"Maccarrone","year":"2000","journal-title":"Lancet"},{"key":"10.1124\/pr.58.3.2_REF724","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.lfs.2005.05.011","article-title":"Cannabinoid receptor homo- and heterodimerization","volume":"77","author":"Mackie","year":"2005","journal-title":"Life Sci"},{"key":"10.1124\/pr.58.3.2_REF725","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1146\/annurev.pharmtox.46.120604.141254","article-title":"Cannabinoid receptors as therapeutic targets","volume":"46","author":"Mackie","year":"2006","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/pr.58.3.2_REF726","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0026-895X(25)13215-X","article-title":"Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells","volume":"44","author":"Mackie","year":"1993","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF727","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1073\/pnas.89.9.3825","article-title":"Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells","volume":"89","author":"Mackie","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.58.3.2_REF728","doi-asserted-by":"crossref","first-page":"6552","DOI":"10.1523\/JNEUROSCI.15-10-06552.1995","article-title":"Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor","volume":"15","author":"Mackie","year":"1995","journal-title":"J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF729","first-page":"G863","article-title":"Distribution and function of the cannabinoid-1 receptor in the modulation of ion transport in the guinea pig ileum: relationship to capsaicin-sensitive nerves","volume":"286","author":"MacNaughton","year":"2004","journal-title":"Am J Physiol"},{"key":"10.1124\/pr.58.3.2_REF730","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0304-3940(92)90832-R","article-title":"Localization of cannabinoid receptor in the human developing and adult basal ganglia: higher levels in the striatonigral neurons","volume":"148","author":"Mailleux","year":"1992","journal-title":"Neurosci Lett"},{"key":"10.1124\/pr.58.3.2_REF731","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1111\/j.1471-4159.1993.tb09807.x","article-title":"Dopaminergic regulation of cannabinoid receptor mRNA levels in the rat caudate-putamen: an in situ hybridization study","volume":"61","author":"Mailleux","year":"1993","journal-title":"J Neurochem"},{"key":"10.1124\/pr.58.3.2_REF732","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/emboj\/20.1.47","article-title":"The endocannabinoid anandamide is a direct and selective blocker of the background K+ channel TASK-1","volume":"20","author":"Maingret","year":"2001","journal-title":"EMBO (Eur Mol Biol Organ) J"},{"key":"10.1124\/pr.58.3.2_REF733","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1124\/jpet.105.093286","volume":"316","author":"Maione","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.58.3.2_REF734","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/nn1521","article-title":"Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus","volume":"8","author":"Makara","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.1124\/pr.58.3.2_REF735","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0304-3959(01)00321-9","article-title":"CB2 cannabinoid receptor-mediated peripheral antinociception","volume":"93","author":"Malan","year":"2001","journal-title":"Pain"},{"key":"10.1124\/pr.58.3.2_REF736","doi-asserted-by":"crossref","first-page":"6643","DOI":"10.1523\/JNEUROSCI.5126-05.2006","article-title":"Opposing crosstalk between leptin and glucocorticoids rapidly modulates synaptic excitation via endocannabinoid release","volume":"26","author":"Malcher-Lopes","year":"2006","journal-title":"J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF737","first-page":"225","article-title":"Involvement of the endocannabinoid system in drug addiction","volume":"29","author":"Maldonado","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/pr.58.3.2_REF738","doi-asserted-by":"crossref","first-page":"9561","DOI":"10.1073\/pnas.160105897","article-title":"The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis","volume":"97","author":"Malfait","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.58.3.2_REF739","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/PL00005041","article-title":"Cannabinoid CB1 receptor-mediated inhibition of the neurogenic vasopressor response in the pithed rat","volume":"356","author":"Malinowska","year":"1997","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF740","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1007\/s00210-001-0498-6","article-title":"Anandamide and methanandamide induce both vanilloid VR1- and cannabinoids CB1 receptor-mediated changes in heart rate and blood pressure in anaesthetized rats","volume":"364","author":"Malinowska","year":"2001","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF741","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0091-3057(01)00567-6","article-title":"Involvement of somatodendritic 5-HT1A receptors in \u03949-tetrahydrocannabinol-induced hypothermia in the rat","volume":"69","author":"Malone","year":"2001","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pr.58.3.2_REF742","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S1590-8658(02)80146-3","article-title":"Functional assessment of neuronal cannabinoid receptors in the muscular layers of human ileum and colon","volume":"34","author":"Manara","year":"2002","journal-title":"Dig Liver Dis"},{"key":"10.1124\/pr.58.3.2_REF743","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0024-3205(01)01110-9","article-title":"Inhibition of peristaltic activity by cannabinoids in the isolated distal colon of mouse","volume":"69","author":"Mancinelli","year":"2001","journal-title":"Life Sci"},{"key":"10.1124\/pr.58.3.2_REF744","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1006\/exnr.1997.6645","article-title":"The cannabinoid receptor agonist WIN 55,212-2 reduces D2, but not D1, dopamine receptor-mediated alleviation of akinesia in the reserpine-treated rat model of Parkinson\u2019s disease","volume":"148","author":"Maneuf","year":"1997","journal-title":"Exp Neurol"},{"key":"10.1124\/pr.58.3.2_REF745","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/sj.bjp.0704220","article-title":"Differential effects of anandamide on acetylcholine release in the guinea-pig ileum mediated via vanilloid and non-CB1 cannabinoid receptors","volume":"134","author":"Mang","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF746","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0006-8993(99)01756-4","article-title":"Opioid and cannabinoid receptor-mediated regulation of the increase in adrenocorticotropin hormone and corticosterone plasma concentrations induced by central administration of \u03949-tetrahydrocannabinol in rats","volume":"839","author":"Manzanares","year":"1999","journal-title":"Brain Res"},{"key":"10.1124\/pr.58.3.2_REF747","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0165-6147(99)01339-5","article-title":"Pharmacological and biochemical interactions between opioids and cannabinoids","volume":"20","author":"Manzanares","year":"1999","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/pr.58.3.2_REF748","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF03033223","article-title":"Role of endocannabinoid system in mental diseases","volume":"6","author":"Manzanares","year":"2004","journal-title":"Neurotox Res"},{"key":"10.1124\/pr.58.3.2_REF749","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00008877-200402000-00003","article-title":"Involvement of 5-HT1A receptors in behavioural effects of the cannabinoid receptor agonist CP 55,940 in male rats","volume":"15","author":"Marco","year":"2004","journal-title":"Behav Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF750","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0091-3057(02)01041-9","article-title":"Involvement of the \u03ba-opioid receptor in the anxiogenic-like effect of CP 55,940 in male rats","volume":"74","author":"Marin","year":"2003","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pr.58.3.2_REF751","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/232579a0","article-title":"Cannabivarin and tetrahydrocannabivarin, two constituents of hashish","volume":"232","author":"Markus","year":"1971","journal-title":"Nature (Lond)"},{"key":"10.1124\/pr.58.3.2_REF752","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1046\/j.1460-9568.1999.00847.x","article-title":"Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain","volume":"11","author":"Marsicano","year":"1999","journal-title":"Eur J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF753","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1088208","article-title":"CB1 cannabinoid receptors and on-demand defense against excitotoxicity","volume":"302","author":"Marsicano","year":"2003","journal-title":"Science (Wash DC)"},{"key":"10.1124\/pr.58.3.2_REF754","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1046\/j.0022-3042.2001.00716.x","article-title":"Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1","volume":"80","author":"Marsicano","year":"2002","journal-title":"J Neurochem"},{"key":"10.1124\/pr.58.3.2_REF755","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nature00839","article-title":"The endogenous cannabinoid system controls extinction of aversive memories","volume":"418","author":"Marsicano","year":"2002","journal-title":"Nature (Lond)"},{"key":"10.1124\/pr.58.3.2_REF756","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0306-4522(98)00052-9","article-title":"Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-na\u00efve rats","volume":"85","author":"Martellotta","year":"1998","journal-title":"Neuroscience"},{"key":"10.1124\/pr.58.3.2_REF757","first-page":"48","article-title":"Structure-anticonvulsant activity relationships of cannabidiol analogs","volume":"79","author":"Martin","year":"1987","journal-title":"NIDA Res Monogr"},{"key":"10.1124\/pr.58.3.2_REF758","first-page":"305","article-title":"Mechanism of action of cannabinoids: how it may lead to treatment of cachexia, emesis, and pain","volume":"2","author":"Martin","year":"2004","journal-title":"J Support Oncol"},{"key":"10.1124\/pr.58.3.2_REF759","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1046\/j.1460-9568.2000.00287.x","article-title":"Cocaine, but not morphine, induces conditioned place preference and sensitization to locomotor responses in CB1 knockout mice","volume":"12","author":"Martin","year":"2000","journal-title":"Eur J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF760","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00213-001-0946-5","article-title":"Involvement of CB1 cannabinoid receptors in emotional behaviour","volume":"159","author":"Martin","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1124\/pr.58.3.2_REF761","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0006-8993(98)01368-7","article-title":"Anatomical basis for cannabinoid-induced antinociception as revealed by intracerebral microinjections","volume":"822","author":"Martin","year":"1999","journal-title":"Brain Res"},{"key":"10.1124\/pr.58.3.2_REF762","doi-asserted-by":"crossref","first-page":"6601","DOI":"10.1523\/JNEUROSCI.16-20-06601.1996","article-title":"Suppression of noxious stimulus-evoked activity in the ventral posterolateral nucleus of the thalamus by the cannabinoid WIN 55,212-2:correlation between electrophysiological and antinociceptive effects","volume":"16","author":"Martin","year":"1996","journal-title":"J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF763","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/0006-8993(93)91334-O","article-title":"Antinociceptive actions of WIN 55,212-2 following intraventricular administration in rats","volume":"629","author":"Martin","year":"1993","journal-title":"Brain Res"},{"key":"10.1124\/pr.58.3.2_REF764","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0304-3959(99)00045-7","article-title":"Spinal cannabinoids are anti-allodynic in rats with persistent inflammation","volume":"82","author":"Martin","year":"1999","journal-title":"Pain"},{"key":"10.1124\/pr.58.3.2_REF765","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/0024-3205(95)00195-C","article-title":"An examination of the central sites of action of cannabinoid-induced antinociception in the rat","volume":"56","author":"Martin","year":"1995","journal-title":"Life Sci"},{"key":"10.1124\/pr.58.3.2_REF766","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0304-3940(98)00044-5","article-title":"Cannabinoid receptor-mediated inhibition of the rat tail-flick reflex after microinjection into the rostral ventromedial medulla","volume":"232","author":"Martin","year":"1998","journal-title":"Neurosci Let"},{"key":"10.1124\/pr.58.3.2_REF767","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0014-2999(97)01560-4","article-title":"Characterization of the acute endocrine actions of (-)-11-hydroxy-\u03948-tetrahydrocannabinol-dimethylheptyl (HU-210), a potent synthetic cannabinoid in rats","volume":"344","author":"Martin-Calderon","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF768","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1192\/bjp.164.5.679","article-title":"Cannabis consumption as a prognostic factor in schizophrenia","volume":"164","author":"Martinez-Arevalo","year":"1994","journal-title":"Br J Psychiatry"},{"key":"10.1124\/pr.58.3.2_REF769","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0306-4522(02)00820-5","article-title":"Sleep modulates cannabinoid receptor 1 expression in the pons of rats","volume":"117","author":"Martinez-Vargas","year":"2003","journal-title":"Neuroscience"},{"key":"10.1124\/pr.58.3.2_REF770","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(95)90485-9","article-title":"Nabilone in the treatment of multiple sclerosis","volume":"345","author":"Martyn","year":"1995","journal-title":"Lancet"},{"key":"10.1124\/pr.58.3.2_REF771","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/S0014-2999(99)00656-1","article-title":"lack of morphine-induced dopamine release in the nucleus accumbens of cannabinoid CB1 receptor knockout mice","volume":"383","author":"Mascia","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF772","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1096\/fj.02-0338fje","article-title":"The endocannabinoid system and the molecular basis of paralytic ileus in mice","volume":"16","author":"Mascolo","year":"2002","journal-title":"FASEB J"},{"key":"10.1124\/pr.58.3.2_REF773","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/s10517-005-0123-7","article-title":"Selective cannabinoid receptor agonist HU-210 decreases pump function of isolated perfused heart: role of cAMP and cGMP","volume":"138","author":"Maslov","year":"2004","journal-title":"Bull Exp Biol Med"},{"key":"10.1124\/pr.58.3.2_REF774","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1038\/sj.bjp.0703990","article-title":"Reduction of opioid dependence by the CB1 antagonist SR141716A in mice: evaluation of the interest in pharmacotherapy of opioid addiction","volume":"132","author":"Mas-Nieto","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF775","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1172\/JCI200419465","article-title":"The endogenous cannabinoid system protects against colonic inflammation","volume":"113","author":"Massa","year":"2004","journal-title":"J Clin Investig"},{"key":"10.1124\/pr.58.3.2_REF776","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1007\/s00109-005-0698-5","article-title":"The endocannabinoid system in the physiology and pathophysiology of the gastrointestinal tract","volume":"83","author":"Massa","year":"2005","journal-title":"J Mol Med"},{"key":"10.1124\/pr.58.3.2_REF777","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1124\/jpet.103.061002","article-title":"Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines","volume":"308","author":"Massi","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.58.3.2_REF778","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/sj.bjp.0705889","article-title":"Effects of cannabinoid receptor-2 activation on accelerated gastrointestinal transit in lipopolysaccharide-treated rats","volume":"142","author":"Mathison","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF778a","series-title":"Proceedings of the 2005 Symposium on the Cannabinoids","first-page":"58","article-title":"Peripheral upregulation of the endocannabionoid system in obesity","author":"Matias","year":"2005"},{"key":"10.1124\/pr.58.3.2_REF780","unstructured":"Matias I, Gonthier M-P, Orlando P, Martiadis V, De Petrocellis L, Cervino C, Petrosino S, Hoareau L, Festy F, Pasquali R, et al. (2006) Regulation, function and dysregulation of endocannabionoids in obesity and hyperglycemis. J Clin Endocr Metab, in press."},{"key":"10.1124\/pr.58.3.2_REF781","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nn1251","article-title":"A single in-vivo exposure to \u03949THC blocks endocannabinoid-mediated synaptic plasticity","volume":"7","author":"Mato","year":"2004","journal-title":"Nat Neurosci"},{"key":"10.1124\/pr.58.3.2_REF782","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1620\/tjem.207.99","article-title":"The cannabinoid 1 receptor antagonist, AM251, prolongs the survival of rats with severe acute pancreatitis","volume":"207","author":"Matsuda","year":"2005","journal-title":"Tohoku J Exp Med"},{"key":"10.1124\/pr.58.3.2_REF783","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","article-title":"Structure of a cannabinoid receptor and functional expression of the cloned cDNA","volume":"346","author":"Matsuda","year":"1990","journal-title":"Nature (Lond)"},{"key":"10.1124\/pr.58.3.2_REF784","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1124\/jpet.302.1.359","article-title":"Characterization of the diarylether sulfonylester (-)-(R)-3-(2-hydroxymethylindanyl-4-oxy)phenyl-4,4,4-trifluoro-1-sulfonate (BAY 38-7271) as a potent cannabinoid receptor agonist with neuroprotective properties","volume":"302","author":"Mauler","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.58.3.2_REF785","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejphar.2003.08.026","article-title":"Amnesia induced by \u03b2-amyloid fragments is counteracted by cannabinoid CB1 receptor blockade","volume":"477","author":"Mazzola","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF786","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.bcp.2004.11.018","article-title":"Effects of cannabinoids on nitric oxide production by chondrocytes and proteoglycan degradation in cartilage","volume":"69","author":"Mbvundula","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF787","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1211\/jpp.58.3.0009","article-title":"Arthritis and cannabinoids: HU-210 and Win-55,212-2 prevent IL-1\u03b1-induced matrix degradation in bovine articular chondrocytes in-vitro","volume":"58","author":"Mbvundula","year":"2006","journal-title":"J Pharm Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF788","doi-asserted-by":"crossref","first-page":"5139","DOI":"10.1021\/jm0302647","article-title":"An aromatic microdomain at the cannabinoid CB1 receptor constitutes an agonist\/inverse agonist binding region","volume":"46","author":"McAllister","year":"2003","journal-title":"J Med Chem"},{"key":"10.1124\/pr.58.3.2_REF789","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1365-2036.1999.00441.x","article-title":"\u0394-9-Tetrahydrocannabinol delays the gastric emptying of solid food in humans: a double-blind, randomized study","volume":"13","author":"McCallum","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1124\/pr.58.3.2_REF790","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.1111\/j.1432-1033.2004.04460.x","article-title":"Structure, expression and regulation of the cannabinoid receptor gene (CB1) in Huntington\u2019s disease transgenic mice","volume":"271","author":"McCaw","year":"2004","journal-title":"Eur J Biochem"},{"key":"10.1124\/pr.58.3.2_REF791","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1146\/annurev.physiol.63.1.815","article-title":"On the cellular and network bases of epileptic seizures","volume":"63","author":"McCormick","year":"2001","journal-title":"Annu Rev Physiol"},{"key":"10.1124\/pr.58.3.2_REF792","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.pharmthera.2004.07.008","article-title":"Anandamide transport","volume":"104","author":"McFarland","year":"2004","journal-title":"Pharmacol Ther"},{"key":"10.1124\/pr.58.3.2_REF793","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1126\/science.1439783","article-title":"What if Minkowski had been ageusic? An alternative angle on diabetes","volume":"258","author":"McGarry","year":"1992","journal-title":"Science (Wash DC)"},{"key":"10.1124\/pr.58.3.2_REF794","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0014-2999(96)00511-0","article-title":"Cannabinoid modulation of rat pup ultrasonic vocalizations","volume":"313","author":"McGregor","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF795","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/0091-3057(95)02066-7","article-title":"Aversive effects of the synthetic cannabinoid CP 55,940 in rats","volume":"53","author":"McGregor","year":"1996","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pr.58.3.2_REF796","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0920-9964(94)90097-3","article-title":"Cannabis and acute psychosis","volume":"13","author":"McGuire","year":"1994","journal-title":"Schizophr Res"},{"key":"10.1124\/pr.58.3.2_REF797","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1182\/blood-2002-01-0098","article-title":"Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease","volume":"100","author":"McKallip","year":"2002","journal-title":"Blood"},{"key":"10.1124\/pr.58.3.2_REF798","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1124\/jpet.102.033506","article-title":"\u03949-Tetrahydrocannabinol-induced apoptosis in the thymus and spleen as a mechanism of immunosuppression in vitro and in vivo","volume":"302","author":"McKallip","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.58.3.2_REF799","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.4049\/jimmunol.174.6.3281","article-title":"\u0394-9-Tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response","volume":"174","author":"McKallip","year":"2005","journal-title":"J Immunol"},{"key":"10.1124\/pr.58.3.2_REF800","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev.biochem.74.082803.133450","article-title":"Structure and function of fatty acid amide hydrolase","volume":"74","author":"McKinney","year":"2005","journal-title":"Annu Rev Biochem"},{"key":"10.1124\/pr.58.3.2_REF801","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/00008877-200312000-00002","article-title":"The cannabinoid CB1 antagonists SR141716A and AM 251 suppress food intake and food-reinforced behavior in a variety of tasks in rats","volume":"14","author":"McLaughlin","year":"2003","journal-title":"Behav Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF802","doi-asserted-by":"crossref","first-page":"A15","DOI":"10.1038\/399a015","article-title":"Emerging insights into the genesis of epilepsy","volume":"399","author":"McNamara","year":"1999","journal-title":"Nature (Lond)"},{"key":"10.1124\/pr.58.3.2_REF803","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1300\/J175v01n03_08","article-title":"Cannabis and cannabis extracts: greater than the sum of their parts?","volume":"1","author":"McPartland","year":"2001","journal-title":"J Cannabis Ther"},{"key":"10.1124\/pr.58.3.2_REF804","series-title":"Cannabis as Therapeutic Agent","first-page":"1","article-title":"The pharmacohistory of cannabis sativa","author":"Mechoulam","year":"1986"},{"key":"10.1124\/pr.58.3.2_REF805","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-D","article-title":"Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors","volume":"50","author":"Mechoulam","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF806","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(98)00649-9","article-title":"V. Endocannabionoids","volume":"359","author":"Mechoulam","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF807","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/37891","article-title":"Anandamide may mediate sleep induction","volume":"389","author":"Mechoulam","year":"1997","journal-title":"Nature (Lond)"},{"key":"10.1124\/pr.58.3.2_REF808","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0040-4039(00)90646-4","article-title":"The absolute configuration of \u0394-1-tetrahydrocannabinol, the major active constituent of hashish","volume":"12","author":"Mechoulam","year":"1967","journal-title":"Tetrahedron Lett"},{"key":"10.1124\/pr.58.3.2_REF809","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0009-3084(00)00184-5","article-title":"A historical overview of chemical research on cannabinoids","volume":"108","author":"Mechoulam","year":"2000","journal-title":"Chem Phys Lipids"},{"key":"10.1124\/pr.58.3.2_REF810","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0009-3084(02)00144-5","article-title":"Cannabidiol: an overview of some chemical and pharmacological aspects. Part I: chemical aspects","volume":"121","author":"Mechoulam","year":"2002","journal-title":"Chem Phys Lipids"},{"key":"10.1124\/pr.58.3.2_REF811","first-page":"RE5","article-title":"Endocannabinoids and neuroprotection","volume":"129","author":"Mechoulam","year":"2002","journal-title":"Sci STKE 2002"},{"key":"10.1124\/pr.58.3.2_REF812","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S1471-4914(02)02276-1","article-title":"Cannabinoids and brain injury: therapeutic implications","volume":"8","author":"Mechoulam","year":"2002","journal-title":"Trends Mol Med"},{"key":"10.1124\/pr.58.3.2_REF813","doi-asserted-by":"crossref","first-page":"11S","DOI":"10.1002\/j.1552-4604.2002.tb05998.x","article-title":"Cannabidiol: an overview of some pharmacological aspects","volume":"42","author":"Mechoulam","year":"2002","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF814","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/BF00314410","article-title":"Effect of cannabinoids on spasticity and ataxia in multiple sclerosis","volume":"236","author":"Meinck","year":"1989","journal-title":"J Neurol"},{"key":"10.1124\/pr.58.3.2_REF815","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1210\/endo.141.1.7239","article-title":"Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation","volume":"141","author":"Melck","year":"2000","journal-title":"Endocrinology"},{"key":"10.1124\/pr.58.3.2_REF816","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0014-5793(99)01639-7","article-title":"Involvement of the cAMP\/protein kinase A pathway and of mitogen-activated protein kinase in the anti-proliferative effects of anandamide in human breast cancer cells","volume":"463","author":"Melck","year":"1999","journal-title":"FEBS Lett"},{"key":"10.1124\/pr.58.3.2_REF817","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1523\/JNEUROSCI.4503-03.2004","article-title":"Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in ventral tegmental area dopamine neurons through activation of CB1 receptors","volume":"24","author":"Melis","year":"2004","journal-title":"J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF818","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neulet.2004.01.025","article-title":"Antagonism of cannabinoid CB1 receptors in the paraventricular nucleus of male rats induces penile erection","volume":"359","author":"Melis","year":"2004","journal-title":"Neurosci Lett"},{"key":"10.1124\/pr.58.3.2_REF819","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neuropharm.2005.09.009","article-title":"The cannabinoid receptor antagonist SR-141716A induces penile erection in male rats: involvement of paraventricular glutamic acid and nitric oxide","volume":"50","author":"Melis","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.58.3.2_REF820","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2174\/1389450053344975","article-title":"Huntington\u2019s disease: new frontiers for molecular and cell therapy","volume":"6","author":"Melone","year":"2005","journal-title":"Curr Drug Targets"},{"key":"10.1124\/pr.58.3.2_REF820a","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1176\/appi.ajp.161.6.975","article-title":"Placebo-controlled evaluation of four novel compounds for the treatment of schizophrenia and schizoaffective disorder","volume":"161","author":"Meltzer","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1124\/pr.58.3.2_REF822","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1097\/00001756-199910190-00021","article-title":"The hypnotic actions of oleamide are blocked by a cannabinoid receptor antagonist","volume":"10","author":"Mendelson","year":"1999","journal-title":"Neuroreport"},{"key":"10.1124\/pr.58.3.2_REF823","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/26481","article-title":"An analgesia circuit activated by cannabinoids","volume":"395","author":"Meng","year":"1998","journal-title":"Nature (Lond)"},{"key":"10.1124\/pr.58.3.2_REF824","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0161-6420(80)35258-5","article-title":"Effect of marihuana on intraocular and blood pressure in glaucoma","volume":"87","author":"Merritt","year":"1980","journal-title":"Ophthalmology"},{"key":"10.1124\/pr.58.3.2_REF825","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.2042-7158.1981.tb13699.x","article-title":"Topical \u03949-tetrahydrocannabinol in hypertensive glaucomas","volume":"33","author":"Merritt","year":"1981","journal-title":"J Pharm Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF826","doi-asserted-by":"crossref","first-page":"467S","DOI":"10.1002\/j.1552-4604.1981.tb02626.x","article-title":"Topical \u03949-tetrahydrocannabinol and aqueous dynamics in glaucoma","volume":"21","author":"Merritt","year":"1981","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF827","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s002130100728","article-title":"Cannabinoid receptor agonist and antagonist effects on motor function in normal and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP)-treated non-human primates","volume":"156","author":"Meschler","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1124\/pr.58.3.2_REF828","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/00002826-200405000-00003","article-title":"Neurokinin B, neurotensin, and cannabinoid receptor antagonists and Parkinson disease","volume":"27","author":"Mesnage","year":"2004","journal-title":"Clin Neuropharmacol"},{"key":"10.1124\/pr.58.3.2_REF829","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/j.1471-4159.2004.02979.x","article-title":"Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis","volume":"92","author":"Mestre","year":"2005","journal-title":"J Neurochem"},{"key":"10.1124\/pr.58.3.2_REF830","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3727\/000000003108748964","article-title":"HGF-, EGF-, and dexamethasone-induced gene expression patterns during formation of tissue in hepatic organoid cultures","volume":"11","author":"Michalopoulos","year":"2003","journal-title":"Gene Expr"},{"key":"10.1124\/pr.58.3.2_REF831","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0006-8993(97)01475-3","article-title":"Ipsilateral turning behavior induced by unilateral microinjections of a cannabinoid into the rat subthalamic nucleus","volume":"793","author":"Miller","year":"1998","journal-title":"Brain Res"},{"key":"10.1124\/pr.58.3.2_REF832","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.physbeh.2003.10.019","article-title":"Cannabinoid agonist, CP 55,940, facilitates intake of palatable foods when injected into the hindbrain","volume":"80","author":"Miller","year":"2004","journal-title":"Physiol Behav"},{"key":"10.1124\/pr.58.3.2_REF833","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s001270170038","article-title":"Genetic liability, illicit drug use, life stress and psychotic symptoms: preliminary findings from the Edinburgh study of people at high risk for schizophrenia","volume":"36","author":"Miller","year":"2001","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"10.1124\/pr.58.3.2_REF834","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1073\/pnas.0510676103","article-title":"N-arachidonoyl L-serine, an endocannabinoidlike brain constituent with vasodilatory properties","volume":"103","author":"Milman","year":"2006","journal-title":"Proc Natl Sci USA"},{"key":"10.1124\/pr.58.3.2_REF835","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0304-3940(02)00936-9","article-title":"Anandamide and noladin ether prevent neurotoxicity of the human amyloid-\u03b2 peptide","volume":"332","author":"Milton","year":"2002","journal-title":"Neurosci Lett"},{"key":"10.1124\/pr.58.3.2_REF836","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pros.10190","article-title":"Antiproliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: implication of epidermal growth factor receptor down-regulation and ceramide production","volume":"56","author":"Mimeault","year":"2003","journal-title":"Prostate"},{"key":"10.1124\/pr.58.3.2_REF837","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nature02440","article-title":"AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus","volume":"428","author":"Minokoshi","year":"2004","journal-title":"Nature (Lond)"},{"key":"10.1124\/pr.58.3.2_REF838","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.neulet.2005.03.019","article-title":"Effect of the cannabinoid ajulemic acid on rat models of neuropathic and inflammatory pain","volume":"382","author":"Mitchell","year":"2005","journal-title":"Neurosci Lett"},{"key":"10.1124\/pr.58.3.2_REF839","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejphar.2004.02.034","article-title":"Atypical cannabinoid stimulates endothelial cell migration via Gi\/Go-coupled receptor distinct from CB1,CB2 or EDG-1","volume":"489","author":"Mo","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF840","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/S0196-9781(00)00324-7","article-title":"Localization of the CB1 cannabinoid receptor in the rat brain: an immunohistochemical study","volume":"21","author":"Moldrich","year":"2000","journal-title":"Peptides"},{"key":"10.1124\/pr.58.3.2_REF841","doi-asserted-by":"crossref","first-page":"9742","DOI":"10.1523\/JNEUROSCI.22-22-09742.2002","article-title":"Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase\/Akt signaling","volume":"22","author":"Molina-Holgado","year":"2002","journal-title":"J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF842","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1097\/00001756-199705260-00027","article-title":"Anandamide suppresses nitric oxide and TNF-\u03b1 responses to Theiler\u2019s virus or endotoxin in astrocytes","volume":"8","author":"Molina-Holgado","year":"1997","journal-title":"Neuroreport"},{"key":"10.1124\/pr.58.3.2_REF843","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.eurpsy.2005.03.006","article-title":"Antipsychotic agents: gradually improving treatment from the traditional oral neuroleptics to the first atypical depot","volume":"20","author":"Moller","year":"2005","journal-title":"Eur Psychiatry"},{"key":"10.1124\/pr.58.3.2_REF844","series-title":"Proceedings of the 2005 Symposium on the Cannabinoids","first-page":"18","article-title":"The role of different neuronal populations in the pharmacological actions of \u03949-tetrahydrocannabinolin","author":"Monory","year":"2005"},{"key":"10.1124\/pr.58.3.2_REF845","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/sj.mp.4001043","article-title":"Opposite modifications in circulating leptin and soluble leptin receptor across the eating disorder spectrum","volume":"7","author":"Monteleone","year":"2002","journal-title":"Mol Psychiatry"},{"key":"10.1124\/pr.58.3.2_REF846","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/sj.npp.1300695","article-title":"Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa","volume":"30","author":"Monteleone","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.58.3.2_REF847","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF00497858","article-title":"Hypnoticlike effects of cannabidiol in the rat","volume":"55","author":"Monti","year":"1977","journal-title":"Psychopharmacology"},{"key":"10.1124\/pr.58.3.2_REF848","doi-asserted-by":"crossref","first-page":"17852","DOI":"10.1073\/pnas.0507470102","article-title":"Identification of a high-affinity binding site involved in the transport of endocannabinoids","volume":"102","author":"Moore","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.58.3.2_REF849","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1128\/iai.23.3.670-674.1979","article-title":"Effects of cannabinoids on host resistance to Listeria monocytogenes and herpes simplex virus","volume":"23","author":"Morahan","year":"1979","journal-title":"Infect Immun"},{"key":"10.1124\/pr.58.3.2_REF850","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/cne.10968","article-title":"Cannabinoid CB1 receptor and serotonin 3 receptor subunit A (5-HT3A) are co-expressed in GABA neurons in the rat telencephalon","volume":"468","author":"Morales","year":"2004","journal-title":"J Comp Neurol"},{"key":"10.1124\/pr.58.3.2_REF851","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0899-9007(01)00574-3","article-title":"Anorexia, sarcopenia, and aging","volume":"17","author":"Morley","year":"2001","journal-title":"Nutrition"},{"key":"10.1124\/pr.58.3.2_REF852","first-page":"H2046","article-title":"Anandamide-induced vasorelaxation in rabbit aortic rings has two components: G protein dependent and independent","volume":"282","author":"Mukhopadhyay","year":"2002","journal-title":"Am J Physiol"},{"key":"10.1124\/pr.58.3.2_REF853","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1124\/mol.104.003558","article-title":"Chemically distinct ligands promote differential CB1 cannabinoid receptor-Gi protein interactions","volume":"67","author":"Mukhopadhyay","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF854","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1517\/14656566.4.10.1717","article-title":"Cannabinoids reduce symptoms of Tourette\u2019s syndrome","volume":"4","author":"M\u00fcller-Vahl","year":"2003","journal-title":"Expert Opin Pharmacother"},{"key":"10.1124\/pr.58.3.2_REF855","first-page":"985","article-title":"Gilles de la Tourette syndrome: effect of nicotine, alcohol and marihuana on clinical symptoms","volume":"68","author":"M\u00fcller-Vahl","year":"1997","journal-title":"Nervenarzt"},{"key":"10.1124\/pr.58.3.2_REF856","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1600-0447.1998.tb10127.x","article-title":"Cannabinoids: possible role in patho-physiology and therapy of Gilles de la Tourette syndrome","volume":"98","author":"M\u00fcller-Vahl","year":"1998","journal-title":"Acta Psychiatr Scand"},{"key":"10.1124\/pr.58.3.2_REF857","first-page":"23","article-title":"Cannabis in movement disorders","volume":"6","author":"M\u00fcller-Vahl","year":"1999","journal-title":"Forsch Komplementarmed"},{"key":"10.1124\/pr.58.3.2_REF858","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/sj.npp.1300047","article-title":"Treatment of Tourette syndrome with \u0394-9-tetrahydrocannabinol (\u03949-THC): no influence on neuropsychological performance","volume":"28","author":"M\u00fcller-Vahl","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.58.3.2_REF859","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1002\/1531-8257(199911)14:6<1038::AID-MDS1024>3.0.CO;2-7","article-title":"Nabilone increases choreatic movements in Huntington\u2019s disease","volume":"14","author":"M\u00fcller-Vahl","year":"1999","journal-title":"Mov Disord"},{"key":"10.1124\/pr.58.3.2_REF860","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1055\/s-2002-25028","article-title":"Treatment of Tourette\u2019s syndrome with \u03949-tetrahydrocannabinol (THC): a randomized crossover trial","volume":"35","author":"M\u00fcller-Vahl","year":"2002","journal-title":"Pharmacopsychiatry"},{"key":"10.1124\/pr.58.3.2_REF861","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1176\/ajp.156.3.495","article-title":"Treatment of Tourette\u2019s syndrome with \u0394-9-tetrahydrocannabinol","volume":"156","author":"M\u00fcller-Vahl","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1124\/pr.58.3.2_REF862","doi-asserted-by":"crossref","first-page":"459","DOI":"10.4088\/JCP.v64n0417","article-title":"\u03949-Tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial","volume":"64","author":"M\u00fcller-Vahl","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1124\/pr.58.3.2_REF863","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature (Lond)"},{"key":"10.1124\/pr.58.3.2_REF864","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/jnci\/55.3.597","article-title":"Antineoplastic activity of cannabinoids","volume":"55","author":"Munson","year":"1975","journal-title":"J Natl Cancer Inst"},{"key":"10.1124\/pr.58.3.2_REF865","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/sleep\/26.8.943","article-title":"Anandamide enhances extracellular levels of adenosine and induces sleep: an in vivo microdialysis study","volume":"26","author":"Murillo-Rodriguez","year":"2003","journal-title":"Sleep"},{"key":"10.1124\/pr.58.3.2_REF866","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1097\/00001756-200107200-00018","article-title":"Anandamide-induced sleep is blocked by SR141716A, a CB1 receptor antagonist and by U73122, a phospholipase C inhibitor","volume":"12","author":"Murillo-Rodriguez","year":"2001","journal-title":"Neuroreport"},{"key":"10.1124\/pr.58.3.2_REF867","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0006-8993(98)00969-X","article-title":"Anandamide modulates sleep and memory in rats","volume":"812","author":"Murillo-Rodriguez","year":"1998","journal-title":"Brain Res"},{"key":"10.1124\/pr.58.3.2_REF868","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.neuroscience.2004.08.044","article-title":"Anandamide content is increased and CB1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia","volume":"129","author":"Muthian","year":"2004","journal-title":"Neuroscience"},{"key":"10.1124\/pr.58.3.2_REF869","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.neuropharm.2003.09.002","article-title":"Decreased alcohol self-administration and increased alcohol sensitivity and withdrawal in CB1 receptor knockout mice","volume":"46","author":"Naassila","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.58.3.2_REF870","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0306-4522(03)00126-X","article-title":"Selective activation of cannabinoid CB2 receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation","volume":"119","author":"Nackley","year":"2003","journal-title":"Neuroscience"},{"key":"10.1124\/pr.58.3.2_REF871","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0306-4522(02)00870-9","article-title":"A peripheral cannabinoid mechanism suppresses spinal fos protein expression and pain behavior in a rat model of inflammation","volume":"117","author":"Nackley","year":"2003","journal-title":"Neuroscience"},{"key":"10.1124\/pr.58.3.2_REF872","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1152\/jn.00886.2003","article-title":"Activation of cannabinoid CB2 receptors suppresses C-fiber responses and windup in spinal wide dynamic range neurons in the absence and presence of inflammation","volume":"92","author":"Nackley","year":"2004","journal-title":"J Neurophysiol"},{"key":"10.1124\/pr.58.3.2_REF873","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejphar.2005.03.037","article-title":"Interaction between \u03b3-aminobutyric acid GABAB and cannabinoid CB1 receptors in spinal pain pathways in rat","volume":"514","author":"Naderi","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF874","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(95)00367-Y","article-title":"45Ca accumulation in rat brain after closed head injury; attenuation by the novel neuroprotective agent HU-211","volume":"685","author":"Nadler","year":"1995","journal-title":"Brain Res"},{"key":"10.1124\/pr.58.3.2_REF875","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0006-8993(93)90804-V","article-title":"Blockade of 45Ca2+ influx through the N-methyl-d-aspartate receptor ion channel by the non-psychoactive cannabinoid HU-211","volume":"622","author":"Nadler","year":"1993","journal-title":"Brain Res"},{"key":"10.1124\/pr.58.3.2_REF876","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0304-3940(93)90555-Y","article-title":"The non-psychotropic cannabinoid (+)-(3S,4S)-7-hydroxy-\u03946-tetrahydrocannabinol 1,1-dimethylheptyl (HU-211) attenuates N-methyl-d-aspartate receptor-mediated neurotoxicity in primary cultures of rat forebrain","volume":"162","author":"Nadler","year":"1993","journal-title":"Neurosci Lett"},{"key":"10.1124\/pr.58.3.2_REF877","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1523\/JNEUROSCI.19-08-02987.1999","article-title":"Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures","volume":"19","author":"Nagayama","year":"1999","journal-title":"J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF878","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0306-4522(03)00339-7","article-title":"Potential role of the cannabinoid receptor CB1 in rapid eye movement sleep rebound","volume":"120","author":"Navarro","year":"2003","journal-title":"Neuroscience"},{"key":"10.1124\/pr.58.3.2_REF879","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ejphar.2004.08.022","article-title":"Cannabinoid receptor antagonist reduces heroin self-administration only in dependent rats","volume":"501","author":"Navarro","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF880","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1523\/JNEUROSCI.21-14-05344.2001","article-title":"Functional interaction between opioid and cannabinoid receptors in drug self-administration","volume":"21","author":"Navarro","year":"2001","journal-title":"J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF881","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/00001756-199701200-00023","article-title":"Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat","volume":"8","author":"Navarro","year":"1997","journal-title":"Neuroreport"},{"key":"10.1124\/pr.58.3.2_REF882","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1111\/j.1572-0241.2002.05852.x","article-title":"Preliminary observation with dronabinol in patients with intractable pruritus secondary to cholestatic liver disease","volume":"97","author":"Neff","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1124\/pr.58.3.2_REF883","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1360-0443.1989.tb00576.x","article-title":"Cannabis and schizophrenia","volume":"84","author":"Negrete","year":"1989","journal-title":"Br J Addict"},{"key":"10.1124\/pr.58.3.2_REF884","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/082585979401000105","article-title":"A phase II study of \u0394-9-tetrahydrocannabinol for appetite stimulation in cancer-associated anorexia","volume":"10","author":"Nelson","year":"1994","journal-title":"J Palliat Care"},{"key":"10.1124\/pr.58.3.2_REF885","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S1044-5765(05)80045-4","article-title":"Molecular mechanism of drug addiction in the mesolimbic dopaminergic pathway","volume":"5","author":"Nestler","year":"2003","journal-title":"Semin Neurosci"},{"key":"10.1124\/pr.58.3.2_REF886","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s00221-006-0503-x","article-title":"Increased cannabinoid receptor density in the posterior cingulate cortex in schizophrenia","volume":"172","author":"Newell","year":"2006","journal-title":"Exp Brain Res"},{"key":"10.1124\/pr.58.3.2_REF887","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/978-1-4615-5347-2_23","article-title":"The role of macrophages in THC-induced alteration of the cytokine network","volume":"437","author":"Newton","year":"1998","journal-title":"Adv Exp Med Biol"},{"key":"10.1124\/pr.58.3.2_REF888","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/oxfordjournals.aje.a115642","article-title":"Illicit drug use and the risk of new-onset seizures","volume":"132","author":"Ng","year":"1990","journal-title":"Am J Epidemiol"},{"key":"10.1124\/pr.58.3.2_REF889","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1191\/1352458504ms1009oa","article-title":"Win 55212-2, a cannabinoid receptor agonist, attenuates leukocyte\/endothelial interactions in an experimental autoimmune encephalomyelitis model","volume":"10","author":"Ni","year":"2004","journal-title":"Mult Scler"},{"key":"10.1124\/pr.58.3.2_REF890","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/01.jcp.0000125688.05091.8f","article-title":"Effect of \u0394-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults","volume":"24","author":"Nicholson","year":"2004","journal-title":"J Clin Psychopharmacol"},{"key":"10.1124\/pr.58.3.2_REF891","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0006-8993(03)02808-7","article-title":"Sodium channel inhibition by anandamide and synthetic cannabimimetics in brain","volume":"978","author":"Nicholson","year":"2003","journal-title":"Brain Res"},{"key":"10.1124\/pr.58.3.2_REF892","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00210-003-0755-y","article-title":"The peripheral sympathetic nervous system is the major target of cannabinoids in eliciting cardiovascular depression","volume":"367","author":"Niederhoffer","year":"2003","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF893","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0022-3565(24)39125-6","article-title":"Cannabinoids cause central sympathoexcitation and bradycardia in rabbits","volume":"294","author":"Niederhoffer","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.58.3.2_REF894","doi-asserted-by":"crossref","first-page":"8826","DOI":"10.1158\/0008-5472.CAN-04-3136","article-title":"2-Arachidonoylglycerol: a novel inhibitor of androgen-independent prostate cancer cell invasion","volume":"64","author":"Nithipatikom","year":"2004","journal-title":"Cancer Res"},{"key":"10.1124\/pr.58.3.2_REF895","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1046\/j.1471-4159.2001.00567.x","article-title":"Cannabinoid receptor agonists inhibit depolarization-induced calcium influx in cerebellar granule neurons","volume":"79","author":"Nogueron","year":"2001","journal-title":"J Neurochem"},{"key":"10.1124\/pr.58.3.2_REF896","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1001\/archinte.166.3.285","article-title":"Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials","volume":"166","author":"Nordmann","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1124\/pr.58.3.2_REF897","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1365-2044.2004.03674.x","article-title":"Initial experiences with medicinal extracts of cannabis for chronic pain: results from 34 \u2018N of 1\u2032 studies","volume":"59","author":"Notcutt","year":"2004","journal-title":"Anaesthesia"},{"key":"10.1124\/pr.58.3.2_REF898","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/cpt197518184","article-title":"The analgesic properties of \u0394-9-tetrahydrocannabinol and codeine","volume":"18","author":"Noyes","year":"1975","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/pr.58.3.2_REF899","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/j.1552-4604.1975.tb02348.x","article-title":"Analgesic effect of \u0394-9-tetrahydrocannabinol","volume":"1","author":"Noyes","year":"1975","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF900","first-page":"S22","article-title":"Pathophysiology of levodopa-induced dyskinesias in Parkinson\u2019s disease: problems with the current model","volume":"47","author":"Obeso","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1124\/pr.58.3.2_REF901","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nm873","article-title":"Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production","volume":"9","author":"Obici","year":"2003","journal-title":"Nat Med"},{"key":"10.1124\/pr.58.3.2_REF902","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1056\/NEJMra040226","article-title":"Therapeutic strategies for rheumatoid arthritis","volume":"350","author":"O\u2019Dell","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1124\/pr.58.3.2_REF903","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1073\/pnas.0504187103","article-title":"Peripheral cannabinoid receptor, CB2, regulates bone mass","volume":"103","author":"Ofek","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.58.3.2_REF904","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1124\/mol.63.3.699","article-title":"Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor","volume":"63","author":"Offert\u00e1ler","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF905","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0896-6273(01)00247-1","article-title":"Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals","volume":"29","author":"Ohno-Shosaku","year":"2001","journal-title":"Neuron"},{"key":"10.1124\/pr.58.3.2_REF906","doi-asserted-by":"crossref","first-page":"5298","DOI":"10.1074\/jbc.M306642200","article-title":"Molecular characterization of a phospholipase D generating anandamide and its congeners","volume":"279","author":"Okamoto","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.58.3.2_REF907","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0022-3565(25)13195-9","article-title":"Pharmacological characterization of cannabinoids in the elevated plus maze","volume":"253","author":"Onaivi","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.58.3.2_REF907a","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/S0006-2952(03)00109-6","article-title":"Novel selective and metabolically stable inhibitors of anandamide cellular uptake","volume":"65","author":"Ortar","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF909","doi-asserted-by":"crossref","first-page":"8184","DOI":"10.1021\/bi049395f","article-title":"Comparison of anandamide transport in FAAH wild-type and knockout neurons: evidence for contributions by both FAAH and the CB1 receptor to anandamide uptake","volume":"43","author":"Ortega-Gutierrez","year":"2004","journal-title":"Biochemistry"},{"key":"10.1124\/pr.58.3.2_REF910","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1096\/fj.04-2464fje","article-title":"Activation of the endocannabinoid system as a therapeutic approach in a murine model of multiple sclerosis","volume":"19","author":"Ortega-Gutierrez","year":"2005","journal-title":"FASEB J"},{"key":"10.1124\/pr.58.3.2_REF911","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/lt.20025","article-title":"De novo breast cancer in patients with liver transplantation: University of Pittsburgh\u2019s experience and review of the literature","volume":"10","author":"Oruc","year":"2004","journal-title":"Liver Transplant"},{"key":"10.1124\/pr.58.3.2_REF912","first-page":"71","article-title":"\u0394-9-Tetrahydrocannabinol on isolated human bronchioles","volume":"246","author":"Orzelek-O\u2019Neil","year":"1980","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1124\/pr.58.3.2_REF913","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0041-008X(80)90176-3","article-title":"The effects of \u0394 9-tetrahydrocannabinol and nabilone on the isolated guinea pig bronchus","volume":"54","author":"Orzelek-O\u2019Neil","year":"1980","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF914","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000087925","article-title":"Cocaine- and amphetamine-related transcript peptide is involved in the orexigenic effect of endogenous anandamide","volume":"81","author":"Osei-Hyiaman","year":"2005","journal-title":"Neuroendocrinology"},{"key":"10.1124\/pr.58.3.2_REF915","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1172\/JCI200523057","article-title":"Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity","volume":"115","author":"Osei-Hyiaman","year":"2005","journal-title":"J Clin Investig"},{"key":"10.1124\/pr.58.3.2_REF916","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/sj.bjp.0705643","article-title":"Characterisation of the vasorelaxant properties of the novel endocannabinoid N-arachidonoyl-dopamine (NADA)","volume":"141","author":"O\u2019Sullivan","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF917","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/sj.bjp.0705810","article-title":"Heterogeneity in the mechanisms of vasorelaxation to anandamide in resistance and conduit rat mesenteric arteries","volume":"142","author":"O\u2019Sullivan","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF918","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ejphar.2005.12.015","article-title":"The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors","volume":"531","author":"Ottani","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF919","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejphar.2004.08.052","article-title":"Differential effects of endogenous and synthetic cannabinoids on voltage-dependent calcium fluxes in rabbit T-tubule membranes: comparison with fatty acids","volume":"502","author":"Oz","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF920","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0014-2999(00)00396-4","article-title":"Endogenous cannabinoid anandamide directly inhibits voltage-dependent Ca2+ fluxes in rabbit T-tubule membranes","volume":"404","author":"Oz","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF921","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1113\/jphysiol.2004.064824","article-title":"Haemodynamic profile and responsiveness to anandamide of TRPV1 receptor knock-out mice","volume":"558","author":"Pacher","year":"2004","journal-title":"J Physiol (Lond)"},{"key":"10.1124\/pr.58.3.2_REF922","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.neuropharm.2004.12.005","article-title":"Blood pressure regulation by endocannabinoids and their receptors","volume":"48","author":"Pacher","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.58.3.2_REF923","series-title":"Cannabinoids","first-page":"599","article-title":"Cardiovascular pharmacology of cannabinoids","author":"Pacher","year":"2005"},{"key":"10.1124\/pr.58.3.2_REF924","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/sj.bjp.0706332","article-title":"Cirrhotic cardiomyopathy: an endocannabinoid connection?","volume":"146","author":"Pacher","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF925","first-page":"H533","article-title":"Hemodynamic profile, responsiveness to anandamide, and baroreflex sensitivity of mice lacking fatty acid amide hydrolase","volume":"289","author":"Pacher","year":"2005","journal-title":"Am J Physiol"},{"key":"10.1124\/pr.58.3.2_REF926","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2174\/0929867043455594","article-title":"Trends in the development of new antidepressants: is there a light at the end of the tunnel?","volume":"11","author":"Pacher","year":"2004","journal-title":"Curr Med Chem"},{"key":"10.1124\/pr.58.3.2_REF926a","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1124\/pr.58.1.6","article-title":"Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol","volume":"58","author":"Pacher","year":"2006","journal-title":"Pharmacol Rev"},{"key":"10.1124\/pr.58.3.2_REF928","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.tips.2005.04.003","article-title":"Nitrosative stress and pharmacological modulation of heart failure","volume":"26","author":"Pacher","year":"2005","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/pr.58.3.2_REF929","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s002210050016","article-title":"Effects of systemic 3-nitropropionic acid-induced lesions of the dorsal striatum on cannabinoid and \u03bc-opioid receptor binding in the basal ganglia","volume":"130","author":"Page","year":"2000","journal-title":"Exp Brain Res"},{"key":"10.1124\/pr.58.3.2_REF930","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1210\/er.2005-0009","article-title":"The emerging role of the endocannabinoid system in endocrine regulation and energy balance","volume":"27","author":"Pagotto","year":"2006","journal-title":"Endocr Rev"},{"key":"10.1124\/pr.58.3.2_REF931","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/sj.jcbfm.9600047","article-title":"CB1 cannabinoid receptors are involved in neuroprotection via NF-\u03baB inhibition","volume":"25","author":"Panikashvili","year":"2005","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1124\/pr.58.3.2_REF932","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.nbd.2005.11.004","article-title":"The endocannabinoid 2-AG protects the blood-brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines","volume":"22","author":"Panikashvili","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1124\/pr.58.3.2_REF933","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/35097089","article-title":"An endogenous cannabinoid (2-AG) is neuroprotective after brain injury","volume":"413","author":"Panikashvili","year":"2001","journal-title":"Nature (Lond)"},{"key":"10.1124\/pr.58.3.2_REF934","doi-asserted-by":"crossref","first-page":"9460","DOI":"10.1073\/pnas.92.21.9460","article-title":"The preimplantation mouse embryo is a target for cannabinoid ligand-receptor signaling","volume":"92","author":"Paria","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.58.3.2_REF935","doi-asserted-by":"crossref","first-page":"20523","DOI":"10.1074\/jbc.M100679200","article-title":"Dysregulated cannabinoid signaling disrupts uterine receptivity for embryo implantation","volume":"276","author":"Paria","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.58.3.2_REF936","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0009-3084(02)00156-1","article-title":"Endocannabinoid signaling in synchronizing embryo development and uterine receptivity for implantation","volume":"121","author":"Paria","year":"2002","journal-title":"Chem Phys Lipids"},{"key":"10.1124\/pr.58.3.2_REF937","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1095\/biolreprod60.5.1151","article-title":"Fatty-acid amide hydrolase is expressed in the mouse uterus and embryo during the periimplantation period","volume":"60","author":"Paria","year":"1999","journal-title":"Biol Reprod"},{"key":"10.1124\/pr.58.3.2_REF938","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S0143-4004(03)00165-6","article-title":"Identification of the CB1 cannabinoid receptor and fatty acid amide hydrolase (FAAH) in the human placenta","volume":"24","author":"Park","year":"2003","journal-title":"Placenta"},{"key":"10.1124\/pr.58.3.2_REF939","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.plefa.2003.04.007","article-title":"Cannabis, cannabinoids and reproduction","volume":"70","author":"Park","year":"2004","journal-title":"Prostaglandins Leukotrienes Essent Fatty Acids"},{"key":"10.1124\/pr.58.3.2_REF940","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s00213-003-1571-2","article-title":"Effect of cannabinoids on lithium-induced vomiting in the Suncus murinus (house musk shrew)","volume":"171","author":"Parker","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1124\/pr.58.3.2_REF941","doi-asserted-by":"crossref","first-page":"9771","DOI":"10.1523\/JNEUROSCI.22-22-09771.2002","article-title":"Increased severity of stroke in CB1 cannabinoid receptor knock-out mice","volume":"22","author":"Parmentier-Batteur","year":"2002","journal-title":"J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF942","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1054\/plef.2001.0355","article-title":"Endocannabinoids in the immune system and cancer: endocannabinoids in the immune system and cancer","volume":"66","author":"Parolaro","year":"2002","journal-title":"Prostaglandins Leukotrienes Essent Fatty Acids"},{"key":"10.1124\/pr.58.3.2_REF943","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/0024-3205(96)00169-5","article-title":"Effects of topical anandamides on intraocular pressure in normotensive rabbits","volume":"58","author":"Pate","year":"1996","journal-title":"Life Sci"},{"key":"10.1124\/pr.58.3.2_REF944","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3109\/02713689508995801","article-title":"Ophthalmic arachidonylethanolamide decreases intraocular pressure in normotensive rabbits","volume":"14","author":"Pate","year":"1995","journal-title":"Curr Eye Res"},{"key":"10.1124\/pr.58.3.2_REF945","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0024-3205(98)00499-8","article-title":"Effect of the CB1 receptor antagonist, SR141716A, on cannabinoid-induced ocular hypotension in normotensive rabbits","volume":"63","author":"Pate","year":"1998","journal-title":"Life Sci"},{"key":"10.1124\/pr.58.3.2_REF946","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/sj.npp.1300535","article-title":"Synergistic interactions between cannabinoids and environmental stress in the activation of the central amygdala","volume":"30","author":"Patel","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.58.3.2_REF947","doi-asserted-by":"crossref","first-page":"5431","DOI":"10.1210\/en.2004-0638","article-title":"Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis","volume":"145","author":"Patel","year":"2004","journal-title":"Endocrinology"},{"key":"10.1124\/pr.58.3.2_REF948","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/sj.bjp.0705334","article-title":"The general anesthetic propofol increases brain N-arachidonylethanolamine (anandamide) content and inhibits fatty acid amide hydrolase","volume":"139","author":"Patel","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF949","series-title":"Marijuana: Chemistry, Pharmacology, Metabolism and Clinical Effects","first-page":"735","article-title":"The actions of cannabis in man","author":"Paton","year":"1973"},{"key":"10.1124\/pr.58.3.2_REF949a","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1080\/00325481.1980.11715451","article-title":"Marijuana and the lung","volume":"67","author":"Patrick","year":"1980","journal-title":"Postgrad Med"},{"key":"10.1124\/pr.58.3.2_REF951","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1042\/BST0330712","article-title":"Cannabinoids and cancer: potential for colorectal cancer therapy","volume":"33","author":"Patsos","year":"2005","journal-title":"Biochem Soc Trans"},{"key":"10.1124\/pr.58.3.2_REF952","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1136\/bmj.325.7374.1195","article-title":"Cannabis use and mental health in young people: cohort study","volume":"325","author":"Patton","year":"2002","journal-title":"BMJ"},{"key":"10.1124\/pr.58.3.2_REF953","doi-asserted-by":"crossref","first-page":"7049","DOI":"10.1016\/S0021-9258(18)68602-8","article-title":"Cloning and expression of mouse fatty acid synthase and other specific mRNA: developmental and hormonal regulation in 3T3-L1 cells","volume":"263","author":"Paulaskis","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.58.3.2_REF954","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/j.lfs.2004.03.026","article-title":"Role of the endocannabinoid system in Alzheimer\u2019s disease: new perspectives","volume":"75","author":"Pazos","year":"2004","journal-title":"Life Sci"},{"key":"10.1124\/pr.58.3.2_REF955","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/gut.48.6.859","article-title":"Cannabinoids and the gastrointestinal tract","volume":"48","author":"Pertwee","year":"2001","journal-title":"Gut"},{"key":"10.1124\/pr.58.3.2_REF956","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0163-7258(02)00255-3","article-title":"Cannabinoids and multiple sclerosis","volume":"95","author":"Pertwee","year":"2002","journal-title":"Pharmacol Ther"},{"key":"10.1124\/pr.58.3.2_REF957","doi-asserted-by":"crossref","first-page":"E625","DOI":"10.1208\/aapsj070364","article-title":"The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids","volume":"7","author":"Pertwee","year":"2005","journal-title":"AAPS J"},{"key":"10.1124\/pr.58.3.2_REF958","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.lfs.2004.10.025","article-title":"Inverse agonism and neutral antagonism at cannabinoid CB1 receptors","volume":"76","author":"Pertwee","year":"2005","journal-title":"Life Sci"},{"key":"10.1124\/pr.58.3.2_REF959","series-title":"Cannabinoids","first-page":"1","article-title":"Pharmacological actions of cannabinoids","author":"Pertwee","year":"2005"},{"key":"10.1124\/pr.58.3.2_REF960","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0091-3057(91)90366-A","article-title":"An investigation of the involvement of GABA in certain pharmacological effects of \u0394-9-tetrahydrocannabinol","volume":"40","author":"Pertwee","year":"1991","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pr.58.3.2_REF961","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0014-2999(94)00618-H","article-title":"Effect of phenylmethylsulphonyl fluoride on the potency of anandamide as an inhibitor of electrically evoked contractions in two isolated tissue preparations","volume":"272","author":"Pertwee","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF962","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1111\/j.1476-5381.1996.tb15663.x","article-title":"Further evidence for the presence of cannabinoid CB1 receptors in guinea-pig small intestine","volume":"118","author":"Pertwee","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF963","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0014-2999(02)02624-9","article-title":"(-)-Cannabidiol antagonizes cannabinoid receptor agonists and noradrenaline in the mouse vas deferens","volume":"456","author":"Pertwee","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF963a","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1055\/s-2006-925401","article-title":"Cannabinoid receptor signaling directly inhibits thermogenesis and alters expression of adiponectin and visfatin","volume":"38","author":"Perwitz","year":"2006","journal-title":"Horm Metab Res"},{"key":"10.1124\/pr.58.3.2_REF965","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0033-3182(80)73129-8","article-title":"Marihuana as a therapeutic agent for muscle spasm or spasticity","volume":"21","author":"Petro","year":"1980","journal-title":"Psychosomatics"},{"key":"10.1124\/pr.58.3.2_REF966","doi-asserted-by":"crossref","first-page":"413S","DOI":"10.1002\/j.1552-4604.1981.tb02621.x","article-title":"Treatment of human spasticity with \u03949-tetrahydrocannabinol","volume":"21","author":"Petro","year":"1981","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF967","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/sj.bjp.0705874","article-title":"Central effects of the cannabinoid receptor agonist WIN55212-2 on respiratory and cardiovascular regulation in anaesthetised rats","volume":"142","author":"Pfitzer","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF968","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/jama.295.7.761","article-title":"Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients","volume":"295","author":"Pi-Sunyer","year":"2006","journal-title":"J Am Med Assoc"},{"key":"10.1124\/pr.58.3.2_REF969","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1055\/s-2004-861497","article-title":"Cerebrovascular risk factors and clinical classification of strokes","volume":"4","author":"Pinto","year":"2004","journal-title":"Semin Vasc Med"},{"key":"10.1124\/pr.58.3.2_REF970","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1054\/plef.2001.0345","article-title":"Endocannabinoids and the gut","volume":"66","author":"Pinto","year":"2002","journal-title":"Prostaglandins Leukotrienes Essent Fatty Acids"},{"key":"10.1124\/pr.58.3.2_REF971","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1053\/gast.2002.34242","article-title":"Endocannabinoids as physiological regulators of colonic propulsion in mice","volume":"123","author":"Pinto","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1124\/pr.58.3.2_REF972","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrn1247","article-title":"The molecular logic of endocannabinoid signaling","volume":"4","author":"Piomelli","year":"2003","journal-title":"Nat Rev Neurosci"},{"key":"10.1124\/pr.58.3.2_REF973","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neuropharm.2003.08.003","article-title":"Cannabinoids modulate neuronal firing in the rat basolateral amygdala: evidence for CB1- and non-CB1-mediated actions","volume":"46","author":"Pistis","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.58.3.2_REF974","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/cpt1972133426","article-title":"\u0394-9-Tetrahydrocannabinol and synhexl: effects on human sleep patterns","volume":"13","author":"Pivik","year":"1972","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/pr.58.3.2_REF975","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1463-1326.2004.00374.x","article-title":"The anti-obesity effect of rimonabant is associated with an improved serum lipid profile","volume":"7","author":"Poirier","year":"2005","journal-title":"Diabetes Obesity Metab"},{"key":"10.1124\/pr.58.3.2_REF976","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0304-3940(03)00397-5","article-title":"Overeating, alcohol and sucrose consumption decrease in CB1 receptor deleted mice","volume":"343","author":"Poncelet","year":"2003","journal-title":"Neurosci Lett"},{"key":"10.1124\/pr.58.3.2_REF977","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/382255a0","article-title":"Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs","volume":"382","author":"Pontieri","year":"1996","journal-title":"Nature (Lond)"},{"key":"10.1124\/pr.58.3.2_REF978","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0169-328X(98)00105-3","article-title":"Cannabinoid receptor CB1 mRNA is highly expressed in the rat ciliary body: implications for the antiglaucoma properties of marihuana","volume":"58","author":"Porcella","year":"1998","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1124\/pr.58.3.2_REF979","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1530\/eje.0.1470255","article-title":"Evidence for functional CB1 cannabinoid receptor expressed in the rat thyroid","volume":"147","author":"Porcella","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"10.1124\/pr.58.3.2_REF980","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1046\/j.1460-9568.2000.01027.x","article-title":"The human eye expresses high levels of CB1 cannabinoid receptor mRNA and protein","volume":"12","author":"Porcella","year":"2000","journal-title":"Eur J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF981","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1046\/j.0953-816X.2000.01401.x","article-title":"The synthetic cannabinoid WIN55212-2 decreases the intraocular pressure in human glaucoma resistant to conventional therapies","volume":"13","author":"Porcella","year":"2001","journal-title":"Eur J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF982","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1096\/fj.02-1129fje","article-title":"Inhibitory effects of cannabinoid CB1 receptor stimulation on tumor growth and metastatic spreading: actions on signals involved in angiogenesis and metastasis","volume":"17","author":"Portella","year":"2003","journal-title":"FASEB J"},{"key":"10.1124\/pr.58.3.2_REF982a","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1124\/jpet.301.3.1020","article-title":"Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor","volume":"301","author":"Porter","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.58.3.2_REF984","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1182\/blood-2004-03-1182","article-title":"Cannabis-induced cytotoxicity in leukemic cell lines: the role of the cannabinoid receptors and the MAPK pathway","volume":"105","author":"Powles","year":"2005","journal-title":"Blood"},{"key":"10.1124\/pr.58.3.2_REF985","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0026-895X(24)26511-1","article-title":"Activation of cannabinoid receptors in rat brain by WIN 55212-2 produces coupling to multiple G protein \u03b1-subunits with different potencies","volume":"57","author":"Prather","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF986","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.tins.2005.03.006","article-title":"Emerging properties of cannabinoid medicines in management of multiple sclerosis","volume":"28","author":"Pryce","year":"2005","journal-title":"Trends Neurosci"},{"key":"10.1124\/pr.58.3.2_REF987","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1093\/brain\/awg224","article-title":"Cannabinoids inhibit neurodegeneration in models of multiple sclerosis","volume":"126","author":"Pryce","year":"2003","journal-title":"Brain"},{"key":"10.1124\/pr.58.3.2_REF988","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0022-3565(24)36640-6","article-title":"Involvement of dynorphin B in the antinociceptive effects of the cannabinoid CP55,940 in the spinal cord","volume":"281","author":"Pugh","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.58.3.2_REF989","first-page":"921","article-title":"\u03949-Tetrahydrocannabinol, euphoria and intraocular pressure in man","volume":"7","author":"Purnell","year":"1975","journal-title":"Ann Ophthalmol"},{"key":"10.1124\/pr.58.3.2_REF990","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/00000542-200310000-00031","article-title":"Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannabinoid receptors","volume":"99","author":"Quartilho","year":"2003","journal-title":"Anesthesiology"},{"key":"10.1124\/pr.58.3.2_REF991","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1523\/JNEUROSCI.23-06-02453.2003","article-title":"A critical role for the cannabinoid CB1 receptors in alcohol dependence and stress-stimulated ethanol drinking","volume":"23","author":"Racz","year":"2003","journal-title":"J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF992","first-page":"H1570","article-title":"Microinjection of a cannabinoid receptor antagonist into the NTS increases baroreflex duration in dogs","volume":"284","author":"Rademacher","year":"2003","journal-title":"Am J Physiol"},{"key":"10.1124\/pr.58.3.2_REF993","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/cpt197721126","article-title":"Effects of intravenous tetrahydrocannabinol on experimental and surgical pain: psychological correlates of the analgesic response","volume":"21","author":"Raft","year":"1977","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/pr.58.3.2_REF994","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1016\/S0024-3205(02)02086-6","article-title":"Cannabinoid modulation of sensory neurotransmission via cannabinoid and vanilloid receptors: roles in regulation of cardiovascular function","volume":"71","author":"Ralevic","year":"2002","journal-title":"Life Sci"},{"key":"10.1124\/pr.58.3.2_REF995","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/14660820310016813","article-title":"Amyotrophic lateral sclerosis: delayed disease progression in mice by treatment with a cannabinoid","volume":"5","author":"Raman","year":"2004","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"10.1124\/pr.58.3.2_REF996","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1523\/JNEUROSCI.4540-04.2005","article-title":"Prevention of Alzheimer\u2019s disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation","volume":"25","author":"Ramirez","year":"2005","journal-title":"J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF997","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2174\/1389557054368817","article-title":"Therapeutic potential of the endocannabinoid system in the brain","volume":"5","author":"Ramos","year":"2005","journal-title":"Mini Rev Med Chem"},{"key":"10.1124\/pr.58.3.2_REF998","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0163-7258(02)00258-9","article-title":"Cardiovascular effects of cannabinoids","volume":"95","author":"Randall","year":"2002","journal-title":"Pharmacol Ther"},{"key":"10.1124\/pr.58.3.2_REF999","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/sj.bjp.0705725","article-title":"The complexities of the cardiovascular actions of cannabinoids","volume":"142","author":"Randall","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1000","first-page":"R345","article-title":"Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice","volume":"284","author":"Ravinet Trillou","year":"2003","journal-title":"Am J Physiol"},{"key":"10.1124\/pr.58.3.2_REF1001","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/sj.ijo.0802583","article-title":"CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity","volume":"24","author":"Ravinet Trillou","year":"2004","journal-title":"Int J Obes"},{"key":"10.1124\/pr.58.3.2_REF1002","first-page":"271","article-title":"Cocaine treatment outcome: cocaine use following inpatient, outpatient and no treatment","volume":"67","author":"Rawson","year":"1986","journal-title":"NIDA Res Monogr"},{"key":"10.1124\/pr.58.3.2_REF1003","doi-asserted-by":"crossref","first-page":"10146","DOI":"10.1523\/JNEUROSCI.23-31-10146.2003","article-title":"Capsazepine protects against neuronal injury caused by oxygen glucose deprivation by inhibiting Ih","volume":"23","author":"Ray","year":"2003","journal-title":"J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF1004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(01)02127-8","article-title":"Long-term alteration of calcium homeostatic mechanisms in the pilocarpine model of temporal lobe epilepsy","volume":"903","author":"Raza","year":"2001","journal-title":"Brain Res"},{"key":"10.1124\/pr.58.3.2_REF1005","series-title":"The Pharmacology of Marijuana","first-page":"763","article-title":"\u0394-9-THC as an effective antidepressant and appetite-stimulating agent in advanced cancer patients","author":"Regelson","year":"1976"},{"key":"10.1124\/pr.58.3.2_REF1006","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.2174\/1381612033454577","article-title":"Pharmacophores for ligand recognition and activation\/inactivation of the cannabinoid receptors","volume":"9","author":"Reggio","year":"2003","journal-title":"Curr Pharm Des"},{"key":"10.1124\/pr.58.3.2_REF1007","first-page":"115","article-title":"Oral-motor dysfunction in children who fail to thrive: organic or non-organic?","volume":"41","author":"Reilly","year":"1999","journal-title":"Dev Med Child Neurol"},{"key":"10.1124\/pr.58.3.2_REF1008","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0140-6736(02)18723-X","article-title":"On therapeutic uses and toxic effects of cannabis indica","volume":"1","author":"Reynolds","year":"1890","journal-title":"Lancet"},{"key":"10.1124\/pr.58.3.2_REF1009","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1046\/j.1471-4159.1998.71041525.x","article-title":"Cannabinoid receptor activation differentially regulates the various adenylyl cyclase isozymes","volume":"71","author":"Rhee","year":"1998","journal-title":"J Neurochem"},{"key":"10.1124\/pr.58.3.2_REF1010","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1021\/jm970126f","article-title":"Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylyl cyclase","volume":"40","author":"Rhee","year":"1997","journal-title":"J Med Chem"},{"key":"10.1124\/pr.58.3.2_REF1011","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1016\/S0014-2999(96)00952-1","article-title":"SR141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice","volume":"319","author":"Richardson","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1012","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0014-2999(97)01621-X","article-title":"Antihyperalgesic effects of spinal cannabinoids","volume":"345","author":"Richardson","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1013","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1523\/JNEUROSCI.18-01-00451.1998","article-title":"Hypoactivity of the spinal cannabinoid system results in NMDA-dependent hyperalgesia","volume":"18","author":"Richardson","year":"1998","journal-title":"J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF1014","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0304-3959(97)00213-3","article-title":"Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors","volume":"75","author":"Richardson","year":"1998","journal-title":"Pain"},{"key":"10.1124\/pr.58.3.2_REF1015","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/ana.410360406","article-title":"Selective vulnerability in Huntington\u2019s disease: preferential loss of cannabinoid receptors in lateral globus pallidus","volume":"36","author":"Richfield","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1124\/pr.58.3.2_REF1016","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0014-2999(94)00490-0","article-title":"(+)-WIN 55,212-2, a novel cannabinoid receptor agonist, exerts antidystonic effects in mutant dystonic hamsters","volume":"264","author":"Richter","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1017","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0014-2999(02)02477-9","article-title":"Effects of pharmacological manipulations of cannabinoid receptors on severity of dystonia in a genetic model of paroxysmal dyskinesia","volume":"454","author":"Richter","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1018","doi-asserted-by":"crossref","first-page":"11070","DOI":"10.1523\/JNEUROSCI.3695-04.2004","article-title":"Independent presynaptic and postsynaptic mechanisms regulate endocannabinoid signaling at multiple synapses in the ventral tegmental area","volume":"24","author":"Riegel","year":"2004","journal-title":"J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF1019","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/0014-5793(94)00773-X","article-title":"SR141716A, a potent and selective antagonist of the brain cannabinoid receptor","volume":"350","author":"Rinaldi-Carmona","year":"1994","journal-title":"FEBS Lett"},{"key":"10.1124\/pr.58.3.2_REF1020","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S0022-3565(24)37266-0","article-title":"SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor","volume":"284","author":"Rinaldi-Carmona","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.58.3.2_REF1020a","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/sj.bjp.0706757","article-title":"\u03bc Opioid and CB1 cannabinoid receptor interactions: reciprocal inhibition of receptor signaling and neuritogenesis","volume":"148","author":"Rios","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1022","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0014-2999(80)90410-0","article-title":"Inhibition of histamine-stimulated gastric acid secretion by \u03949-tetrahydrocannabinol in rat isolated stomach","volume":"65","author":"Rivas-V","year":"1980","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1023","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1523\/JNEUROSCI.21-01-00109.2001","article-title":"Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens","volume":"21","author":"Robbe","year":"2001","journal-title":"J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF1024","doi-asserted-by":"crossref","first-page":"8384","DOI":"10.1073\/pnas.122149199","article-title":"Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens","volume":"99","author":"Robbe","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.58.3.2_REF1025","series-title":"Cannabinoids","first-page":"719","article-title":"Human studies of cannabinoids and medicinal cannabis","author":"Robson","year":"2005"},{"key":"10.1124\/pr.58.3.2_REF1026","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1126\/science.276.5321.2050","article-title":"Activation of corticotrophin-releasing factor in the limbic system during cannabinoid withdrawal","volume":"276","author":"Rodriguez de Fonseca","year":"1997","journal-title":"Science (Wash DC)"},{"key":"10.1124\/pr.58.3.2_REF1027","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF03033228","article-title":"Role of the endogenous cannabinoid system as a modulator of dopamine transmission: implications for Parkinson\u2019s disease and schizophrenia","volume":"3","author":"Rodriguez De Fonseca","year":"2001","journal-title":"Neurotox Res"},{"key":"10.1124\/pr.58.3.2_REF1028","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0022-3565(25)12276-3","article-title":"Corticotropin-releasing factor (CRF) antagonist [d-Phe12,Nle21,38,C\u03b1MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats","volume":"276","author":"Rodriguez de Fonseca","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.58.3.2_REF1029","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1212\/01.wnl.0000176753.45410.8b","article-title":"Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis","volume":"65","author":"Rog","year":"2005","journal-title":"Neurology"},{"key":"10.1124\/pr.58.3.2_REF1030","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0165-3806(02)00306-1","article-title":"Antinociceptive, behavioural and neuroendocrine effects of CP 55,940 in young rats","volume":"136","author":"Romero","year":"2002","journal-title":"Brain Res Dev Brain Res"},{"key":"10.1124\/pr.58.3.2_REF1031","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0306-4522(97)00552-6","article-title":"Loss of cannabinoid receptor binding and messenger RNA levels and cannabinoid agonist-stimulated [35S]guanylyl-5\u2032O-(thio)-triphosphate binding in the basal ganglia of aged rats","volume":"84","author":"Romero","year":"1998","journal-title":"Neuroscience"},{"key":"10.1124\/pr.58.3.2_REF1032","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0024-3205(99)00618-9","article-title":"Unilateral 6-hydroxydopamine lesions of nigrostriatal dopaminergic neurons increased CB1 receptor mRNA levels in the caudate-putamen","volume":"66","author":"Romero","year":"2000","journal-title":"Life Sci"},{"key":"10.1124\/pr.58.3.2_REF1033","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0006-8993(95)00835-E","article-title":"Time-course of the effects of anandamide, the putative endogenous cannabinoid receptor ligand, on extrapyramidal function","volume":"694","author":"Romero","year":"1995","journal-title":"Brain Res"},{"key":"10.1124\/pr.58.3.2_REF1034","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/0024-3205(95)00186-A","article-title":"The endogenous cannabinoid receptor ligand, anandamide, inhibits the motor behavior: role of nigrostriatal dopaminergic neurons","volume":"56","author":"Romero","year":"1995","journal-title":"Life Sci"},{"key":"10.1124\/pr.58.3.2_REF1035","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0163-7258(02)00253-X","article-title":"The endogenous cannabinoid system and the basal ganglia. Biochemical, pharmacological, and therapeutic aspects","volume":"95","author":"Romero","year":"2002","journal-title":"Pharmacol Ther"},{"key":"10.1124\/pr.58.3.2_REF1036","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1053\/gast.2002.30305","article-title":"Endogenous cannabinoids: a new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat","volume":"122","author":"Ros","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1124\/pr.58.3.2_REF1037","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1124\/jpet.105.092858","article-title":"R(+)-Methanandamide and other cannabinoids induce the expression of cyclooxygenase-2 and matrix metalloproteinases in human nonpigmented ciliary epithelial cells","volume":"316","author":"Rosch","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.58.3.2_REF1038","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1158\/0008-5472.CAN-03-3425","article-title":"Marijuana use and risk of oral squamous cell carcinoma","volume":"64","author":"Rosenblatt","year":"2004","journal-title":"Cancer Res"},{"key":"10.1124\/pr.58.3.2_REF1038a","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/0041-008X(74)90228-2","article-title":"Acute, subacute and 23-day chronic marihuana inhalation toxicities in the rat","volume":"28","author":"Rosenkrantz","year":"1974","journal-title":"Taxicol Appl Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1038ab","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/sj.bjp.0702351","article-title":"Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630","volume":"126","author":"Ross","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1041","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1210\/jc.2004-1287","article-title":"Human sperm express cannabinoid receptor Cb1, the activation of which inhibits motility, acrosome reaction, and mitochondrial function","volume":"90","author":"Rossato","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1124\/pr.58.3.2_REF1042","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/434708a","article-title":"Pharmacology: marijuana and your heart","volume":"434","author":"Roth","year":"2005","journal-title":"Nature (Lond)"},{"key":"10.1124\/pr.58.3.2_REF1043","first-page":"171","article-title":"Cholecystokinin receptor subtypes: role in the modulation of anxiety-related and reward-related behaviours in animal models","volume":"28","author":"Rotzinger","year":"2003","journal-title":"J Psychiatry Neurosci"},{"key":"10.1124\/pr.58.3.2_REF1044","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM200105313442207","article-title":"Amyotrophic lateral sclerosis","volume":"344","author":"Rowland","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1124\/pr.58.3.2_REF1045","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s002130100910","article-title":"Effects of the cannabinoid receptor antagonist SR 141716, alone and in combination with dexfenfluramine or naloxone, on food intake in rats","volume":"159","author":"Rowland","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1124\/pr.58.3.2_REF1046","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/S0024-3205(00)00547-6","article-title":"Long-term treatment with SR141716A, the CB1 receptor antagonist, influences morphine withdrawal syndrome","volume":"66","author":"Rubino","year":"2000","journal-title":"Life Sci"},{"key":"10.1124\/pr.58.3.2_REF1047","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1155\/2003\/675976","article-title":"Treatment of chronic intractable neuropathic pain with dronabinol: case report of two adolescents","volume":"8","author":"Rudich","year":"2003","journal-title":"Pain Res Manag"},{"key":"10.1124\/pr.58.3.2_REF1048","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/S0026-895X(24)23114-X","article-title":"The CB(1) cannabinoid receptor is coupled to the activation of c-Jun N-terminal kinase","volume":"58","author":"Rueda","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1048a","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1124\/jpet.103.049924","article-title":"Synthesis and characterization of NESS 0327: a novel putative antagonist of the CB1 cannabinoid receptor","volume":"306","author":"Ruiu","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.58.3.2_REF1050","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.mehy.2005.08.026","article-title":"A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol","volume":"66","author":"Russo","year":"2006","journal-title":"Med Hypotheses"},{"key":"10.1124\/pr.58.3.2_REF1051","first-page":"31","article-title":"Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?","volume":"25","author":"Russo","year":"2004","journal-title":"Neuro Endocrinol Lett"},{"key":"10.1124\/pr.58.3.2_REF1051a","first-page":"341","article-title":"ACEA (arachidonyl-2-chloroethylamide), the selective cannabinoid CB1 receptor agonist, protects against aspirin-induced gastric ulceration","volume":"61","author":"Rutkowska","year":"2006","journal-title":"Pharmazie 2006"},{"key":"10.1124\/pr.58.3.2_REF1053","first-page":"200","article-title":"Effects of cannabinoids on the anxiety-like response in mice","volume":"58","author":"Rutkowska","year":"2006","journal-title":"Pharmacol Rep"},{"key":"10.1124\/pr.58.3.2_REF1054","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.febslet.2004.11.085","article-title":"Identification and characterisation of a novel splice variant of the human CB1 receptor","volume":"579","author":"Ryberg","year":"2005","journal-title":"FEBS Lett"},{"key":"10.1124\/pr.58.3.2_REF1055","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.bcp.2003.12.003","article-title":"Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes","volume":"67","author":"Saario","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1056","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.neuropharm.2005.02.010","article-title":"Pain measurements and side effect profile of the novel cannabinoid ajulemic acid","volume":"48","author":"Salim","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.58.3.2_REF1057","first-page":"5784","article-title":"Inhibition of glioma growth in vivo by selective activation of the CB2 cannabinoid receptor","volume":"61","author":"S\u00e1nchez","year":"2001","journal-title":"Cancer Res"},{"key":"10.1124\/pr.58.3.2_REF1058","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0014-5793(98)01085-0","article-title":"\u03949-Tetrahydrocannabinol induces apoptosis in C6 glioma cells","volume":"436","author":"S\u00e1nchez","year":"1998","journal-title":"FEBS Lett"},{"key":"10.1124\/pr.58.3.2_REF1059","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0026-895X(24)12551-5","article-title":"The CB1 cannabinoid receptor of astrocytes is coupled to sphingomyelin hydrolysis through the adaptor protein fan","volume":"59","author":"S\u00e1nchez","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1060","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0898-6568(03)00036-6","article-title":"Activation of phosphoinositide 3-kinase\/PKB pathway by CB1 and CB2 cannabinoid receptors expressed in prostate PC-3 cells: involvement in Raf-1 stimulation and NGF induction","volume":"15","author":"S\u00e1nchez","year":"2003","journal-title":"Cell Signal"},{"key":"10.1124\/pr.58.3.2_REF1060a","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0304-3940(98)00368-1","article-title":"Cannabinoid effects in basal ganglia in a rat model of Parkinson\u2019s disease","volume":"248","author":"Sa\u00f1udo-Pe\u00f1a","year":"1998","journal-title":"Neurosci Lett"},{"key":"10.1124\/pr.58.3.2_REF1062","first-page":"1115","article-title":"CB1 receptor localization in spinal cord and roots, dorsal root ganglion, and peripheral nerve","volume":"12","author":"Sa\u00f1udo-Pe\u00f1a","year":"1999","journal-title":"Acta Pharmacol Sin"},{"key":"10.1124\/pr.58.3.2_REF1063","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0024-3205(99)00293-3","article-title":"Motor actions of cannabinoids in the basal ganglia output nuclei","volume":"65","author":"Sa\u00f1udo-Pe\u00f1a","year":"1999","journal-title":"Life Sci"},{"key":"10.1124\/pr.58.3.2_REF1064","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/(SICI)1098-2396(199801)28:1<27::AID-SYN4>3.0.CO;2-E","article-title":"Effects of intrapallidal cannabinoids on rotational behavior in rats: interactions with the dopaminergic system","volume":"28","author":"Sa\u00f1udo-Pe\u00f1a","year":"1998","journal-title":"Synapse"},{"key":"10.1124\/pr.58.3.2_REF1065","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1146\/annurev.neuro.25.032502.111311","article-title":"The central autonomic nervous system: conscious visceral perception and autonomic pattern generation","volume":"25","author":"Saper","year":"2002","journal-title":"Annu Rev Neurosci"},{"key":"10.1124\/pr.58.3.2_REF1066","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1158\/0008-5472.CAN-04-3410","article-title":"Cannabinoid receptor as a novel target for the treatment of prostate cancer","volume":"65","author":"Sarfaraz","year":"2005","journal-title":"Cancer Res"},{"key":"10.1124\/pr.58.3.2_REF1067","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1046\/j.1471-4159.2003.01663.x","article-title":"ASK1-p38 MAPK\/JNK signaling cascade mediates anandamide-induced PC12 cell death","volume":"85","author":"Sarker","year":"2003","journal-title":"J Neurochem"},{"key":"10.1124\/pr.58.3.2_REF1068","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0014-5793(00)01425-3","article-title":"Anandamide induces apoptosis of PC-12 cells: involvement of superoxide and caspase-3","volume":"472","author":"Sarker","year":"2000","journal-title":"FEBS Lett"},{"key":"10.1124\/pr.58.3.2_REF1069","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1023\/B:CEMN.0000018619.18631.53","article-title":"Detection of cannabinoid CB1, adenosine A1, muscarinic acetylcholine, and GABAB receptor-dependent G protein activity in transducin-deactivated membranes and autoradiography sections of rat retina","volume":"24","author":"Savinainen","year":"2004","journal-title":"Cell Mol Neurobiol"},{"key":"10.1124\/pr.58.3.2_REF1070","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0169-328X(98)00277-0","article-title":"Identification and cloning of three novel human G protein-coupled receptor genes GPR52, \u03a8GPR53 and GPR55: GPR55 is extensively expressed in human brain","volume":"64","author":"Sawzdargo","year":"1999","journal-title":"Mol Brain Res"},{"key":"10.1124\/pr.58.3.2_REF1071","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1146\/annurev.med.54.101601.152143","article-title":"AIDS-related malignancies","volume":"54","author":"Scadden","year":"2003","journal-title":"Annu Rev Med"},{"key":"10.1124\/pr.58.3.2_REF1072","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1161\/01.STR.0000023491.63693.18","article-title":"Release of fatty acid amides in a patient with hemispheric stroke: a microdialysis study","volume":"33","author":"Schabitz","year":"2002","journal-title":"Stroke"},{"key":"10.1124\/pr.58.3.2_REF1073","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00000542-200602000-00012","article-title":"Effects of general anesthesia on anandamide blood levels in humans","volume":"104","author":"Schelling","year":"2006","journal-title":"Anesthesiology"},{"key":"10.1124\/pr.58.3.2_REF1074","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00210-003-0787-3","article-title":"Analysis of the respiratory effects of cannabinoids in rats","volume":"368","author":"Schmid","year":"2003","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1075","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0014-5793(95)01194-J","article-title":"Occurrence and postmortem generation of anandamide and other longchain N-acylethanolamines in mammalian brain","volume":"375","author":"Schmid","year":"1995","journal-title":"FEBS Lett"},{"key":"10.1124\/pr.58.3.2_REF1076","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1073\/pnas.94.8.4188","article-title":"Changes in anandamide levels in mouse uterus are associated with uterine receptivity for embryo implantation","volume":"94","author":"Schmid","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.58.3.2_REF1077","doi-asserted-by":"crossref","first-page":"9302","DOI":"10.1016\/S0021-9258(17)44667-9","article-title":"Metabolism on N-acylethanolamine phospholipids by a mammalian phosphodiesterase of the phospholipase D type","volume":"258","author":"Schmid","year":"1983","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.58.3.2_REF1078","doi-asserted-by":"crossref","first-page":"14145","DOI":"10.1016\/S0021-9258(17)38695-7","article-title":"Properties of rat liver N-acylethanolamine amidohydrolase","volume":"260","author":"Schmid","year":"1985","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.58.3.2_REF1079","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1212\/WNL.53.9.2209-a","article-title":"Suppression of pendular nystagmus by smoking cannabis in a patient with multiple sclerosis","volume":"53","author":"Schon","year":"1999","journal-title":"Neurology"},{"key":"10.1124\/pr.58.3.2_REF1080","first-page":"184","article-title":"Low level of response to alcohol as a predictor of future alcoholism","volume":"151","author":"Schuckit","year":"1997","journal-title":"Am J Psychiatry"},{"key":"10.1124\/pr.58.3.2_REF1081","first-page":"1078","article-title":"A tale of two cells: endocannabinoid-signaling regulates functions of neurons and sperm","volume":"73","author":"Schuel","year":"2005","journal-title":"Biol Reprod"},{"key":"10.1124\/pr.58.3.2_REF1082","doi-asserted-by":"crossref","first-page":"11891","DOI":"10.1073\/pnas.0404366101","article-title":"The inhibitory effect of anandamide on luteinizing hormone-releasing hormone secretion is reversed by estrogen","volume":"101","author":"Scorticati","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.58.3.2_REF1083","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.pain.2004.01.020","article-title":"Evidence that CB-1 and CB-2 cannabinoid receptors mediate antinociception in neuropathic pain in the rat","volume":"109","author":"Scott","year":"2004","journal-title":"Pain"},{"key":"10.1124\/pr.58.3.2_REF1084","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/nrn1245","article-title":"Monitoring of stored and available fuel by the CNS: implications for obesity","volume":"4","author":"Seeley","year":"2003","journal-title":"Nat Neurosci"},{"key":"10.1124\/pr.58.3.2_REF1085","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1046\/j.1471-4159.2001.00308.x","article-title":"Agonist efficacy and receptor efficiency in heterozygous CB1 knockout mice: relationship of reduced CB1 receptor density to G-protein activation","volume":"77","author":"Selley","year":"2001","journal-title":"J Neurochem"},{"key":"10.1124\/pr.58.3.2_REF1086","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1177\/0269881105049040","article-title":"Cannabis as a risk factor for psychosis: systematic review","volume":"19","author":"Semple","year":"2005","journal-title":"J Psychopharmacol"},{"key":"10.1124\/pr.58.3.2_REF1087","first-page":"CD001332","article-title":"Anti-spasticity agents for multiple sclerosis","volume":"4","author":"Shakespeare","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1124\/pr.58.3.2_REF1088","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1378\/chest.71.4.558b","article-title":"Tetrahydrocannabinol as a bronchodilator: Why bother","volume":"71","author":"Shapiro","year":"1977","journal-title":"Chest"},{"key":"10.1124\/pr.58.3.2_REF1089","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1159\/000307060","article-title":"The ocular manifestations of the cannabinols","volume":"168","author":"Shapiro","year":"1974","journal-title":"Ophthalmologica"},{"key":"10.1124\/pr.58.3.2_REF1090","first-page":"pe15","article-title":"Central and peripheral signaling mechanisms involved in endocannabinoid regulation of feeding: a perspective on the munchies","volume":"277","author":"Sharkey","year":"2005","journal-title":"SciSTKE"},{"key":"10.1124\/pr.58.3.2_REF1091","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/00008877-200312000-00001","article-title":"Antidepressant-like and anorectic effects of the cannabinoid CB1 receptor inverse agonist AM251 in mice","volume":"14","author":"Shearman","year":"2003","journal-title":"Behav Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1092","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1124\/mol.54.3.459","article-title":"Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity","volume":"54","author":"Shen","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1093","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0026-895X(24)23149-7","article-title":"\u03949-Tetrahydrocannabinol acts as a partial agonist to modulate glutamatergic synaptic transmission between rat hippocampal neurons in culture","volume":"55","author":"Shen","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1094","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1074\/jbc.270.8.3726","article-title":"An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing","volume":"270","author":"Shire","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.58.3.2_REF1095","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0165-5728(96)00181-6","article-title":"Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-\u03b1 inhibitor and an effective neuroprotectant","volume":"72","author":"Shohami","year":"1997","journal-title":"J Neuroimmunol"},{"key":"10.1124\/pr.58.3.2_REF1096","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0006-8993(94)01433-I","article-title":"Long-term effect of HU-211, a novel non-competitive NMDA antagonist, on motor and memory functions after closed head injury in the rat","volume":"674","author":"Shohami","year":"1995","journal-title":"Brain Res"},{"key":"10.1124\/pr.58.3.2_REF1097","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1089\/neu.1993.10.109","article-title":"A nonpsychotropic cannabinoid, HU-211, has cerebroprotective effects after closed head injury in the rat","volume":"10","author":"Shohami","year":"1993","journal-title":"J Neurotrauma"},{"key":"10.1124\/pr.58.3.2_REF1098","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0022-3565(25)23416-4","article-title":"Psychoactive cannabinoids reduce gastrointestinal propulsion and motility in rodents","volume":"249","author":"Shook","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.58.3.2_REF1099","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/sj.bjp.0706755","article-title":"Endocannabinoids potently protect the newborn brain against AMPA-kainate receptor-mediated excitotoxic damage","volume":"148","author":"Shouman","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1099a","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0022-3565(25)20744-3","article-title":"Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands","volume":"278","author":"Showalter","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.58.3.2_REF1101","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1023\/A:1018427320658","article-title":"Marijuana use and cancer incidence (California, United States)","volume":"8","author":"Sidney","year":"1997","journal-title":"Cancer Causes Control"},{"key":"10.1124\/pr.58.3.2_REF1102","first-page":"126","article-title":"Association study of cannabinoid receptor gene (CNR1) alleles and anorexia nervosa: differences between restricting and bingeing\/purging subtypes","volume":"125B","author":"Siegfried","year":"2004","journal-title":"Am J Med Genetics"},{"key":"10.1124\/pr.58.3.2_REF1103","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/hep.20667","article-title":"Anandamide induces necrosis in primary hepatic stellate cells","volume":"41","author":"Siegmund","year":"2005","journal-title":"Hepatology"},{"key":"10.1124\/pr.58.3.2_REF1104","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1212\/WNL.57.11.2108","article-title":"Cannabinoids reduce levodopa-induced dyskinesia in Parkinson\u2019s disease: a pilot study","volume":"57","author":"Sieradzan","year":"2001","journal-title":"Neurology"},{"key":"10.1124\/pr.58.3.2_REF1105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.0305-1846.2001.00299.x","article-title":"The selective vulnerability of nerve cells in Huntington\u2019s disease","volume":"27","author":"Sieradzan","year":"2001","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1124\/pr.58.3.2_REF1106","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1056\/NEJMcp043762","article-title":"Clinical practice: chronic insomnia","volume":"353","author":"Silber","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1124\/pr.58.3.2_REF1107","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1006\/exnr.2001.7649","article-title":"Striatal cannabinoid CB1 receptor mRNA expression is decreased in the reserpine-treated rat model of Parkinson\u2019s disease","volume":"169","author":"Silverdale","year":"2001","journal-title":"Exp Neurol"},{"key":"10.1124\/pr.58.3.2_REF1108","first-page":"179","article-title":"SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset","volume":"9","author":"Simiand","year":"1998","journal-title":"Behav Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1109","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1001\/jama.295.7.826","article-title":"Obesity research\u2014 limitations of methods, measurements, and medications","volume":"295","author":"Simons-Morton","year":"2006","journal-title":"J Am Med Assoc"},{"key":"10.1124\/pr.58.3.2_REF1110","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0304-3940(99)00922-2","article-title":"Endocannabinoids protect cerebral cortical neurons from in vitro ischemia in rats","volume":"278","author":"Sinor","year":"2000","journal-title":"Neurosci Lett"},{"key":"10.1124\/pr.58.3.2_REF1111","doi-asserted-by":"crossref","first-page":"8394","DOI":"10.1073\/pnas.082235799","article-title":"A missense mutation in human fatty acid amide hydrolase associated with problem drug use","volume":"99","author":"Sipe","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.58.3.2_REF1112","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/sj.ijo.0802954","article-title":"Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH)","volume":"29","author":"Sipe","year":"2005","journal-title":"Int J Obes"},{"key":"10.1124\/pr.58.3.2_REF1113","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1212\/01.WNL.0000129703.59857.D6","article-title":"Marijuana as a treatment for epilepsy and multiple sclerosis? A \u201cgrass roots\u201d movement","volume":"62","author":"Sirven","year":"2004","journal-title":"Neurology"},{"key":"10.1124\/pr.58.3.2_REF1114","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.1073\/pnas.93.9.3984","article-title":"The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons","volume":"93","author":"Skaper","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.58.3.2_REF1115","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0015-0282(16)59400-X","article-title":"Drug abuse and reproduction","volume":"48","author":"Smith","year":"1987","journal-title":"Fertil Steril"},{"key":"10.1124\/pr.58.3.2_REF1116","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0091-3057(97)00583-2","article-title":"Characterization of \u03949-tetrahydrocannabinol and anandamide antinociception in nonarthritic and arthritic rats","volume":"60","author":"Smith","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pr.58.3.2_REF1117","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0022-3565(25)22356-4","article-title":"The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice","volume":"270","author":"Smith","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.58.3.2_REF1118","first-page":"748","article-title":"GW-1000: GW pharmaceuticals","volume":"5","author":"Smith","year":"2004","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1124\/pr.58.3.2_REF1119","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1517\/14740338.4.3.443","article-title":"The safety of cannabinoids for the treatment of multiple sclerosis","volume":"4","author":"Smith","year":"2005","journal-title":"Expert Opin Drug Saf"},{"key":"10.1124\/pr.58.3.2_REF1120","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0022-3565(24)39213-4","article-title":"Effects of cannabinoid receptor agonist and antagonist ligands on production of inflammatory cytokines and anti-inflammatory interleukin-10 in endotoxemic mice","volume":"293","author":"Smith","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.58.3.2_REF1121","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0014-2999(01)01142-6","article-title":"Modulation of cytokine responses in Corynebacterium parvum-primed endotoxemic mice by centrally administered cannabinoid ligands","volume":"425","author":"Smith","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1122","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000136851","article-title":"Evaluation of antiulcer activity of \u03949-tetrahydrocannabinol in the Shay rat test","volume":"17","author":"Sofia","year":"1978","journal-title":"Pharmacology"},{"key":"10.1124\/pr.58.3.2_REF1123","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0022-3565(25)29636-7","article-title":"Anti-edema and analgesic properties of \u03949-tetrahydrocannabinol (THC)","volume":"186","author":"Sofia","year":"1973","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.58.3.2_REF1124","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1038\/sj.npp.1300720","article-title":"Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems","volume":"30","author":"Solinas","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.58.3.2_REF1125","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0026-895X(25)09082-0","article-title":"A lysine residue of the cannabinoid receptor is critical for receptor recognition by several agonists bu not WIN55212-2","volume":"49","author":"Song","year":"1996","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1126","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0022-3565(24)35269-3","article-title":"Involvement of cannabinoid receptors in the intraocular pressure-lowering effects of WIN55212-2","volume":"292","author":"Song","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.58.3.2_REF1127","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1038\/sj.npp.1300707","article-title":"Lack of CB1 cannabinoid receptor impairs cocaine self-administration","volume":"30","author":"Soria","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.58.3.2_REF1128","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.23.021704.115707","article-title":"Immunology of multiple sclerosis","volume":"23","author":"Sospedra","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"10.1124\/pr.58.3.2_REF1129","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0192-0561(91)90011-U","article-title":"\u0394-9-Tetrahydrocannabinol augments murine retroviral induced immunosuppression and infection","volume":"13","author":"Specter","year":"1991","journal-title":"Int J Immunopharmacol"},{"key":"10.1124\/pr.58.3.2_REF1130","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3109\/10826087109057790","article-title":"Cannabis-induced psychosis","volume":"6","author":"Spencer","year":"1971","journal-title":"Int J Addict"},{"key":"10.1124\/pr.58.3.2_REF1131","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/sj.bjp.0703497","article-title":"Characterization of the effects of cannabinoids on guinea-pig tracheal smooth muscle tone: role in the modulation of acetylcholine release from parasympathetic nerves","volume":"130","author":"Spicuzza","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1132","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0162-3109(98)00041-1","article-title":"\u03949 Tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells","volume":"40","author":"Srivastava","year":"1998","journal-title":"Immunopharmacology"},{"key":"10.1124\/pr.58.3.2_REF1133","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0014-2999(01)01438-8","article-title":"Cannabinoid CB1 receptor expression, activation and detection of endogenous ligand in trabecular meshwork and ciliary process tissues","volume":"431","author":"Stamer","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1134","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/cpt1978234397","article-title":"Effect of a nitrogen analog of tetrahydrocannabinol on cancer pain","volume":"23","author":"Staquet","year":"1978","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/pr.58.3.2_REF1135","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.neuint.2003.08.009","article-title":"Receptor-independent depression of DA and 5-HT uptake by cannabinoids in rat neocortex-involvement of Na+\/K+-ATPase","volume":"44","author":"Steffens","year":"2004","journal-title":"Neurochem Int"},{"key":"10.1124\/pr.58.3.2_REF1136","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/nature03389","article-title":"Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice","volume":"434","author":"Steffens","year":"2005","journal-title":"Nature (Lond)"},{"key":"10.1124\/pr.58.3.2_REF1137","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1476-5381.1996.tb15683.x","article-title":"Physiological and behavioural effects of the endogenous cannabinoid, arachidonylethanolamide (anandamide), in the rat","volume":"119","author":"Stein","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1138","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/glia.20084","article-title":"Cannabinoid signaling in glial cells","volume":"48","author":"Stella","year":"2004","journal-title":"Glia"},{"key":"10.1124\/pr.58.3.2_REF1139","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/42015","article-title":"A second endogenous cannabinoid that modulates long-term potentiation","volume":"388","author":"Stella","year":"1997","journal-title":"Nature (Lond)"},{"key":"10.1124\/pr.58.3.2_REF1140","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0014-2999(98)00472-5","article-title":"Pulmonary actions of anandamide, an endogenous cannabinoid receptor agonist, in guinea pigs","volume":"355","author":"Stengel","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1141","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.bcp.2005.03.027","article-title":"Differential CB1 and CB2 cannabinoid receptor-inotropic response of rat isolated atria: endogenous signal transduction pathways","volume":"69","author":"Sterin-Borda","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1142","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1139\/y02-005","article-title":"Effect of cannabinoids on neural transmission in rat gastric fundus","volume":"80","author":"Storr","year":"2002","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1143","first-page":"G110","article-title":"Cannabinoid receptor type 1 modulates excitatory and inhibitory neurotransmission in mouse colon","volume":"286","author":"Storr","year":"2004","journal-title":"Am J Physiol"},{"key":"10.1124\/pr.58.3.2_REF1144","doi-asserted-by":"crossref","first-page":"14565","DOI":"10.1073\/pnas.96.25.14565","article-title":"Cannabinoid CB1 receptors and ligands in vertebrate retina: localization and function of an endogenous signaling system","volume":"96","author":"Straiker","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.58.3.2_REF1145","first-page":"2442","article-title":"Localization of cannabinoid CB1 receptors in the human anterior eye and retina","volume":"40","author":"Straiker","year":"1999","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1124\/pr.58.3.2_REF1146","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0006-8993(98)01031-2","article-title":"Evidence for a role of endogenous cannabinoids in the modulation of acute and tonic pain sensitivity","volume":"813","author":"Strangman","year":"1998","journal-title":"Brain Res"},{"key":"10.1124\/pr.58.3.2_REF1147","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.exer.2004.12.003","article-title":"Stimulation of cannabinoid (CB1) and prostanoid (EP2) receptors opens BKCa channels and relaxes ocular trabecular meshwork","volume":"80","author":"Stumpff","year":"2005","journal-title":"Exp Eye Res"},{"key":"10.1124\/pr.58.3.2_REF1148","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1074\/jbc.274.5.2794","article-title":"Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor: structure-activity relationship of 2-arachidonoylglycerol, ether-linked analogues, and related compounds","volume":"274","author":"Sugiura","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.58.3.2_REF1149","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/bbrc.1995.2437","article-title":"2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain","volume":"215","author":"Sugiura","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/pr.58.3.2_REF1150","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1006\/bbrc.2000.2686","article-title":"Generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in picrotoxinin-administered rat brain","volume":"271","author":"Sugiura","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/pr.58.3.2_REF1151","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1021\/jm9608725","article-title":"New approaches to antiglaucoma therapy","volume":"40","author":"Sugrue","year":"1997","journal-title":"J Med Chem"},{"key":"10.1124\/pr.58.3.2_REF1152","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/art.20050","article-title":"A novel synthetic, nonpsychoactive cannabinoid acid (HU-320) with anti-inflammatory properties in murine collagen-induced arthritis","volume":"50","author":"Sumariwalla","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1124\/pr.58.3.2_REF1153","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1042\/bj20040031","article-title":"Biosynthesis of anandamide and N-palmitoylethanolamine by sequential actions of phospholipase A2 and lysophospholipase D","volume":"380","author":"Sun","year":"2004","journal-title":"Biochem J"},{"key":"10.1124\/pr.58.3.2_REF1154","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.bbalip.2005.08.010","article-title":"Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages","volume":"1736","author":"Sun","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/pr.58.3.2_REF1155","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s00210-005-1074-2","article-title":"Clozapine decreases [3H] CP 55940 binding to the cannabinoid1 receptor in the rat nucleus accumbens","volume":"371","author":"Sundram","year":"2005","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1156","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.neuropharm.2005.10.007","article-title":"Inhibition of fatty-acid amide hydrolase enhances cannabinoid stress-induced analgesia: sites of action in the dorsolateral periaqueductal gray and rostral ventromedial medulla","volume":"50","author":"Suplita","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.58.3.2_REF1157","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/bmj.38149.566979.AE","article-title":"Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial","volume":"329","author":"Svendsen","year":"2004","journal-title":"BMJ"},{"key":"10.1124\/pr.58.3.2_REF1158","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0022-3565(24)29602-6","article-title":"Effects of cannabinoids on sympathetic and parasympathetic neuroeffector transmission in the rabbit heart","volume":"297","author":"Szabo","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.58.3.2_REF1159","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1046\/j.1460-9568.2002.02041.x","article-title":"Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids","volume":"15","author":"Szabo","year":"2002","journal-title":"Eur J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF1160","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.2337\/diabetes.54.12.3510","article-title":"Resistance to diet-induced obesity in \u03bc-opioid receptor-deficient mice: evidence for a \u201cthrifty gene\u201d","volume":"54","author":"Tabarin","year":"2005","journal-title":"Diabetes"},{"key":"10.1124\/pr.58.3.2_REF1161","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.neuroscience.2006.01.024","article-title":"The CB1 receptor mediates glutamatergic synaptic suppression in the hippocampus","volume":"139","author":"Takahashi","year":"2006","journal-title":"Neuroscience"},{"key":"10.1124\/pr.58.3.2_REF1162","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0014-2999(99)00384-2","article-title":"Dependence of mesolimbic dopamine transmission on delta9-tetrahydrocannabinol","volume":"376","author":"Tanda","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1163","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/80577","article-title":"Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys","volume":"3","author":"Tanda","year":"2000","journal-title":"Nat Neurosci"},{"key":"10.1124\/pr.58.3.2_REF1164","doi-asserted-by":"crossref","first-page":"71S","DOI":"10.1002\/j.1552-4604.2002.tb06006.x","article-title":"Respiratory and immunologic consequences of marijuana smoking","volume":"42","author":"Tashkin","year":"2002","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1165","first-page":"57","article-title":"Bronchial effects of aerosolized \u03949-tetrahydrocannabinol in healthy and asthmatic subjects","volume":"115","author":"Tashkin","year":"1977","journal-title":"Am Rev Respir Dis"},{"key":"10.1124\/pr.58.3.2_REF1166","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1056\/NEJM197308162890702","article-title":"Acute pulmonary physiologic effects of smoked marijuana and oral 9-tetrahydrocannabinol in healthy young men","volume":"289","author":"Tashkin","year":"1973","journal-title":"N Engl J Med"},{"key":"10.1124\/pr.58.3.2_REF1167","first-page":"420","article-title":"Acute effects of smoked marijuana and oral \u03949-tetrahydrocannabinol on specific airway conductance in asthmatic subjects","volume":"109","author":"Tashkin","year":"1974","journal-title":"Am Rev Respir Dis"},{"key":"10.1124\/pr.58.3.2_REF1168","first-page":"377","article-title":"Effects of smoked marijuana in experimentally induced asthma","volume":"112","author":"Tashkin","year":"1975","journal-title":"Am Rev Respir Dis"},{"key":"10.1124\/pr.58.3.2_REF1169","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1097\/00007611-198810000-00003","article-title":"Marijuana as a potential respiratory tract carcinogen: a retrospective analysis of a community hospital population","volume":"81","author":"Taylor","year":"1988","journal-title":"South Med J"},{"key":"10.1124\/pr.58.3.2_REF1170","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0014-4886(03)00083-9","article-title":"Combination of dexanabinol and tempol in focal cerebral ischemia: is there a ceiling effect?","volume":"182","author":"Teichner","year":"2003","journal-title":"Exp Neurol"},{"key":"10.1124\/pr.58.3.2_REF1171","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nm1421","article-title":"CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis","volume":"12","author":"Teixeira-Clerc","year":"2006","journal-title":"Nat Med"},{"key":"10.1124\/pr.58.3.2_REF1172","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0014-2999(75)90087-4","article-title":"Acute and chronic effects of \u03b29-tetrahydrocannabinol on seizures in the gerbil","volume":"31","author":"Ten Ham","year":"1975","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1173","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/89040","article-title":"Advances in schizophrenia","volume":"7","author":"Thaker","year":"2001","journal-title":"Nat Med"},{"key":"10.1124\/pr.58.3.2_REF1174","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/sj.bjp.0706045","article-title":"Synergistic and additive interactions of the cannabinoid agonist CP55,940 with \u03bc opioid receptor and \u03b12-adrenoceptor agonists in acute pain models in mice","volume":"144","author":"Tham","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1175","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bbr.2005.06.021","article-title":"Ethanol self-administration and ethanol conditioned place preference are reduced in mice lacking cannabinoid CB1 receptors","volume":"164","author":"Thanos","year":"2005","journal-title":"Behav Brain Res"},{"key":"10.1124\/pr.58.3.2_REF1176","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/24614","article-title":"Ethanol consumption and resistance are inversely related to neuropeptide Y levels","volume":"396","author":"Thiele","year":"1998","journal-title":"Nature (Lond)"},{"key":"10.1124\/pr.58.3.2_REF1177","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/sj.bjp.0706414","article-title":"Evidence that the plant cannabinoid \u03949-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist","volume":"146","author":"Thomas","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1178","doi-asserted-by":"crossref","first-page":"14115","DOI":"10.1073\/pnas.94.25.14115","article-title":"Unique allosteric regulation of 5-hydroxytryptamine receptor-mediated signal transduction by oleamide","volume":"94","author":"Thomas","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.58.3.2_REF1179","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1046\/j.1471-4159.1999.0722370.x","article-title":"The endogenous lipid oleamide activates serotonin 5-HT7 neurons in mouse thalamus and hypothalamus","volume":"72","author":"Thomas","year":"1999","journal-title":"J Neurochem"},{"key":"10.1124\/pr.58.3.2_REF1180","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/nn757","article-title":"Long-term depression in the nucleus accumbens: a neural correlate of behavioral sensitization to cocaine","volume":"4","author":"Thomas","year":"2001","journal-title":"Nat Neurosc"},{"key":"10.1124\/pr.58.3.2_REF1181","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1212\/WNL.58.9.1323","article-title":"Cannabinoids in MS: potentially useful but not just yet!","volume":"58","author":"Thompson","year":"2002","journal-title":"Neurology"},{"key":"10.1124\/pr.58.3.2_REF1182","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s00213-004-2047-8","article-title":"The cannabinoid CB1 receptor antagonist SR141716A reduces appetitive and consummatory responses to food","volume":"179","author":"Thornton-Jones","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1124\/pr.58.3.2_REF1183","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1089\/aid.1997.13.305","article-title":"The safety and pharmacokinetics of single-agent and combination therapy with megestrol acetate and dronabinol for the treatment of HIV wasting syndrome: the DATRI 004 Study Group. Division of AIDS Treatment Research Initiative","volume":"13","author":"Timpone","year":"1997","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1124\/pr.58.3.2_REF1184","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1136\/bjo.2003.032250","article-title":"Cannabinoids and glaucoma","volume":"88","author":"Tomida","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1124\/pr.58.3.2_REF1185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-1781(03)00052-0","article-title":"Cannabis use and anxiety in daily life: a naturalistic investigation in a non-clinical population","volume":"118","author":"Tournier","year":"2003","journal-title":"Psychiatry Res"},{"key":"10.1124\/pr.58.3.2_REF1186","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.323.7303.16","article-title":"Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review","volume":"323","author":"Tram\u00e8r","year":"2001","journal-title":"Br Med J"},{"key":"10.1124\/pr.58.3.2_REF1187","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1007\/s00018-005-5230-0","article-title":"Molecular complexity in establishing uterine receptivity and implantation","volume":"62","author":"Tranguch","year":"2005","journal-title":"Cell Mol Life Sci"},{"key":"10.1124\/pr.58.3.2_REF1188","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1176\/ajp.135.10.1213","article-title":"Marijuana use in schizophrenia: a clear hazard","volume":"135","author":"Treffert","year":"1978","journal-title":"Am J Psychiatry"},{"key":"10.1124\/pr.58.3.2_REF1189","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0306-4522(97)00436-3","article-title":"Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system","volume":"83","author":"Tsou","year":"1998","journal-title":"Neuroscience"},{"key":"10.1124\/pr.58.3.2_REF1190","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0306-4522(96)83015-6","article-title":"Suppression of noxious stimulus-evoked expression of Fos protein-like immunoreactivity in rat spinal cord by a selective cannabinoid agonist","volume":"70","author":"Tsou","year":"1996","journal-title":"Neuroscience"},{"key":"10.1124\/pr.58.3.2_REF1191","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0306-4522(99)00086-X","article-title":"Cannabinoid CB1 receptors are localized primarily on cholecystokinin-containing GABAergic interneurons in the rat hippocampal formation","volume":"93","author":"Tsou","year":"1999","journal-title":"Neuroscience"},{"key":"10.1124\/pr.58.3.2_REF1192","doi-asserted-by":"crossref","first-page":"11082","DOI":"10.1074\/jbc.M413473200","article-title":"Molecular characterization of N-acylethanolamine-hydrolyzing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase","volume":"280","author":"Tsuboi","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.58.3.2_REF1193","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/sj.bjp.0705968","article-title":"The cannabinoid CB1 receptor antagonist SR141716 blocks the orexigenic effects of intrahypothalamic ghrelin","volume":"143","author":"Tucci","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1194","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/schbul\/16.1.87","article-title":"Impact of substance abuse on the course and outcome of schizophrenia","volume":"16","author":"Turner","year":"1990","journal-title":"Schizophr Bull"},{"key":"10.1124\/pr.58.3.2_REF1195","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/mds.10305","article-title":"Systematic review of incidence studies of Parkinson\u2019s disease","volume":"18","author":"Twelves","year":"2003","journal-title":"Mov Disord"},{"key":"10.1124\/pr.58.3.2_REF1196","doi-asserted-by":"crossref","first-page":"9374","DOI":"10.1523\/JNEUROSCI.23-28-09374.2003","article-title":"Biphasic effects of cannabinoids on acetylcholine release in the hippocampus: site and mechanism of action","volume":"23","author":"Tzavara","year":"2003","journal-title":"J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF1196a","doi-asserted-by":"crossref","first-page":"23823","DOI":"10.1074\/jbc.270.40.23823","article-title":"Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide","volume":"270","author":"Ueda","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.58.3.2_REF1198","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1023\/A:1015526217332","article-title":"Activation of cannabinoid receptors decreases the area of ischemic myocardial necrosis","volume":"133","author":"Ugdyzhekova","year":"2002","journal-title":"Bull Exp Biol Med"},{"key":"10.1124\/pr.58.3.2_REF1199","first-page":"17","article-title":"Specificity of the anti-arrhythmic effect of \u03ba1-opioid receptor agonists","volume":"64","author":"Ugdyzhekova","year":"2001","journal-title":"Eksp Klin Farmakol"},{"key":"10.1124\/pr.58.3.2_REF1200","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1254\/jphs.FMJ04003X4","article-title":"New perspectives in the studies on endocannabinoid and cannabis: cannabinoid receptors and schizophrenia","volume":"96","author":"Ujike","year":"2004","journal-title":"J Pharmacol Sci"},{"key":"10.1124\/pr.58.3.2_REF1201","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/sj.mp.4001029","article-title":"CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia","volume":"7","author":"Ujike","year":"2002","journal-title":"Mol Psychiatry"},{"key":"10.1124\/pr.58.3.2_REF1202","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1213\/01.ane.0000194587.94260.1d","article-title":"The additive antinociceptive interaction between WIN 55,212-2, a cannabinoid agonist, and ketorolac","volume":"102","author":"Ulugol","year":"2006","journal-title":"Anesth Analg"},{"key":"10.1124\/pr.58.3.2_REF1203","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/sj.bjp.0706391","article-title":"Anandamide reduces infarct size in rat isolated hearts subjected to ischaemia-reperfusion by a novel cannabinoid mechanism","volume":"146","author":"Underdown","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1204","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1300\/J251v07n01_04","article-title":"\u0394-9-THC in the treatment of spasticity associated with multiple sclerosis","volume":"7","author":"Ungerleider","year":"1987","journal-title":"Adv Alcohol Subst Abuse"},{"key":"10.1124\/pr.58.3.2_REF1205","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.neuropharm.2004.01.003","article-title":"Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors","volume":"46","author":"Urig\u00fcen","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.58.3.2_REF1206","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/sj.bjp.0706134","article-title":"Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism","volume":"144","author":"Vaccani","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1207","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1056\/NEJM197305102881902","article-title":"Singledose effects of marihuana smoke: bronchial dynamics and respiratory-center sensitivity in normal subjects","volume":"288","author":"Vachon","year":"1973","journal-title":"N Engl J Med"},{"key":"10.1124\/pr.58.3.2_REF1208","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s002130050013","article-title":"A behavioural model to reveal place preference to \u03949-tetrahydrocannabinol in mice","volume":"147","author":"Valjent","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1124\/pr.58.3.2_REF1209","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1046\/j.1460-9568.2000.00929.x","article-title":"Reduction of stress-induced analgesia but not of exogenous opioid effects in mice lacking CB1 receptors","volume":"12","author":"Valverde","year":"2000","journal-title":"Eur J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF1210","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejphar.2003.08.101","article-title":"The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders","volume":"480","author":"van der Stelt","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1211","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1111\/j.1432-1033.2004.04081.x","article-title":"Endovanilloids: putative endogenous ligands of transient receptor potential vanilloid 1 channels","volume":"271","author":"van der Stelt","year":"2004","journal-title":"Eur J Biochem"},{"key":"10.1124\/pr.58.3.2_REF1211a","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1096\/fj.04-3010fje","article-title":"A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson\u2019s disease","volume":"19","author":"van der Stelt","year":"2005","journal-title":"FASEB J"},{"key":"10.1124\/pr.58.3.2_REF1213","doi-asserted-by":"crossref","first-page":"6475","DOI":"10.1523\/JNEUROSCI.21-17-06475.2001","article-title":"Neuroprotection by \u03949-tetrahydrocannabinol, the main active compound in marijuana, against ouabain-induced in vivo excitotoxicity","volume":"21","author":"van der Stelt","year":"2001","journal-title":"J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF1214","doi-asserted-by":"crossref","first-page":"8765","DOI":"10.1523\/JNEUROSCI.21-22-08765.2001","article-title":"Exogenous anandamide protects rat brain against acute neuronal injury in vivo","volume":"21","author":"van der Stelt","year":"2001","journal-title":"J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF1215","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1191\/1352458504ms1048oa","article-title":"Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover study","volume":"10","author":"Vaney","year":"2004","journal-title":"Mult Scler"},{"key":"10.1124\/pr.58.3.2_REF1216","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(05)66374-X","article-title":"Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study","volume":"365","author":"Van Gaal","year":"2005","journal-title":"Lancet"},{"key":"10.1124\/pr.58.3.2_REF1217","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1191\/1352458504ms1044oa","article-title":"Multiple sclerosis following treatment with a cannabinoid receptor-1 antagonist","volume":"10","author":"van Oosten","year":"2004","journal-title":"Mult Scler"},{"key":"10.1124\/pr.58.3.2_REF1217a","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1126\/science.1115740","article-title":"Identification and functional characterization of brainstem cannabinoid CB2 receptors","volume":"310","author":"Van Sickle","year":"2005","journal-title":"Science (Wash DC)"},{"key":"10.1124\/pr.58.3.2_REF1219","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0014-2999(95)00181-J","article-title":"Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide","volume":"278","author":"Varga","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1220","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1161\/01.HYP.28.4.682","article-title":"Mechanism of the hypotensive action of anandamide in anesthetized rats","volume":"28","author":"Varga","year":"1996","journal-title":"Hypertension"},{"key":"10.1124\/pr.58.3.2_REF1221","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1096\/fasebj.12.11.1035","article-title":"Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension","volume":"12","author":"Varga","year":"1998","journal-title":"FASEB J"},{"key":"10.1124\/pr.58.3.2_REF1222","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.2042-7158.1975.tb09406.x","article-title":"Effect of \u03949-tetrahydrocannabinol on experimental hypertension in rats","volume":"27","author":"Varma","year":"1975","journal-title":"J Pharm Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1223","doi-asserted-by":"crossref","first-page":"RC188","DOI":"10.1523\/JNEUROSCI.21-24-j0003.2001","article-title":"Metabotropic glutamate receptors drive the endocannabinoid system in the hippocampus","volume":"21","author":"Varma","year":"2001","journal-title":"J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF1224","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.neuropharm.2004.04.016","article-title":"Hypothesis: cannabinoid therapy for the treatment of gliomas","volume":"47","author":"Velasco","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.58.3.2_REF1225","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/376590a0","article-title":"Inhibition by anandamide of gap junctions and intercellular calcium signalling in striatal astrocytes","volume":"376","author":"Venance","year":"1995","journal-title":"Nature (Lond)"},{"key":"10.1124\/pr.58.3.2_REF1226","first-page":"335","article-title":"Anti-ischemia activity of HU-211, a non-psychotropic synthetic cannabinoid","volume":"60","author":"Vered","year":"1994","journal-title":"Acta Neurochir Suppl"},{"key":"10.1124\/pr.58.3.2_REF1227","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1210\/en.2004-0059","article-title":"Evidence for an interaction between CB1 cannabinoid and melanocortin NCR-4 receptors in regulating food intake","volume":"145","author":"Verty","year":"2004","journal-title":"Endocrinology"},{"key":"10.1124\/pr.58.3.2_REF1228","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s00213-003-1451-9","article-title":"The cannabinoid receptor antagonist SR 141716 attenuates overfeeding induced by systemic or intracranial morphine","volume":"168","author":"Verty","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1124\/pr.58.3.2_REF1229","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2174\/1389450053174514","article-title":"Cannabinoids and the regulation of ingestive behavior","volume":"6","author":"Vickers","year":"2005","journal-title":"Curr Drug Targets"},{"key":"10.1124\/pr.58.3.2_REF1230","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00213-002-1384-8","article-title":"Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa\/fa) compared to lean Zucker rats","volume":"167","author":"Vickers","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1124\/pr.58.3.2_REF1231","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/00005344-199608000-00022","article-title":"Cardiovascular effects of (-)-11-OH-delta 8-tetrahydrocannabinol-dimethylheptyl in rats","volume":"28","author":"Vidrio","year":"1996","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1232","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.pbb.2005.01.021","article-title":"Molecular and cellular basis of cannabinoid and opioid interactions","volume":"81","author":"Vigano","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pr.58.3.2_REF1233","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00213-005-0114-4","article-title":"Molecular mechanisms involved in the asymmetric interaction between cannabinoid and opioid systems","volume":"182","author":"Vigano","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1124\/pr.58.3.2_REF1234","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.lfs.2005.05.041","article-title":"Endocannabinoid lipids and mediated system: Implications for alcoholism and neuropsychiatric disorders","volume":"77","author":"Vinod","year":"2005","journal-title":"Life Sci"},{"key":"10.1124\/pr.58.3.2_REF1235","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.pbb.2005.01.029","article-title":"Endocannabinoid system and stress and anxiety responses","volume":"81","author":"Viveros","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pr.58.3.2_REF1236","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0014-2999(01)01413-3","article-title":"Evidence for presynaptic cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in the guinea pig lung","volume":"431","author":"Vizi","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1237","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0166-4328(02)00370-4","article-title":"WIN 55,212-2 decreases the reinforcing actions of cocaine through CB1 cannabinoid receptor stimulation","volume":"141","author":"Vlachou","year":"2003","journal-title":"Behav Brain Res"},{"key":"10.1124\/pr.58.3.2_REF1238","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/(SICI)1099-1166(199709)12:9<913::AID-GPS663>3.0.CO;2-D","article-title":"Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer\u2019s disease","volume":"12","author":"Volicer","year":"1997","journal-title":"J Geriat Psychiatry"},{"key":"10.1124\/pr.58.3.2_REF1239","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1176\/ajp.156.9.1440","article-title":"Prediction of reinforcing responses to psychostimulants in humans by brain dopamine D2 receptor levels","volume":"156","author":"Volkow","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1124\/pr.58.3.2_REF1240","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/386830a0","article-title":"Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects","volume":"386","author":"Volkow","year":"1997","journal-title":"Nature (Lond)"},{"key":"10.1124\/pr.58.3.2_REF1241","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0925-4927(01)00104-4","article-title":"Cannabis induced dopamine release: an in-vivo SPECT study","volume":"107","author":"Voruganti","year":"2001","journal-title":"Psychiatry Res"},{"key":"10.1124\/pr.58.3.2_REF1242","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1528-1157.1975.tb06071.x","article-title":"Effects of tetrahydrocannabinols on kindled amygdaloid seizures and photogenic seizures in Senegalese baboons, Papio papio","volume":"16","author":"Wada","year":"1975","journal-title":"Epilepsia"},{"key":"10.1124\/pr.58.3.2_REF1243","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1528-1157.1975.tb06080.x","article-title":"Antiepileptic and prophylactic effects of tetrahydrocannabinols in amygdaloid kindled cats","volume":"16","author":"Wada","year":"1975","journal-title":"Epilepsia"},{"key":"10.1124\/pr.58.3.2_REF1244","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1191\/1352458504ms1082oa","article-title":"Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients","volume":"10","author":"Wade","year":"2004","journal-title":"Mult Scler"},{"key":"10.1124\/pr.58.3.2_REF1245","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1191\/0269215503cr581oa","article-title":"A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms","volume":"17","author":"Wade","year":"2003","journal-title":"Clin Rehabil"},{"key":"10.1124\/pr.58.3.2_REF1246","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/01.fjc.0000175437.87283.f2","article-title":"Coronary vasodilator effects of endogenous cannabinoids in vasopressin-preconstricted unpaced rat isolated hearts","volume":"46","author":"Wagner","year":"2005","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1247","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1016\/S0735-1097(01)01671-0","article-title":"Endogenous cannabinoids mediate hypotension after experimental myocardial infarction","volume":"38","author":"Wagner","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/pr.58.3.2_REF1248","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/sj.bjp.0705156","article-title":"CB1 cannabinoid receptor antagonism promotes remodeling and cannabinoid treatment prevents endothelial dysfunction and hypotension in rats with myocardial infarction","volume":"138","author":"Wagner","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1249","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0014-2999(01)01112-8","article-title":"Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB1 receptors","volume":"423","author":"Wagner","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1250","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/37371","article-title":"Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock","volume":"390","author":"Wagner","year":"1997","journal-title":"Nature (Lond)"},{"key":"10.1124\/pr.58.3.2_REF1251","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1161\/01.HYP.33.1.429","article-title":"Mesenteric vasodilation mediated by endothelial anandamide receptors","volume":"33","author":"Wagner","year":"1999","journal-title":"Hypertension"},{"key":"10.1124\/pr.58.3.2_REF1252","first-page":"H2491","article-title":"The endocannabinoid arachidonyl ethanolamide (anandamide) increases pulmonary arterial pressure via cyclooxygenase-2 products in isolated rabbit lungs","volume":"289","author":"Wahn","year":"2005","journal-title":"Am J Physiol"},{"key":"10.1124\/pr.58.3.2_REF1253","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0022-3565(24)38093-0","article-title":"The central cannabinoid receptor (CB1) mediates inhibition of nitric oxide production by rat microglial cells","volume":"288","author":"Waksman","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.58.3.2_REF1254","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0163-7258(02)00252-8","article-title":"Cannabinoid analgesia","volume":"95","author":"Walker","year":"2002","journal-title":"Pharmacol Ther"},{"key":"10.1124\/pr.58.3.2_REF1255","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S1526-5900(00)90085-3","article-title":"Identification of the role of endogenous cannabinoids in pain modulation: strategies and pitfalls","volume":"1","author":"Walker","year":"2000","journal-title":"J Pain"},{"key":"10.1124\/pr.58.3.2_REF1256","doi-asserted-by":"crossref","first-page":"12198","DOI":"10.1073\/pnas.96.21.12198","article-title":"Pain modulation by release of the endogenous cannabinoid anandamide","volume":"96","author":"Walker","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.58.3.2_REF1257","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0009-3084(02)00152-4","article-title":"Endocannabinoids and related fatty acid derivatives in pain modulation","volume":"121","author":"Walker","year":"2002","journal-title":"Chem Phys Lipids"},{"key":"10.1124\/pr.58.3.2_REF1258","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1124\/jpet.103.051920","article-title":"The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy","volume":"307","author":"Wallace","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.58.3.2_REF1259","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0014-2999(02)02331-2","article-title":"Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity","volume":"452","author":"Wallace","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1260","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00520-002-0387-7","article-title":"Established and potential therapeutic applications of cannabinoids in oncology","volume":"11","author":"Walsh","year":"2003","journal-title":"Support Care Cancer"},{"key":"10.1124\/pr.58.3.2_REF1261","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1523\/JNEUROSCI.23-04-01398.2003","article-title":"Nonpsychotropic cannabinoid receptors regulate microglial cell migration","volume":"23","author":"Walter","year":"2003","journal-title":"J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF1262","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/sj.bjp.0705667","article-title":"Cannabinoids and neuroinflammation","volume":"141","author":"Walter","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1263","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s00213-006-0343-1","article-title":"\u0394-9-Tetrahydrocannabinol for nighttime agitation in severe dementia","volume":"185","author":"Walther","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1124\/pr.58.3.2_REF1264","doi-asserted-by":"crossref","unstructured":"Wang H, Dey SK, and Maccarrone M (2006) Jekyll and Hyde: two faces of cannabinoid signaling in male and female fertility. Endocr Rev, in press.","DOI":"10.1210\/er.2006-0006"},{"key":"10.1124\/pr.58.3.2_REF1265","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/nm1104","article-title":"Aberrant cannabinoid signaling impairs oviductal transport of embryos","volume":"10","author":"Wang","year":"2004","journal-title":"Nat Med"},{"key":"10.1124\/pr.58.3.2_REF1266","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1095\/biolreprod60.4.839","article-title":"Stage-specific excitation of cannabinoid receptor exhibits differential effects on mouse embryonic development","volume":"60","author":"Wang","year":"1999","journal-title":"Biol Reprod"},{"key":"10.1124\/pr.58.3.2_REF1267","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1073\/pnas.0336351100","article-title":"Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice","volume":"100","author":"Wang","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.58.3.2_REF1268","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1358\/dnp.2000.13.3.657283","article-title":"Role of immune and inflammatory mediators in CNS injury","volume":"13","author":"Wang","year":"2000","journal-title":"Drug News Perspect"},{"key":"10.1124\/pr.58.3.2_REF1269","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/01.HYP.0000174596.95607.fd","article-title":"VR1-mediated depressor effects during high-salt intake: role of anandamide","volume":"46","author":"Wang","year":"2005","journal-title":"Hypertension"},{"key":"10.1124\/pr.58.3.2_REF1270","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1006\/abio.2001.5015","article-title":"Simultaneous measurement of anandamide and 2-arachidonoylglycerol by polymyxin B-selective adsorption and subsequent high-performance liquid chromatography analysis: increase in endogenous cannabinoids in the sera of patients with endotoxic shock","volume":"294","author":"Wang","year":"2001","journal-title":"Anal Biochem"},{"key":"10.1124\/pr.58.3.2_REF1271","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00008877-200509000-00010","article-title":"The role of CB1 receptors in sweet versus fat reinforcement: effect of CB1 receptor deletion, CB1 receptor antagonism (SR141716A) and CB1 receptor agonism (CP-55940)","volume":"16","author":"Ward","year":"2005","journal-title":"Behav Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1272","doi-asserted-by":"crossref","first-page":"27A","DOI":"10.1155\/2005\/847562","article-title":"Cannabinoids for the treatment of pain: an update on recent clinical trials","volume":"10","author":"Ware","year":"2005","journal-title":"Pain Res Manag"},{"key":"10.1124\/pr.58.3.2_REF1273","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1742-1241.2004.00271.x","article-title":"The medicinal use of cannabis in the UK: results of a nationwide survey","volume":"59","author":"Ware","year":"2005","journal-title":"Int J Clin Pract"},{"key":"10.1124\/pr.58.3.2_REF1274","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/s0304-3959(02)00400-1","article-title":"Cannabis use for chronic non-cancer pain: results of a prospective survey","volume":"102","author":"Ware","year":"2003","journal-title":"Pain"},{"key":"10.1124\/pr.58.3.2_REF1275","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0014-5793(95)00027-7","article-title":"The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamide","volume":"359","author":"Wartmann","year":"1995","journal-title":"FEBS Lett"},{"key":"10.1124\/pr.58.3.2_REF1276","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/978-1-4684-5925-8_7","article-title":"Influence of marijuana components (THC and CBD) on human mononuclear cell cytokine secretion in vitro","volume":"288","author":"Watzl","year":"1991","journal-title":"Adv Exp Med Biol"},{"key":"10.1124\/pr.58.3.2_REF1277","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000126646","article-title":"Effect of the brain constituent anandamide, a cannabinoid receptor agonist, on the hypothalamo-pituitaryadrenal axis in the rat","volume":"59","author":"Weidenfeld","year":"1994","journal-title":"Neuroendocrinology"},{"key":"10.1124\/pr.58.3.2_REF1278","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0022-3565(25)39420-6","article-title":"Oral alcohol self-administration stimulates dopamine release in the rat nucleus accumbens: genetic and motivational determinants","volume":"267","author":"Weiss","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.58.3.2_REF1279","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.0105-2896.2005.00264.x","article-title":"The immune system, amyloid-\u03b2 peptide, and Alzheimer\u2019s disease","volume":"205","author":"Weksler","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1124\/pr.58.3.2_REF1280","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0022-3565(25)10720-9","article-title":"Antinociceptive activity of intrathecally administered cannabinoids alone and in combination with morphine in mice","volume":"262","author":"Welch","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.58.3.2_REF1281","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1006\/bbrc.1997.7222","article-title":"Arachidonyl ethanolamide (anandamide) activates the parvocellular part of hypothalamic paraventricular nucleus","volume":"237","author":"Wenger","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/pr.58.3.2_REF1282","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0306-4522(94)90511-8","article-title":"Cannabinoid receptor binding and messenger RNA expression in human brain: an in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer\u2019s brains","volume":"63","author":"Westlake","year":"1994","journal-title":"Neuroscience"},{"key":"10.1124\/pr.58.3.2_REF1283","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.fertnstert.2005.08.027","article-title":"Effects of \u0394-9-tetrahydrocannabinol, the primary psychoactive cannabinoid in marijuana, on human sperm function in vitro","volume":"85","author":"Whan","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1124\/pr.58.3.2_REF1284","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejphar.2005.10.043","article-title":"A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833","volume":"528","author":"Whiteside","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1285","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0014-2999(93)90646-Y","article-title":"\u03949-Tetrahydrocannabinol and anandamide enhance the ability of muscimol to induce catalepsy in the globus pallidus of rats","volume":"250","author":"Wickens","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1286","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/sj.bjp.0706157","article-title":"CB1 cannabinoid receptor-mediated modulation of food intake in mice","volume":"145","author":"Wiley","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1287","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s002130050953","article-title":"Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors","volume":"143","author":"Williams","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pr.58.3.2_REF1288","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0091-3057(01)00694-3","article-title":"Reversal of \u03949-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine","volume":"71","author":"Williams","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pr.58.3.2_REF1289","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0031-9384(98)00170-X","article-title":"Hyperphagia in prefed rats following oral \u03949-THC","volume":"65","author":"Williams","year":"1998","journal-title":"Physiol Behav"},{"key":"10.1124\/pr.58.3.2_REF1290","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejphar.2006.04.003","article-title":"Time course of the enhancement and restoration of the analgesic efficacy of codeine and morphine by delta(9)-tetrahydrocannabinol","volume":"539","author":"Williams","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1291","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1136\/thx.31.6.720","article-title":"Bronchodilator effect of \u03941-tetrahydrocannabinol administered by aerosol of asthmatic patients","volume":"31","author":"Williams","year":"1976","journal-title":"Thorax"},{"key":"10.1124\/pr.58.3.2_REF1292","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev.immunol.17.1.255","article-title":"Immunologic basis of antigen-induced airway hyperresponsiveness","volume":"17","author":"Wills-Karp","year":"1999","journal-title":"Annu Rev Immunol"},{"key":"10.1124\/pr.58.3.2_REF1293","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0896-6273(01)00372-5","article-title":"Presynaptic specificity of endocannabinoid signalling in the hippocampus","volume":"31","author":"Wilson","year":"2001","journal-title":"Neuron"},{"key":"10.1124\/pr.58.3.2_REF1294","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/35069076","article-title":"Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses","volume":"410","author":"Wilson","year":"2001","journal-title":"Nature (Lond)"},{"key":"10.1124\/pr.58.3.2_REF1295","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1126\/science.1063545","article-title":"Endocannabinoid signaling in the brain","volume":"296","author":"Wilson","year":"2002","journal-title":"Science (Wash DC)"},{"key":"10.1124\/pr.58.3.2_REF1296","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0162-3109(94)90056-6","article-title":"Suppression of experimental autoimmune encephalomyelitis by cannabinoids","volume":"28","author":"Wirguin","year":"1994","journal-title":"Immunopharmacology"},{"key":"10.1124\/pr.58.3.2_REF1297","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nrn1406","article-title":"Dopamine, learning and motivation","volume":"5","author":"Wise","year":"2004","journal-title":"Nat Rev Neurosci"},{"key":"10.1124\/pr.58.3.2_REF1298","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.tips.2005.10.006","article-title":"A therapeutic role for cannabinoid CB1 receptor antagonists in major depressive disorders","volume":"26","author":"Witkin","year":"2005","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/pr.58.3.2_REF1299","doi-asserted-by":"crossref","first-page":"6362","DOI":"10.1073\/pnas.0510418103","article-title":"Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection","volume":"103","author":"Witting","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.58.3.2_REF1300","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1073\/pnas.0306707101","article-title":"P2X7 receptors control 2-arachidonoylglycerol production by microglial cells","volume":"101","author":"Witting","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.58.3.2_REF1301","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jpainsymman.2004.07.011","article-title":"Cannabis use in HIV for pain and other medical symptoms","volume":"29","author":"Woolridge","year":"2005","journal-title":"J Pain Symptom Manage"},{"key":"10.1124\/pr.58.3.2_REF1302","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.gastro.2005.05.026","article-title":"Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing","volume":"129","author":"Wright","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1124\/pr.58.3.2_REF1303","doi-asserted-by":"crossref","first-page":"334S","DOI":"10.1002\/j.1552-4604.1981.tb02612.x","article-title":"The antinociceptive effects of intrathecally administered levonantradol and desacetyllevonantradol in the rat","volume":"21","author":"Yaksh","year":"1981","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1304","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/nm788","article-title":"Adiponectin stimulates glucose utilization and fattyacid oxidation by activating AMP-activated protein kinase","volume":"8","author":"Yamauchi","year":"2002","journal-title":"Nat Med"},{"key":"10.1124\/pr.58.3.2_REF1305","doi-asserted-by":"crossref","first-page":"7877","DOI":"10.1073\/pnas.0602661103","article-title":"Adenosine A2a blockade prevents synergy between \u03bc-opiate and cannabinoid CB1 receptors and eliminates heroin-seeking behavior in addicted rats","volume":"103","author":"Yao","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.58.3.2_REF1306","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/(SICI)1096-9861(19991206)415:1<80::AID-CNE6>3.0.CO;2-H","article-title":"Immunocytochemical localization of cannabinoid CB1 receptor and fatty acid amide hydrolase in rat retina","volume":"415","author":"Yazulla","year":"1999","journal-title":"J Comp Neurol"},{"key":"10.1124\/pr.58.3.2_REF1307","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1017\/S0952523800173079","article-title":"Cannabinoid receptors on goldfish retinal bipolar cells: electron-microscope immunocytochemistry and whole-cell recordings","volume":"17","author":"Yazulla","year":"2000","journal-title":"Vis Neurosci"},{"key":"10.1124\/pr.58.3.2_REF1308","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1089\/neu.1996.13.49","article-title":"HU-211, a nonpsychotropic cannabinoid, produces short- and long-term neuroprotection after optic nerve axotomy","volume":"13","author":"Yoles","year":"1996","journal-title":"J Neurotrauma"},{"key":"10.1124\/pr.58.3.2_REF1309","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1523\/JNEUROSCI.0054-06.2006","article-title":"Localization of diacylglycerol lipase-\u03b1 around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidinoyl-glycerol, and presynaptic cannabinoid CB1 receptor","volume":"26","author":"Yoshida","year":"2006","journal-title":"J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF1310","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000087361","article-title":"Endogenous cannabinoid receptor agonists inhibit neurogenic inflammations in guinea pig airways","volume":"138","author":"Yoshihara","year":"2005","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1124\/pr.58.3.2_REF1311","first-page":"S115","article-title":"The cannabinoids in MS study\u2014final results from 12 months follow-up","volume":"109","author":"Zajicek","year":"2004","journal-title":"Mult Scler"},{"key":"10.1124\/pr.58.3.2_REF1312","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0140-6736(03)14738-1","article-title":"Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial","volume":"362","author":"Zajicek","year":"2003","journal-title":"Lancet"},{"key":"10.1124\/pr.58.3.2_REF1313","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0042-6989(02)00494-7","article-title":"Dexanabinol (HU-211) has a beneficial effect on axonal sprouting and survival after rat optic nerve crush injury","volume":"43","author":"Zalish","year":"2003","journal-title":"Vision Res"},{"key":"10.1124\/pr.58.3.2_REF1314","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.1523\/JNEUROSCI.3554-05.2006","article-title":"Two brain sites for cannabinoid reward","volume":"26","author":"Zangen","year":"2006","journal-title":"J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF1315","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0920-9964(93)90032-E","article-title":"Current cannabis use and tardive dyskinesia","volume":"11","author":"Zaretsky","year":"1993","journal-title":"Schizophr Res"},{"key":"10.1124\/pr.58.3.2_REF1316","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1021\/jm00356a017","article-title":"New antihypertensive cannabinoids","volume":"26","author":"Zaugg","year":"1983","journal-title":"J Med Chem"},{"key":"10.1124\/pr.58.3.2_REF1317","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.pnpbp.2003.11.005","article-title":"Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia","volume":"28","author":"Zavitsanou","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1124\/pr.58.3.2_REF1318","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0304-3940(99)00762-4","article-title":"Chronic l-DOPA treatment increases striatal cannabinoid CB1 receptor mRNA expression in 6-hydroxydopamine-lesioned rats","volume":"276","author":"Zeng","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1124\/pr.58.3.2_REF1319","first-page":"1071","article-title":"Marijuana use and increased risk of squamous cell carcinoma of the head and neck","volume":"8","author":"Zhang","year":"1999","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1124\/pr.58.3.2_REF1320","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/0192-0561(92)90017-F","article-title":"Inhibition by \u0394-9-tetrahydrocannabinol of tumor necrosis factor \u03b1 production by mouse and human macrophages","volume":"14","author":"Zheng","year":"1992","journal-title":"Int J Immunopharmacol"},{"key":"10.1124\/pr.58.3.2_REF1321","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0192-0561(95)00107-7","article-title":"\u0394-9-Tetrahydrocannabinol suppresses tumor necrosis factor \u03b1 maturation and secretion but not its transcription in mouse macrophages","volume":"18","author":"Zheng","year":"1996","journal-title":"Int J Immunopharmacol"},{"key":"10.1124\/pr.58.3.2_REF1322","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4049\/jimmunol.165.1.373","article-title":"\u0394-9-Tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway","volume":"165","author":"Zhu","year":"2000","journal-title":"J Immunol"},{"key":"10.1124\/pr.58.3.2_REF1323","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.neuropharm.2005.01.005","article-title":"Cannabinoids produce neuroprotection by reducing intracellular calcium release from ryanodine-sensitive stores","volume":"48","author":"Zhuang","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.58.3.2_REF1324","doi-asserted-by":"crossref","first-page":"9499","DOI":"10.1523\/JNEUROSCI.21-23-09499.2001","article-title":"Absence of \u0394-9-tetrahydrocannabinol dysphoric effects in dynorphin-deficient mice","volume":"21","author":"Zimmer","year":"2001","journal-title":"J Neurosci"},{"key":"10.1124\/pr.58.3.2_REF1325","doi-asserted-by":"crossref","first-page":"5780","DOI":"10.1073\/pnas.96.10.5780","article-title":"Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice","volume":"96","author":"Zimmer","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.58.3.2_REF1326","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1590\/S0100-879X2006000400001","article-title":"Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug","volume":"39","author":"Zuardi","year":"2006","journal-title":"Braz J Med Biol Res"},{"key":"10.1124\/pr.58.3.2_REF1327","first-page":"485","article-title":"Antipsychotic effect of cannabidiol","volume":"56","author":"Zuardi","year":"1995","journal-title":"J Clin Psychiatry"},{"key":"10.1124\/pr.58.3.2_REF1328","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF00432554","article-title":"Action of cannabidiol on the anxiety and other effects produced by \u03949-THC in normal subjects","volume":"76","author":"Zuardi","year":"1982","journal-title":"Psychopharmacology"},{"key":"10.1124\/pr.58.3.2_REF1329","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0006-2952(02)01604-0","article-title":"Suppression of human monocyte interleukin-1\u03b2 production by ajulemic acid, a nonpsychoactive cannabinoid","volume":"65","author":"Zurier","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1330","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/1529-0131(199801)41:1<163::AID-ART20>3.0.CO;2-9","article-title":"Dimethylheptyl-THC-11 oic acid: a nonpsychoactive antiinflammatory agent with a cannabinoid template structure","volume":"41","author":"Zurier","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1124\/pr.58.3.2_REF1331","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0014-2999(00)00207-7","article-title":"The anandamide transport inhibitor AM404 activates vanilloid receptors","volume":"396","author":"Zygmunt","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.58.3.2_REF1332","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/22761","article-title":"Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide","volume":"400","author":"Zygmunt","year":"1999","journal-title":"Nature (Lond)"}],"container-title":["Pharmacological Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699724116857?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699724116857?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/pr.58.3.2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T08:14:19Z","timestamp":1738570459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031699724116857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":1332,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0031699724116857"],"URL":"https:\/\/doi.org\/10.1124\/pr.58.3.2","relation":{},"ISSN":["0031-6997"],"issn-type":[{"value":"0031-6997","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Endocannabinoid System as an Emerging Target of Pharmacotherapy","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/pr.58.3.2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}